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Abstract 
 
 The first study was looking into the phytochemical analysis of herbal 
medicinal plant from Malaysia. Phenolic compounds in an aqueous infusion from 
leaves of Ficus deltoidea (Moraceae), a well-known herbal tea in Malaysia, were 
analysed by HPLC coupled to photodiode-array and fluorescence detectors and 
an electrospray ionization tandem mass spectrometer. Following chromatography 
of extracts on a reverse phase C12 column 25 flavonoids were characterized 
and/or tentatively identified, with the main constituents being flavan-3-ol 
monomers, proanthocyanidins and C-linked flavone glycosides. The 
proanthocyanidins were dimers and trimers comprising (epi)catechin and 
(epi)afzelechin units. No higher molecular weight proanthocyanidin polymers were 
detected. The antioxidant activity of F. deltoidea extract was analysed using HPLC 
with on-line antioxidant detection.  This revealed that 85% of the total antioxidant 
activity of the aqueous F. deltoidea infusion was attributable to the flavan-3-ol 
monomers and the proanthocyanidins 
 
 In terms of the bioavailability of hydroxycinnamates with the high 
occurrence of p-coumaroylquinic acid in F. deltoidea extract, further study was 
carried out using radiolabeled caffeic acid. In the study, male Sprague-Dawley rats 
ingested 140 x 106 dpm of [3-14C]trans-caffeic acid and over the ensuing 72 h 
period body tissues, plasma, urine and faeces were collected and the overall 
levels of radioactivity determined. Where sufficient radioactivity had accumulated 
samples were analysed by HPLC with on-line radioactivity and tandem mass 
spectrometric detection. Nine labeled compounds were identified, the substrate 
and its cis isomer, 3-O- and 4-O-sulphates and glucuronides of caffeic acid, 4-O-
sulphates and glucuronides of ferulic acid and isoferulic acid-4-O-sulphate. Four 
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unidentified metabolites were also detected. After passing down the 
gastrointestinal tract the majority of the radiolabeled metabolites were excreted in 
urine with minimal accumulation in plasma. Only relatively small amounts of 
unidentified 14C-labeled metabolites were expelled in faeces. There was little or no 
accumulation of radioactivity in body tissues, including the brain. The overall 
recovery of radioactivity 72 h after ingestion of [3-14C]caffeic acid was ~80% of 
intake.   
The role of colonic microflora in the metabolism of caffeic acid was carried 
using an in vitro model of the human colonic microflora. Caffeic acid (55 µmoles) 
was incubated with human faecal materials obtained from five Asian donors, and 
caffeic acid degradation was monitored from 0-8 h. Faecal samples were analysed 
by GC-MS, where major phenolic acids identified were dihydrocaffeic acid, 3-(3-
hydroxyphenyl)propionic acid and phenylacetic acid. Caffeic acid was quickly 
degraded by the colonic microflora, as it disappeared after 4 h of incubation in two 
of the faecal samples. The degree of degradation of caffeic acid was significantly 
influenced by the addition of glucose as well as individual variations in the density 
and the composition of microflora. These findings support extensive metabolism of 
caffeic acid in the colon, depending on the substrate concentration and the 
supplement of glucose which resulting the formation of simple phenolics.
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1 GENERAL INTRODUCTION 
1.1 Herbal medicinal plants  
Plants have been used as medicinal remedies long before recorded history. 
Ancient Chinese and Egyptian writing describe medicinal uses of plants. In China 
the first ever documented information about the use of herbal remedies was 
carried out by the legendary Shen Nong, believed to be the father of Chinese 
medicine, who lived around 2000 B.C (Frederick, 1973). Ibn Sina (known in 
Europe as Avicenna), a Persian who worked as a pharmacist and physician in 
Egypt, is well known for his definitive medical work, Canon Medicine which was 
used as  a standard medical text up to 1650 in many medieval universities 
including the  universities of Montpellier and Lueven (Britannica, 2012). In Canon 
Medicine or The Canon, he describes some 760 medicinal plants and drugs that 
could be derived from them (Tschanz, 2003). By definition herbal medicines 
include herbs, herbal material, herbal preparations and commercial herbal 
products, that contain as active ingredients parts of plants, or other plants 
material or combinations (WHO, 2000). 
In the early 19th century, when chemical analyses first become available, 
scientists started to extract potential active compounds from herbal plants. 
Subsequently, developments in synthetic chemistry reduced the use of herbal 
plants in modern medicine. More recently, however, in a number of countries 
including Malaysia, there has been a renewed interest in the phytochemicals 
that occur in herbal medicinal plants which are being used increasingly as 
alternative treatments in health care, as in many instances modern medicines 
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and drugs are not only expensive but can also be associated with adverse side 
effects. 
 Recently, the World Health Organization estimated that ~80% of the world 
population is using herbal medicines as a part of their primary care (WHO, 2001). 
In the USA the increased cost of prescription medications, together with an 
interest in returning to natural products or organic remedies, has led to 
approximately 20% of the population using herbal products (Bent, 2008). 
Worldwide consumption of herbal medicines has increased markedly, and it has 
been estimated by the Secretariat of the Convention on Biological Diversity, that 
global sales of herbal products reached $60 billion in 2000 (WHO, 2003). 
 Natural products are major sources for drug development, with 
approximately one-third of top-selling drugs have been derived from plant 
ingredients (Strohl, 2000). Although knowledge of these plant ingredients is 
increasing, information on their mode of action and clinical pharmacology is still 
scarce, which limits the efforts for standardization, evaluation and further 
utilization of herbal remedies (Ma et al., 2009).  
1.2 Trend of herbal remedies in Malaysia 
Malaysia is among the countries which favour the use of herbal medicines in 
primary care. Because of the large diversity of plant species, reported to be the 
twelfth largest in the world, Malaysia has a massive resource of potential 
medicinal plants (Noridayu et al., 2011). It was reported that about 12,000 
flowering plants may to have potential health promoting properties, however 
only 1,300 species have been identified for medicinal purposes (Jamal et al., 
2010). Herbal plants have been the basis of traditional medicines throughout the 
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world and in Malaysia they have been utilized by three major ethnics groups: the 
Malay community through shaman and midwives, traditional Chinese herbal 
medicines, and Ayurveda by Indians (WHO, 2001). The knowledge of the use of 
herbal and medicinal plants has been passed from one generation to another 
with some of these medications being self-prescribed for health maintenance, 
treatment, and prevention of minor ailments and also for chronic illness (Siti et 
al., 2009). 
In Malaysia, the use of herbal and medicinal plants for various applications 
either for prevention, healing and treatment of certain diseases has been well 
recognized as alternative medications alongside modern medicines. These 
traditional medications have come together under Traditional of Complementary 
Medicine (TCAM) a body which has been formed by Ministry of Health, Malaysia. 
The Ministry of Health offers TCAM in some of the public hospitals as an 
alternative medication to the patients, including treatments such as 
acupuncture and massage. The important of TCAM has been recognized by 
WHO(2001), as it reported that 50-80% of the population of developed and 
developing countries use some form of TCAM for prevention and promotion of 
health, with most of them relying on herbal plants. 
Nowadays, herbal uses are not only restricted for healing and treatment 
purposes, but also extended on a worldwide basis to cosmetics and 
nutraceuticals. In Malaysia, herbal products have generated substantial income. 
In the years 2000 to 2005 the annual sales for traditional medicines increased 
from US$ 385 million (RM 1 billion) to US$ 1.29 billion (RM 4.5 billion) (BERNAMA, 
2011). The high demand for the herbal products has encouraged farmers to 
cultivate selected herbal medicinal plants on a large scale. This kind of 
Chapter 1 2013 
 
4 
 
plantation not only supplies the raw materials needed on a large scale but also 
helps to sustain the supply, since the natural habitats of these plants are now 
under the threat of deforestation. The Government of Malaysia has also 
introduced a scheme known as “one district one industry” that encourages 
people in villages either to invest in the small industry or to grow herbal plants, 
starting in their own gardens, which indirectly has increased the local people’s 
knowledge of the uses of these plants and promoted their increased use as local 
medicines.  
However, despite the huge demand for herbal products there is the 
drawback of a lack of scientific evidence about their efficacy. The major 
concern is their safety and actual impact on human health. Vast numbers of 
commercial herbal medicines have not been thoroughly checked and submitted 
to rigorous scientific testing and qualities of the ingredients used are not 
standardized. This is a problem not just in Malaysia but also in Europe and 
America.  Although herbal products are considered natural as they are of plant 
origin, it does not mean that they are harmless. Certain plants contain toxins as 
protectants. Compounds such as alkaloids, apiole and certain lignans are toxic to 
the liver, terpenes and saponins to the  kidneys, and sesquiterpene  lactones and 
furanocumarins can adversely affect the skin (Capasso et al., 2000). There is also 
the possibility that herbal remedies might contain added adulterants and inferior 
ingredients (Zhang et al., 2012). Therefore precautionary steps must be taken 
before a plant or a product can be safely being prescribed as a medicinal 
remedy. The safety of herbal remedies is of particular importance since most of 
these products are self-prescribed and patients rarely notify their doctor about 
their use. As a further complication, many herbal products sold as dietary 
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supplements lack toxicological data and reliable information on their clinical 
efficacy. 
These circumstances have led to more focused research being carry out by 
research institutes such as MARDI (Malaysia Agricultural Research and 
Development Institute), FRIM (Forest Research Institute Malaysia), IMR (Institute 
for Medical Research) and also by local universities, in terms of phytochemical 
analysis of potential herbal medicinal plants in order to evaluate their safety 
and effectiveness and define and verify their therapeutic values. Such research 
will also help to achieve an overall improvement in the standard and quality of 
herbal medicines. These scientific findings when combined with traditional 
knowledge from local practitioners will generate information on drug-targeted 
biochemicals from herbal plants which will be of value to both local traders and 
the pharmaceutical industry. 
1.3 Phenolic compounds from medicinal herbs and 
dietary plants 
Secondary metabolites are chemical compounds produced exclusively by 
plants.They are synthesized for protection against herbivores, microbial and 
viral pests, as colouring agents, scent, or attractants and also as hormones 
(Jaganath et al., 2009). Many of these phytochemicals, including terpenoids, 
alkaloids and phenolics, have been found to have an impact on human health 
(Pandey and Rizvi, 2009). In contrast, primary metabolites, such as sugars, fats, 
and amino acids are the nutrients that are essential for plants growth and 
development. In recent times plant secondary metabolites have become of 
increasing scientific interest due to their beneficial effects on human health. 
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This can be seen from the large number of publications focusing on 
phytochemicals, their in vitro and in vivo activities and their potential impact on 
human health (Scalbert et al., 2005). 
Phenolics are a class of chemical compounds having at least one aromatic 
ring with one or more hydroxyl group attached to it. They are synthesized 
exclusively in plants from L-tyrosine or L-phenylalanine + malonyl-CoA via the 
shikimate pathway. These important dietary constituents include simple and low 
molecular weight compounds such as hydroxybenzoic acids, phenylpropanoids, 
(hydroxycinnamic acids), flavonoids (three-ring hydroxylated polyphenols- which 
are synthesized by the pathways illustrated in Figure 1.1), complex derivativies 
such as tannins and derived polyphenols such as theaflavins and thearubigins 
which are not present in the leaves of Camellia sinsensis but form during the 
fermentation process that converts green tea to black tea (Miller and Ruiz-
Larrea, 2002).  
Some plant secondary metabolites are believed to be produced as a result 
of the plant’s interaction with the environment, such as their response to stress 
and defense against bacterial and viral pathogens. In humans they appear to 
have desirable medicinal effects, with antioxidant and anticancer properties. In 
nature, phenolics are usually found conjugated to sugars and organic acids and 
can be classified into two groups: flavonoid and non-flavonoid compounds which 
consist of hydroxycinnamics, hydrolysable tannins, stilbenes and lignans (Table 
1.1). 
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Figure 1. 1 Schematic diagram of the main pathways and enzymes involved for the synthesis of 
flavonoids and stilbenes. Enzymes abbreviations: SS-stilbenes synthase, CHS-chalcone synthase, 
CHR-chalcone reductase, CHI-chacole isomerise, IFS-isoflavone synthase, FNS-flavones 
synthase, FLS-flavonol synthase, DFR-dhydroflavonol 4-reductase, ANS-anthocyanidin 4-
reductase, F3H- flavanone 3-hydroxylase, F3H-flavonol 3-hydroxylase, LAR-leucocyanidin 4-
reductase, LDOX-leucocyanidin deoxygenase, ANR- anthocyanidin reductase, EU-extension  units, 
TU-terminal unit. 
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Table 1.1 Main classes of phenolic compound  
Classes and subclasses  Examples of specific compounds 
Flavonoids 
Flavonols    Kaempferol, quercetin, myricetin 
Flavones    Apigenin, luteolin 
Flavanones    Naringenin, hesperetin 
Flavan-3-ols    Catechins, gallocatechin 
Anthocyanidins   Pelargonidin, cyanidin, malvidin 
Isoflavones    Daidzein, genistein, glycitein 
Condensed tannins   Trimeric procyanidin, prodelphinidin 
Non-flavonoids 
Phenolic acids   Gallic, protocatechuic, p-hydroxybenzoic acids             
Hydroxycinnamates   Coumaric, caffeic, ferulic, sinapic acids 
Hydrolyzable tannins  Pentagalloylglucose, sanguiin H-6 
Stilbenes    Resveratrol 
Lignans    Secoisolariresinol, matairesinol 
 
1.3.1 Flavonoids 
Flavonoids are a group of more than 4,000 phenolic compounds and 
are ubiquitous in nature (Iwashina, 2000). They are present in fruits, 
vegetables, and beverages including tea, fruit juices, wines and herbs. 
They occur in all parts of plants but are not synthesized by humans or 
fungi. These compounds play an important role in plant development, 
defense and pollination and they are responsible for the attractive colours 
of flowers, fruit, and leaves, (de Groot and Rauen, 1998). It has been 
estimated 1 x 109 tonnes of flavonoids and related compounds are produced 
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annually by plants, this is equivalent to about 2% of all photosynthesized 
carbon (Andrew and John, 2011). 
  Flavonoids occur primarily conjugated with either one or more 
sugar residues that are linked to hydroxyl groups, but association with 
other compounds including carboxylic and organic acids, amines and lipids 
also takes place. Flavonoids with sugar moieties are referred as the 
flavonoids glycosides whereas aglycones are flavonoids without a sugar 
moiety. Flavonoids occur predominantly in planta as glycosides. 
Glycosylation increases their solubility in water facilitating their storage in 
vacuoles of flowers, leaves, stems and roots (Cuyckens and Claeys, 2004). 
Flavonoids occur as O- or C-linked glycosidic conjugates. Although any 
hydroxyl group can be glycosylated, certain positions are favoured: e.g. the 
7-hydroxyl group in flavones, flavonones and isoflavones, the 3- and 7-
hydroxyls in flavonols and flavan-3-ols, and the 3- and 5-hydroxyls in 
anthocyanidins (Cavaliere et al., 2005). 
The structures of flavonoids are based on the flavonoid nucleus, which 
consists of three phenolics rings. These (poly)phenolic compounds possess 
15 carbon atoms represented as C6-C3-C6 structure. The basic structure 
allows for a magnitude of substitution patterns in the A, B and C rings. 
Flavonoids are classified into several sub-classes depending on the degree 
of unsaturation and oxidation of basic 15-carbon skeleton. The main groups 
of dietary importance are flavones, flavonols, flavan-3-ols, flavanones, 
anthocyanidins and isoflavones. The basic chemical structures of these six 
classes of flavonoids are illustrated in Figure 1.2. 
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                         Figure 1. 2  Basic structures of flavonoids. 
 
1.3.1.1 Flavonols 
Flavonols are a major class of flavonoids with a hydroxyl group at the 3-
position (Figure 1.3). They exist mainly as conjugated glycosides in plants. 
Glucose and galactose are the most common sugar moieties, while less 
common are rutinose, arabinose, xylose and rhamnose. Quercetin and 
kaempferol are flavonols that occur in many fruits, leaves and vegetables, 
isorhamnetin occurs in onions and pears and myricetin in berries, maize 
and tea (Hertog et al., 1993). This group of compounds were reported to 
have an effect on certain type of such viruses such as herpex virus, 
respiratory syncytical virus, parainfluenza virus and adenovirus. This 
antiviral activity of quercetin includes antiinfective and antireplicative 
capabilities (Wang et al., 1998). 
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Figure 1. 3 Structures of common flavonols. 
 
1.3.1.2 Flavan-3-ols 
Flavan-3-ols are complex subclasses of flavonoids comprising of 
monomers, oligomers and polymeric proanthocyanidins. One example of 
monomeric flavan-3-ols is (+)-catechin  that can exist together with its 
isomer (–)-epicatechin, these monomers are abundant in ripe fruits, leaves, 
tea and red wine (Manach et al., 2004). The beneficial effects of green tea 
are attributed to the presence of flavan-3-ols which represent 30-40% of 
the dry weight of the leaf (Wang and Ho, 2009). Predominantly flavan-3-ol 
monomers found in green tea are (–)-epigallocatechin, (–)-epicatechin-3-O-
gallate and (–)-epigallocatechin-3-O-gallate (Del Rio et al., 2004) (Figure 
1.4).  
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Figure 1. 4 Structures of flavan-3-ols monomers. 
 
Tea is categorized based on the type of fermentation which occurs 
during the manufacturing process; ‘non-fermented’ green tea refers to 
drying and steaming the fresh leaves to inactivate polyphenol oxidase 
activity. Preparation of ‘semi fermented’ oolong tea involves subjecting 
the green leaves a partial fermentation prior to drying. ‘Fermented’ black 
and red (Pu-Erh) teas, have undergone a post-harvest full fermentation 
before drying and steaming (Cabrera et al., 2006). With black tea, 
oxidation is catalyzed by polyphenol oxidase activity, whereas 
microorganisms are used in the manufacture of red tea (Wu and Wei, 
2002). During fermentation the polyphenolic compounds come into contact 
with polyphenol oxidases and flavan-3-ols are converted to theaflavins and 
thearubigins. As result, black teas contain high amounts of theaflavins and 
thearubigins, compounds that do not occur in green tea (Figure 1.5). 
Thearubigins are brownish in colour, water soluble and have a high 
molecular weight, and are the major phenolic compound of black tea. 
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Figure 1. 5 Fermentation to produce black tea results in polyphenol oxidase catalysed 
reactions that transform flavan-3-ol monomers to dimer-like theaflavins and the polymeric 
thearubigins. 
 
1.3.1.3 Flavanones 
Flavanones are abundant in citrus fruits. Hesperetin (3,5,7-trihydroxy-
4-methoxyflavanone) is found principally as its rhamnose-glucose 
conjugate, hesperetin-7-O-rutinoside (hesperidin) (Figure 1.6), in oranges 
and some herbs (Ignat et al., 2011). Other flavanone aglycones include 
naringenin (Figure 1.6) (4,5,7-trihydroxyflavanone) and eriodictyol 
(3,4,5,7,-tetrahydroxyflavanone). Flavanone rutinosides are tasteless. In 
contrast, flavanone neohesperidoside conjugates, such as hesperetin-7-O-
neohesperidoside (neohesperidin) from bitter orange (Citrus aurantium) 
and naringenin-7-O-neohesperidoside (naringen) from grapefruit (Citrus 
paradisi), have an intensely bitter taste (Tomás-Barberán and Clifford, 
2000).  Flavanones are usually conjugated with a disaccharide at C-7, and 
their levels vary depending on the part of citrus fruit, with highest 
concentrations occurring in the peel (Chanet et al., 2012). This sub-class of 
flavonoids are reported to exert many beneficial health effects on human 
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possessing antioxidant, cardioprotective and anti-carcinogenic properties 
(Rice-Evans et al., 1996; Chanet et al., 2012). 
 
Figure 1. 6 Structures of hesperidin and naringin, flavanone glycosides. 
 
1.3.1.4 Flavones 
Flavones occur principally in herbs. They can be found in all parts of the 
plant, above-and below ground, in vegetative and generative organs: stem, 
leaves, buds, bark, heartwood, thorns, rhizomes, flower, farina, fruits, 
seed and also in roots and leaf exudates (Martens and Mithöfer, 2005). The 
main flavones are apigenin (4,5,7-trihydroxyflavone) which occurs in 
vegetables such as celery, and luteolin (3,4,5,7-tetrahydroxyflavone) a 
component of green peppers (Hertog et al., 1992) (see Figure 1.7). 
Flavones are found as both O-or C-glycosides, (Wu et al., 2004b). This class 
of flavonoid has a double bond between carbon 2 and carbon 3 in the C-ring 
of the flavan skeleton with usually no substituent at C3. They are 
synthesized via the anthocyanidin/proanthocyanidin pathway with 
flavanones as the immediate precursor (Fig. 1.1).   
Flavones have antioxidant, antimutagenic, anti-cancer and anti-HIV 
properties (Williams et al., 1999). Epidemiological and animal studies 
suggest that a high dietary intake of flavonoids, including flavones, has 
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been reported to have protective effects against several degenerative 
diseases, such as lung and colon cancer, coronary heart disease, chronic 
inflammation, and osteoporosis (Elliott et al., 2000).The effects of flavones 
as antiproliferative agents have been studied extensively using several 
tumour cell lines. It was reported that flavones such as apigenin have a 
significant effect in inhibiting the growth of human carcinoma cells 
(Kathirvel et al., 2009). 
 
Figure 1. 7 Structures of common flavones. 
1.3.1.5 Anthocyanins 
Anthocyanins are the glycoside form of anthocyanidins. The word 
anthocyanin is derived from the Greek anthos = flower and kianos = blue. 
Anthocyanins are pigments occurring in vegetables, leaves, flowers and 
fruits such as grapes, berries, apples, and are responsible for vibrant pink, 
red, violet and blue colorations (Charron et al., 2009). Anthocyanins are 
positively charged at acidic pH. In solution anthocyanins occurs in 
equilibrium with essentially four molecular forms: the flavylium cation, the 
quinodal base, the hemiacetal, and chalcone (Figure 1.8) (Cooke et al., 
2005), and their relative amounts vary with both pH and the structure of 
the individual anthocyanins. The stable flavylium anthocyanins only exist at 
pH <2. Their unique structures play an important role in determining their 
absorption, metabolism, bioavailability, and consequently biological 
responses to anthocyanins (Prior, 2012). 
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Figure 1. 8 Anthocyanin structures and pH induced transformations (Prior, 2012). 
 
The aglycones of anthocyanins are unstable and very susceptible to 
degradation. In plants, anthocyanins are glycosylated, typically with 
glucose at position 3, and esterified with various organic acids and phenolic 
acids. This glycosylation can stabilize anthocyanins and protect them from 
light, pH and oxidation conditions (Manach et al., 2004). A huge variety of 
anthocyanins occur in nature with the most common being glycosides of 
cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin and 
peonidin (Andersen and Jordheim, 2006) (Figure 1.9). 
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Figure 1. 9 Structures of aglycones and glycoside anthocyanins found in berries. 
 
In plants anthocyanins play an important role in defense against 
environmental stress factors, such as UV light, in attracting insect 
pollinators to flowers and animals to fruits which help dispense the seed. 
Plant colouring properties from anthocyanins are important as natural 
colorants of food and beverages. Anthocyanins have been reported to 
possess a variety of health benefits, such as anticancer, protective against 
cardiovascular disease, and anti-neurodegeneratives, and anti-
hyperglycemic effect (Matsui et al., 2002; Faria et al., 2010; Wallace, 
2011). 
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1.3.1.6 Isoflavones 
Isoflavones are produced almost exclusively by members of the 
leguminosae (specifically in the subfamily Papilionoideae) with the best-
known source being soybean (Manach et al., 2004). They also exist, albeit 
in much lower concentrations, in other botanical families such as 
Compositae, Iridaceae, Myristicaceae and Rosaceae (Dweck, 2006). 
Isoflavones can acts as steroidal mimics by filling the stereochemical space 
that is occupied by estrogenic compounds. In plants, isoflavones and their 
derivatives act as phytoalexins against pathogenic fungi and microbe 
infection, while in soybean they are involved in nitrogen fixation.  
A study has demonstrated that isoflavones have potent antioxidant 
properties comparable to that of vitamin E. Some of isoflavones possess 
anti-cancer activity, including certain types of breast cancer and prostate 
cancer. The isoflavones daidzein and genistein  (Figure 1.10) are found 
mainly in soy, soy products, legumes, and red clover (Peterson and Dwyer, 
1998). They are also detected in medicinal herbs of Leguminosae, such as 
Astragalus mongholicus (Cai et al., 2004). Daidzein is also classified as a 
phytoestrogen as it has estrogen-like activity. Daidzein glycosides, 
including daidzein-7-O-(6-O-malonyl)glucoside, are the second most 
abundant isoflavones in soybeans after genistein glycosides. Daidzein and 
genistein glycosides are normally found in nonfermented soy foods (tofu) 
while the aglycone predominates in fermented soy foods such as miso and 
tempeh (Zubik and Meydani, 2003). 
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Figure 1. 10  Structures of common isoflavone aglycones. 
 
1.3.2 Non-flavonoids  
The C6-C1 phenolic acids are important dietary non-flavonoids. The non-
flavonoid, gallic acid (3,4,5-trihydroxybenzoic acid) plays a major role in 
stabilizing and enhancing the colour of red wine, and also adds the flavour 
of the wine (Moreno-Arribas et al., 2009).  
1.3.2.1 Hydroxycinnamic acids 
Hydroxycinnamic acids are non-flavonoid compounds widely distributed 
in plants and are found in foodstuffs and beverages such as coffee, wine 
and fruit juices (Clifford, 2000). They have a basic C6-C3 structure, with one 
or more hydroxyl groups attached to the phenyl moiety, some of which may 
be methylated. p-Coumaric, caffeic, ferulic, and sinapic acids are the main 
representatives of dietary hydroxycinnamates (Figure 1.11) (Clifford, 2000; 
Manach et al., 2004). They occur both as free acids and esterified either 
with quinic acid, glucose, or carboxylic acids such as shikimic or tartaric 
acid (Herrmann and Nagel, 1989). Esterification of caffeic acid, ferulic and 
p-coumaric acid with quinic acid produces a family of compounds known as 
chlorogenic acids (Fig. 1.11). They are abundant in coffee beverage, 
artichoke, cherries, blueberries, aubergine and apples (Herrmann and 
Nagel, 1989; Clifford, 2000; Manach et al., 2004). 
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 In coffee, which is a major source of chlorogenic acids, the main sub-
classes are caffeoylquinic acids, dicaffeoylquinic acid, and feruloyquinic 
acids (Monteiro et al., 2007). It is estimated that 5-O-caffeoylquinic acid 
accounts for 35% of total caffeoylquinic acids in roasted coffee, which also 
contains dicaffeoylquinic acid isomers (Farah and Donangelo, 2006). 
Caftaric acid (2-O-caffeoyltartaric acid) is a caffeic acid-tartaric acid 
conjugate found in grapes, spinach, lettuce and wine (Clifford, 2000). 
Glycosylated hydroxycinnamic acids are found in kale, spinach, and 
tomatoes; malic acid esters occur in radishes and chicory, while rosmarinic 
acid esters, and are found in rosemary, oregano, thyme, and sage 
(Herrmann and Nagel, 1989). 
 
 
Figure 1. 11  Structure of common hydroxycinnamics and quinic acid conjugates. 
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Dietary hydroxycinnamates normally occur in the trans form although 
transition to cis form is readily induced by UV irradiation (Clifford et al., 
2008). The isomers of these hydroxycinnamic acids depend on the position 
to the ester linkage. 1-, 3-, 4-, or 5-O-Caffeoylquinic acid isomers have 
been identified. These compounds are major components in the human diet 
with coffee being the principal source (Clifford, 1999). They possess strong 
antioxidant activity (Williamson and Clifford, 2010) and there is 
considerable interest in their ability to inhibit various degenerative 
diseases as they have been reported to exert inhibitory effects against 
cardiovascular disease, diabetes mellitus and Alzheimer’s disease, as well 
as having antibacterial and anti-inflammatory properties (Lindsay et al., 
2002; Federico et al., 2004; Larrosa et al., 2009; Gordon and Wishart, 
2010). 
1.3.2.2 Lignans 
Lignans are one of the major classes of phytoestrogens, formed by two 
phenylpropane units (Fresco et al., 2006). Linseed is the main source of 
lignans, in the form of the lignanolides, secoisolariciresinol and 
matairesinol. Much lower levels of lignans are found in cereal, grains, fruit 
and certain vegetables (Milder et al., 2005). Plant lignans, such 
secoiolariciresinol diglucoside, which is found in flaxseed (Linum 
usitatissimum), is a precursor of the mammalian lignans, enterodiol and 
enterolactone, metabolites produced by the colonic microflora (Figure 
1.12). These metabolites have been reported to exert phytoestrogenic and 
antioxidant effects both in vivo and in vitro (Kitts et al., 1999; Prasad, 
2000). Cyclolignanolide, first identified in Podophyllum peltatum, is also 
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found in the Chinese medical plant Sinopodophyllum emodi which is well 
known as the source of the tumor therapy drug podophyllotoxin (Huang et 
al., 2009). 
 
Figure 1. 12 Colonic microflora metabolism of plant lignin secoisolariciresinol diglucoside 
into the aglycones enterodiol and enterolactone (Hu et al., 2007). 
 
1.3.2.3 Stilbenes 
Stilbenes are small group of phenylpropanoids which have C6-C2-C6 
structure. They can be either constitutive components, or induced in 
response to environmental stresses and are therefore known as 
phytoalexins, a class of antimicrobial compounds produced by plants as a 
defense against pathogens. They are very minor constituents in the human 
diet. Plants naturally contain stilbenes in both free and glycosylated forms 
(Figure 1.13). The most well known and well characterized stilbene is 
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resveratrol (3,5,4-trihydroxy-trans-stilbene) which is synthesized by 
condensation of 4-coumaryl CoA with three units of malonyl-CoA via 
shikimate pathway (Fig. 1.1). Resveratrol exists as trans and cis isomers, is 
commonly found in grapes, mulberries, and peanuts. It exerts a wide 
variety of pharmacological activities with anticancer and cardiovascular 
protective effects, prevention of ischemic injuries and extension the life 
expectancy of various organisms (Baur and Sinclair, 2006). Resveratrol was 
first isolated in 1963 from Polygonum cuspidatam, known as Ko-jo-kon in 
Japan, which is used by Asian traditional practitioners for treating 
suppurative dermatitis, gonorrhoea, favus and hyperlipemia (Saiko et al., 
2008). In addition to resveratrol, other stilbene structures include 
piceatannol, pinosylvin, rhapontigenin and ptestilbene (Roupe et al., 2006). 
 
Figure 1. 13  Structures of free and glycosylated resveratrol. 
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1.3.2.4 Tannins 
Tannins are water soluble, high molecular weight (ranging from 500-4000 
Da) polyphenolic compounds. They are the second most abundant group of  
natural phenolics after lignin and can be categorized as hydrolysable 
tannins (gallo and ellagitannins) (Aron and Kennedy, 2008) and condensed 
tannins (proanthocyanidins)(Cai et al., 2004)(see Figure 1.14). Ellagitannins 
differ from proanthocyanidins in their chemical structures and their 
occurrence. Hydrolysable tannins are derivatives of gallic acid and ellagic 
acid which are the main precursors of the more complex gallotannins and 
ellagitannins (Gross, 1992). Proanthocyanidins are oligomers and polymers 
of flavan-3-ols and are more and wide spread in the plant kingdom than 
hydrolysable tannins. Proanthocyanidins are major components in grapes, 
especially seeds, and cocoa while ellagitannins occur in fruits like 
strawberries, raspberries, blackberries, apples, and pomegranate (Clifford 
and Scalbert, 2000). Ellagitannins are esters of hexahydroxydiphenic acid 
and a polyol (glucose of quinic acid), and are converted to ellagic acid by 
acid or base hydrolysis. Tannin constituents with anticancer properties 
have been detected in many traditional Chinese medicinal plants (Cai et 
al., 2004). 
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Figure 1. 14  Structures of hydrolysable and condensed tannins. 
 
1.4 Dietary (poly)phenols 
Flavonoids and cinnamic acids are two important groups of dietary 
phenolics. The most reported sources of these dietary compounds are beverages 
such as tea (flavan-3-ols) and coffee (cinnamic acids) along with red wine and 
cocoa-based products (see Table 1.2). Tea, which is consumed in amounts only 
exceeded by water, is prepared from young leaves of Camellia spp. Annually 
~3.2 million metric tons of dried leaves were processed into black tea (78%),  
green tea (20%) and the rest of oolong tea (Crozier et al., 2009). One litre of 
strong black tea can provide ~0.5 g or more of phenolics, with flavanols and the 
derived flavan-3-ols theaflavins and thearubigins being the main constituents 
(Balentine et al., 1997).  
 
Chapter 1 2013 
 
26 
 
Table 1.2 Typical sources of dietary phenolic compounds 
Phenolic compounds Basic molecular structure Typical sources 
Flavan-3-ols 
Catechin 
Epicatechin 
 
 
Tea, red wine, and 
chocolate (Del Rio et al., 
2004) 
Flavanols 
Quercetin 
Myricetin 
 
 
Onion, broccoli, beans, 
apple and tea (Hertog et 
al., 1993) 
Flavones 
Apigenin 
Luteolin 
 
 
 Vegetables (red pepper 
and celery) (Hertog et al., 
1992) 
Anthocyanidins 
Pelargonidin 
Cyanidin 
Delphinidin 
Peonidin 
Malvidin 
 
 
Red fruits ( plum and 
grape) and berries 
(strawberry, raspberry, 
blueberry, blackberry, red 
and black currant) (Borges 
et al., 2010) 
Flavanones 
Naringin 
Hesperetin 
 
 
Citrus fruits (orange, lemon, 
limes and tangerines) 
(Peterson et al., 2006) 
Isoflavones 
Daidzein 
Genistein 
Glycitein 
 
 
 
Soyabeans and soy 
products  (Peterson and 
Dwyer, 1998) 
Hydroxycinnamates 
Chlorogenic  acids 
Ferulic acid 
 
 
 
Coffee, blueberry, apple 
and cider (Clifford, 1999) 
 
Tannins 
Ellagitannins 
Proanthocyanidins 
 
Pomegranate, raspberries, 
walnut and  wine (Crozier 
et al., 2006) . 
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Quercetin conjugates, the principal dietary flavonol, are particularly 
abundant in onions (0.3 mg/g fresh weight) and tea (10-25 mg/L) which are the 
main sources of flavonols in the Dutch diet (Hertog et al., 1993). Quercetin 
glycosides are also common in a wide variety of plants products (fruits, 
vegetables, cereals, legumes). It was reported that in the USA human dietary 
intake of flavones and flavonols is estimated to be ~20 to 22 mg/day (Sampson 
et al., 2002). Unlike quercetin, the isoflavones, daidzein and genistein occur 
almost exclusively in soya and soya products. The isoflavone content of soya and 
its derived products varies as a reflection of the geographic zone and growing 
conditions as well as processing methods (Manach et al., 2004). Soybeans contain 
between 580-3800 mg of isoflavones/kg fresh weight, and soymilk ~30 to 175 
mg/L (Reinli and Block, 1996). It has been estimated that ~10% of Asian 
population consumes 25 g of soy protein per day which corresponds to an 
isoflavone intake of 100 mg isoflavones (Messina et al., 2006). In Japan, the 
average dietary intake of isoflavones is 30-40 mg/day, which is higher than the 
amounts consumed in Western countries (Wakai et al., 1999). 
Anthocyanins are major dietary components for those who eat berries and 
drink red wine on the regular basis. One hundred gram of berries might contain 
up to 500 mg of anthocyanins, while serving 200 g of aubergine or black grapes 
can provide up to 1500 mg of athocyanins (Manach et al., 2005). In Finland, the 
mean dietary intake of anthocyanins has been estimated to be 82 mg/day, with 
berries, red wine and juices, and the colouring agent E163 as the main sources 
(Manach et al., 2005). 
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Citrus fruits are main dietary source of flavanones and their concentrations 
vary depending on the part of the fruit that is consumed. Citrus peels (albedo 
and flavedo), are richest in flavanones compared to the juices (Tomás-Barberán 
and Clifford, 2000). It has been estimated that the mean flavanone content in 
orange juice (hesperidin and narirutin) range between 14-77 mg/100 mL, 
whereas with grapefruit juices containing naringin intake was estimated to be 
17- 76 mg/100 mL (Ross et al., 2000; Tomás-Barberán and Clifford, 2000). The 
daily flavanone intake in French and German adults has been estimated to vary 
from 2.7 to 78 mg of aglycone equivalents (Erdman et al., 2007; Pérez-Jiménez 
et al., 2011). 
Flavones, mainly glycosides of luteolin and apigenin, have a limited 
distribution in fruits and vegetables, and as a consequence, their daily intake in 
different countries was estimated <1-2 mg/d, which is low compared to other 
flavonoids (Beecher, 2003).  
As noted previously, coffee is a very rich source of chlorogenic acids and as 
such ~70% of the world’s intake is through the consumption of coffee (Grigg, 
2002). 5-O-Caffeoylquinic acid is the main chlorogenic acid found in green coffee 
beans (Clifford, 1999). It was reported that one cup of instant coffee (200 mL) 
contains 50-150 mg of chlorogenic acid (Clifford, 1999). It has been reported 
that coffee contributes 92% of caffeic acid and 82% of the chlorogenic acid 
intake in Germany (Radtke et al., 1998). Hydroxycinnamic acids intake varies 
widely. Coffee drinkers can consume up to 500-800 mg/d while for people who 
did not drink coffee the amount is  >25 mg/d (Clifford, 2000). A recent study has 
shown that the caffeoylquinic acid content of a single serving of espresso coffee 
from high street coffee shops in Glasgow ranged from 24 to 322 mg (Crozier et 
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al., 2012b). This implies that for regular coffee drinkers may have a 
caffeoylquinic acid intake well in excess of 1 g/day. 
   It was reported that two thirds of the (poly)phenols consumed in the 
diets are flavonoids. The daily flavonoids intake in the USA population based on 
5 classes of flavonoids excluding isoflavones was reported as 1 g/d (Kühnau, 
1976), whereas for a Dutch population the total flavonoids intake might be  at 
least 75 mg/d (Arts et al., 2001). In the Spanish adult population, the total 
flavonoid intake was reported 313 mg/day, with proanthocyanidins as the main 
contributor and isoflavones as the lowest (Zamora-Ros et al., 2010).This 
indicates that the total (poly)phenol intake depends to a great degree on dietary 
habits and preferences.  
1.5 Beneficial health effects of dietary (poly)phenols  
Research on dietary flavonoids was awakened with the discovery of French 
Paradox (Renaud and de Lorgeril, 1992). The French Paradox is defined as a low 
incidence of coronary heart disease associated with a high fat diet and red wine 
consumption. It has been well established that (poly)phenol-rich foods and 
beverages may increase plasma antioxidant activity. Antioxidants have been 
associated with reduced levels of oxidative stress to lymphocytic DNA. 
Antioxidants will protect cell against oxidative damage and prevent the risk of 
various degenerative diseases. Numerous studies have shown that intake of 
(poly)phenols can prevent or reduce the deleterious effects of oxygen-derived 
free radicals. Elevated levels of reactive oxygen species can lead to clinical 
disorder such as arteriosclerosis, ischemia-reperfusion injury, cancer, stroke and 
neurodegenerative disorder (Gotz et al., 1994; Halliwell, 2001)                                                                                                                                                                      
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1.5.1 Cardiovascular disease 
Epidemiological studies have revealed that high consumption of fruits 
and vegetables is associated with a lowered risk of cardiovascular disease 
(CVD) (Dauchet et al., 2006). Such a diet contains high levels of 
(poly)phenolic compounds that inhibit the oxidation of low density 
lipoprotein (LDL) which initiates is associated with the development of 
atherosclerosis (Halliwell, 1989). (Poly)phenols act as antioxidants, have 
anti-platelet and anti-inflammatory effects, increase HDL and improve 
endothelial function. 
Consumption of flavanone-rich citrus fruit has been reported to have a 
strong inverse relationship with CVD incidence and reduced mortality risk 
from coronary heart disease (Mink et al., 2007; Yamada et al., 2011). 
Quercetin glycosides from onion have an inverse association with mortality 
from coronary heart disease through inhibiting the expression of 
metalloproteinase 1(MMP1), and atherosclerotic plaques (Song et al., 
2001). Diets rich in (poly)phenols have been reported to help reverse 
hyperlipidemia and reduced the oxidation of LDL (Yang et al., 2001). 
1.5.2 Anti-cancer properties 
Hollman et al.(1996) have reported that consumption of fruits, 
vegetables, spices, cereals and beverages, rich in flavonoids (in reality 
flavonols and flavones), helps prevent many degenerative diseases 
including cancer. Epidemiological studies on (poly)phenol intake by 
different populations have established an inverse association between the 
high intake and the risk of cancer (Le Marchand, 2002). 
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The mechanism by which flavonoids exert their effects is through 
their interaction with phase I metabolising enzymes (such as cytochrome  
P450) and phase II metabolising enzymes (GST, quinone reductase, and UDP-
GT). These enzymes have a protective role against cellular damage and are 
involved in detoxification and elimination of carcinogens from the body 
(Maheep et al., 2011). Flavonoids from citrus fruits and tea have been 
widely studied in cancer prevention and induction of apoptosis. Flavonols 
and flavones have been shown to inhibit the action of a cytochrome P450 
that activates several human carcinogens (Lautraite et al., 2002) while 
catechins increase the activity of several detoxifying and antioxidant 
enzymes (Khan et al., 1992). Tea flavonols and flavan-3-ols are reported to 
have protective effects against stomach cancer (Inoue et al., 1998). 
Isoflavones have protective effect against mammary tumours and inhibit 
tumorigenesis in several animal models for prostate cancer (Messina et al., 
1994). High intake of isoflavone-rich soy was associated with a reduced risk 
of premenopausal breast cancer in case-control studies conducted in 
Singapore and Japan (Lee et al., 1991; Hirose et al., 1995). Although 
inverse correlation between high (poly)phenol intake with low cancer risk 
has been reported, a number of studies have found no association (Zheng et 
al., 1996; Chow et al., 1999; Julie et al., 2005). The discrepancies observed 
could be due to other constituents in the diet, lifestyle factors such as 
smoking, and early life exposure with specific diets (Le Marchand, 2002).   
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1.5.3 Anti-diabetic effect 
Tea, contains high levels of flavonols and flavan-3-ols. Based on the 
epidemiological studies it was reported that green tea has an effect on 
glucose tolerance. When green tea was fed to rats, they acquired lower 
levels of glucose, insulin, triglycerides and free fatty acids than control rats 
(Wu et al., 2004a). (–)-Epicatechin-3-O-gallate was shown to inhibit glucose 
uptake in Caco-2 cells and the sodium–dependent glucose transporter 
(SGLT), and is the principal compound that enhances insulin activity 
(Anderson and Polansky, 2002). The high intake of flavan-3-ols (tea and 
cocoa) and isoflavones (soy and soy products) have been reported to 
improve insulin sensitivity and reduce type II-diabetes in medicated 
postmenopausal women (Curtis et al., 2012).  Red fruits such as berries 
(strawberries and raspberries) contain anthocyanins that can inhibit -
glucosidase activity, and ellagitannins that inhibit -amylase activity. The 
inhibition of these digestive enzymes has potential synergism in reducing 
the blood glucose levels  for controlling type II diabetes and starch 
degradation after ingestion of starch-rich meals (McDougall and Stewart, 
2005).  
1.5.4 Neuroprotective effects 
Neurodegenerative diseases developed through oxidative stress and 
damage to brain macromolecules and defined as hereditary and sporadic 
conditions which lead into dysfunction of nervous system. Alzheimer’s 
disease is very common, affecting up to 18 million people worldwide 
(Pandey and Rizvi, 2009). It was reported that people who follow a 
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Mediterranean diet have lower mortality from Alzheimer disease 
(Scarmeas et al., 2007).The Mediterranean diet is characterized with the 
high intake of vegetables, legumes, fruits, cereals and unsaturated fatty 
acids with low intake of meat and poultry (Trichopoulou et al., 2003).  
Epigallocatechin-3-O-gallate exert protective effect against the 
neurotoxin MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine), an 
inducer of Parkinson-like disease symptoms (Rossi et al., 2008). 
1.5.5 Other diseases 
Consumption of dietary (poly)phenols has also been linked with 
several other health benefits. Intake of apple and soy has a reported 
positive association with lung function in asthma patients (Pandey and 
Rizvi, 2009). Diets containing the soy isoflavones genistein and daizdein 
have a significant bone-sparing effect (Setchell and Lydeking-Olsen, 2003). 
Flavonols and flavan-3-ols found in tea have protective effects against the 
adverse reaction of skin following UV exposure in animal models (Kim et 
al., 2005). Theaflavins present in black tea has reported to have anti HIV-I 
activity (Pandey and Rizvi, 2009).   
1.6 Bioavailability of dietary (poly)phenols 
  Bioaccessibility is defined as the amount of a food component present in 
the gut, released of its constituent food matrix and passing through the 
intestinal barrier. Only (poly)phenols that are accessible in the gut are 
potentially bioavailable. The amount of the (poly)phenols consumed in the diet 
and its bioavailability is important to evaluate the correlation of (poly)phenols 
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intake with human health. Information on bioavailability of dietary (poly)phenols 
has been obtained by measuring their concentrations in plasma and urine after 
the intake of a specific compound or a food with known content of the 
compound interest. Parameters which are used to measure their bioavailability 
are; area under the curve (AUC), which provides a gauge of the metabolite 
concentration in blood versus time; Tmax, time at which the concentration of the 
compound in blood has reached a maximum, and Cmax, referring to the maximum 
plasma concentration (Piskula et al., 2012). 
Dietary (poly)phenols have received much attention due to their potential 
beneficial effects on health, which are based largely on epidemiological 
evidence.  It has been estimated that the (poly)phenols dietary intake can range 
between 0.15-1.0 g/day of total phenolics (Scalbert and Williamson, 2000). 
However, most of these compounds have limited bioavailability with only low 
amounts being transiently detected in plasma after ingestion. 
Dietary (poly)phenols, such as flavonoids and hydroxycinnamates, with the 
notable exception of flavan-3-ols, occur principally in foods as glycoside 
conjugates that are hydrophilic and poorly absorbed. The absorption of some of 
these compounds into the circulatory system occurs in the small intestine with 
the hydrolysis of glycoside conjugates and release of the aglycone through the 
action of lactase phloridzin hydrolase (LPH). LPH has a high affinity for 
flavonoid-O--glucosides, and this results in the released of aglycones which are 
more lipophilic and can permeate the epithelial cell by passive diffusion (Day et 
al., 2000). Glycosides which have been transported into the epithelial cell 
possibly by sodium-dependent glucose transport (SGLT) can be hydrolysed by 
cytosolic -glucosidase (CBG) (al-Swayeh et al., 2000).  
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These two routes hydrolyses of glucoside conjugates are known as 
“LPH/diffusion” and “transport /CBG”. Released aglycones will undergo 
sulfation, glucuronidation and/or methylation by sulfotransferases (SULT), 
uridine-5-phosphate glucuronosyltransferases (UGT) and catechol-O-
methyltransferases (COMT). This concept of (poly)phenols absorption is 
simplified as illustrated in Figure 1.15.  
 
 
Figure 1. 15 Schematic diagram metabolism of dietary (poly)phenols in the lumen and 
enterocytes of the digestive tract.  
(Poly)phenols glycosides (PP-glycosides) reach small intestine with some being 
hydrolysed by lactase hydrolase phloridzin (LPH), or transported into the enterocytes by 
glucose transporters such as SGLT-1 and hydrolysed by cytosolic  -glucosidase  (CBG) 
to release the aglycone (PP) which will be further metabolised by metabolising enzymes  
into conjugates. PP-glycosides that are not absorbed will reach the colon. 
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Some of these metabolites formed in the enterocyte efflux back into the 
small intestine with the help of adenosine triphosphate (ATP)-binding cassette 
(ABC) family transporters, multidrug resistance protein (MRP), and P-
glycoprotein (P-gp)  (Crozier et al., 2009). The metabolites are also absorbed 
into the portal vein the of blood stream, rapidly reach the liver for further phase 
II metabolism, and enterohepatic recirculation may result in some recycling back 
to the small intestine through bile excretion (Donovan et al., 2006a). Some of 
(poly)phenol conjugates, such as rutinosides, have sugar moieties resistant to 
the action of LPH/CBG are not absorbed in the small intestine and so pass into 
the large intestine. In the large intestine, the colonic microflora will hydrolyse 
the conjugating sugars to release the aglycones which undergo ring fission 
yielding catabolites, including phenolic acids and hydroxycinnamates. These can 
be absorbed from the colon into the circulatory system and subsequently 
undergo phase II metabolism in the liver, and possibly the kidneys, before being 
eliminated in urine (Figure 1.16). 
Recent findings on the bioavailability of dietary (poly)phenolic compounds 
have pointed out that (poly)phenol glucuronide, methyl and sulphate conjugates 
are treated as xenobiotics, as they are rapidly turned over and excreted via the 
kidneys (Tomás-Barbéran et al., 2012). As a result, AUC values of plasma 
pharmacokinetics do not necessarily provide accurate quantitative data on 
absorption. More reliable measurement of absorption can be obtained from 
urinary excretion, however, this is restricted by the inability to include 
metabolites sequestration in body tissues. 
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Figure 1. 16 Simplified routes of metabolism of dietary (poly)phenols. White arrows depict 
the flow of intact (poly)phenol compounds ( i.e.  flavonoid glucosides). Orange arrows 
depict the flow of colonic catabolites after the ring fission (i.e. phenolic acids and 
aglycones). Some metabolites are excreted into the faeces, while others will be 
reabsorbed and subjected to further metabolism in the liver. 
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1.6.1 Flavan-3-ols 
 The bioavailability of green tea in humans was investigated by 
Stalmach et al. (2009). Plasma and urine were collected 0-24 h after 
drinking 500 mL of green tea containing 648 µmol of flavan-3-ols. In 
plasma, 12 metabolites were detected in the form of O-methylated, 
sulphated and glucuronide conjugates of (epi)catechin and 
(epi)gallocatechin together with unmetabolised (–)-epigallocatechin-3-O-
gallate and (–)-epicatechin-3-O-gallate with the Tmax values ranging from 1.6 
to 2.3 h. All metabolites are present in only trace amounts in plasma after 
8 h and had cleared the circulatory system 24 h after intake. These Tmax 
values and the pharmacokinetic profiles are indicative of the absorption in 
the small intestine. 
No parent flavan-3-ols were found in urine, and the metabolite profile 
was similar to that detected in plasma except for two additional 
(epi)catechin-O-sulphates. Total urinary excretion was 8.1% of 648 µmol of 
flavan-3-ol intake. High levels of excretion relative to intake was observed 
for (epi)gallocatechin (11.4%) and (epi)catechin (24.5%) metabolites. In 
iloestomists, after they drank green tea (634 µmol of flavan-3-ols), 69% of 
intake was recovered in 0-24 h ileal fluid (Stalmach et al., 2010a), whereas 
in volunteers with a functioning colon, the majority of these ingested 
flavan-3-O-ols will subjected to further metabolism by the colonic 
microflora.  
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Cocoa is another important source of flavan-3-ols that has been well 
studied in humans. Humans consumed 40 g dark chocolate consisting of 282 
µmol of (–)-epicatechin reached Cmax of 355 nM with a Tmax of 2 h, 
characteristic of absorption in the upper GI tract (Richelle et al., 1999). 
Further research by Baba et al. (2000) in which humans ingested 760 µmol 
of (–)-epicatechin and 210 µmol (+)-catechin, observed metabolites in 
plasma with a Cmax of 4.8 µM  and Tmax of 2 h,  with total urinary excretion 
equivalent to 29.9% of the ingested flavan-3-ols. This comparatively high 
bioavailability was also observed in another study in which human consume 
a cocoa beverage containing 22 µmol of catechin and 23 µmol of 
epicatechin. O-Methyl-(epi)catechin-O-sulphate and an (epi)catechin-O-
sulphate were detected in the plasma, both with a Cmax below 100 nM and a 
Tmax of less than 1.5 h (Mullen et al., 2009) and a combined excretion 
equivalent to ~20% of intake. These high levels of excretion are similar with 
those obtained from green tea studies confirming that (-)-epicatechin and 
(+)-catechin are highly bioavailable in the human body. 
Most flavan-3-ols are present in nature in different enantiomeric 
forms, such as (-)-epicatechin ), (+)-epicatechin ), (+)- catechin, and (-)- 
catechin (Figure 1.17). Transformation of enantiomers can take place in 
the gastrointestinal tract and/or during food processing (Hurst et al., 
2011).  
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Figure 1. 17 Chemical structure of flavonol stereoisomers (-)-epicatechin, (+)-epicatechin, 
(-)-catechin, and (+)-catechin. 
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of each other but non-superposable or not identical, whereas 
diastereoisomers are stereoisomers that are not enantiomers. 
Diastereoisomism are stereoisomers which have different configurations at 
a stereiocenter and are not mirror images of each other.  Stereoisomers are 
absorbed differently, as reported in rats were (-)-catechin is absorbed more 
readily than (+)-catechin (Donovan et al., 2006b). A more detailed study on 
the bioavailability of different flavan-3-ol enantiomers was carried out in a 
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of the stereoisomers was ranked as (-)-epicatechin > (-)-catechin > (+)-
epicatechin = (+)-catechin. There were also differences in the flavonol 
metabolite profile obtained with catechin and epicatechin epimers. Both 
3- and 4-O-methylated epicatechin derivatives are only present in urine 
and plasma after the intake of epicatechin enantiomers while the levels of 
nonmethylated metabolites of (-)-epicatechin were higher than those of its 
enantiomer (+)-epicatechin. In the study, the individual concentration of 
stereoisomers in the cocoa drink are not fully determined, which raises to 
the possibilities that the differences observed might also due to the varying 
stereochemical ratios presence in the cocoa drink (Crozier et al., 2012a). 
1.6.2 Flavonols  
Quercetin, particularly in onions, is the most studied flavonol. Among 
the early human bioavailability studies is an investigation by  Aziz et al. 
(1998) in which volunteers ingested 300 g of lightly fried onions which 
contain conjugates of quercetin and isorhamnetin. Plasma peak 
concentration (Cmax) was 1.3 h and 1.8 h for quercetin-4-O-glucoside and 
isorhamnetin-4-O-glucoside respectively and total urine recovery 24 h after 
intake was 17.4% for isorhamnetin-4-glucoside and 0.2% as in quercetin-4-
glucoside. Later it became evident that these glucosides were misidentified 
and was probably flavonol glucuronides, standards of which were not 
available at the time. Subsequently, after pioneering work by Day and 
Williamson (2001), volunteers were fed lightly fried onions containing 275 
µmol of flavonol glucosides principally quercetin-4-glucoside and 
quercetin-3-4-diglucoside. With the aid of HPLC-MS and reference 
compounds, a number of metabolites were identified in plasma including 
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quercetin-3-O-sulphate, quercetin-3-O-glucuronide, isorhamnetin-3-O-
glucuronide, quercetin-O-diglucuronide and quercetin-O-glucuronide-O-
sulphate (Mullen et al., 2006). Rapid elimination of the metabolites was 
observed with Cmax of some metabolites of <1 h being observed. Total 
metabolite excretion in urine 0-24 h after intake was 4.7% of the ingested 
parent flavonols. 
In a human study with tomato juice containing 176 µmol of quercetin-
3-O-rutinoside, two metabolites were detected in the plasma, quercetin-3-
O-glucuronide and isorhamnetin-3-O-glucuronide (Jaganath et al., 2006). 
The Cmax values obtained were much lower and Tmax times were longer than 
those observed in the onion studies. The Tmax values of ~4 h indicated 
absorption in the colon, which supported by evidence obtained in a parallel 
study with iloestomists where 86% of ingested quercetin-3-O-rutinoside was 
recovered in ileal effluent. This also indicates that the flavonol 
disaccharide was not cleaved by either LPH or CBG, confirming an earlier 
report by Day et al.(2000). In the healthy subjects with an intact 
functioning colon, the quercetin rutinoside reaching the colon would be 
subject to the action of the colonic microflora resulting in the release of 
quercetin which in the wall of the large intestine acts as a substrate for 
phase II enzymes resulting in low level absorption of quercetin metabolites. 
It is of interest to note that quercetin released in the small intestine was 
glucuronidated, sulphated and methylated (Mullen et al., 2006), while only 
glucuronide and methyl metabolites were formed in the colon. This 
suggests that the colon, unlike the small intestine, lacks SULTs capable of 
catalysing the formation of quercetin-3-sulphate. It also implies that 
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further sulfation of quercetin metabolites does not occur after entry into 
the circulatory system (Jaganath et al., 2006).  
1.6.3 Proanthocyanidins 
Proanthocyanidins (condensed tannins), are dimers, oligomers and 
polymers of flavan-3-ols. (+)-Catechin and (–)-epicatechin are the main 
constituent sub-units but other monomers, namely (epi)gallocatechin and 
(epi)afzelechin are also found. They are widely distributed in cocoa, 
grapes, apples, strawberries, and red wine (Crozier et al., 2010). It has 
been estimated the intake of proanthocyanidin in the USA adults is 95 mg/d 
(Wang et al., 2011). Numerous studies indicated that polymeric 
proanthocyanidins are not absorbed in the small intestine. Most will reach 
colon where they are catabolised by the microflora forming phenolic acids 
such as 3-(3-hydroxyphenyl)hydracrylic acid and 4-O-methyl-gallic acid 
which are absorbed into the circulatory system and excreted in urine 
(Déprez et al., 2000; Gonthier et al., 2003a).  
Only small amounts of procyanidin dimers B1 and B2 were detected in 
human plasma after consumption of a grape seed extract (Sano et al., 
2003) and cocoa (Holt et al., 2002).The absorption of B2 dimer was ~100 
fold lower than that of flavan-3-ol monomers confirmed that 
polymerization impairs intestinal absorption. Feeding rats with 14C-
radiolabeled procyanidin B2 resulted in 80% of radioactive compound being 
absorbed and eliminated in urine, with only small amounts of radioactivity 
appearing in blood which reach maximum at 6 h after ingestion suggesting 
it was the result of catabolism by the colonic microflora (Stoupi et al., 
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2010). The rate of procyanidin degradation by the microbiota depends on 
the degree of polymerization, with smaller dimers and trimers being broken 
down more rapidly than the large polymeric forms (Gonthier et al., 2003a). 
1.6.4 Flavanones 
 Previous studies using enzyme hydrolysis reported that orange juice 
flavanone rutinoside are absorbed in the large intestine (Erlund et al., 
2001; Manach et al., 2003). Mullen et al.(2008a) investigated the 
bioavailability of flavanones in humans who drank orange juice, containing 
168 µmol of hesperetin-7-O-rutinoside and 12 µmol of naringenin-7-O-
rutinoside. Circulatory and urinary flavanone metabolites were analysed by 
HPLC-MS2. Hesperetin-7-O-glucuronide and a second hesperetin-O-
glucuronide were detected in the plasma with a combined Cmax of 922 
nmol/L at Tmax of 4.4 h. Additional metabolites were detected in urine, 
including a third hesperetin-O-glucuronide, a hesperetin-O-glucuronide-O-
sulphate and hesperetin-O-diglucuronide. Differences in the metabolites 
found in plasma and urine indicate the post-absorption of phase II 
metabolism. Excretion 0-24 h after orange juice ingestion corresponded to 
6.5% of hesperetin-7-O-rutinoside intake, whereas elimination of naringenin 
glucuronides in equivalent to 17.3% of naringenin-7-O-rutinoside intake. 
These differences of excretion of naringenin and hesperetin, relative to the 
amounts ingested, is a trend that had been reported previously with 
flavanones, but there are exceptions where such differences were not 
observed (Manach et al., 2005). There are two possibilities that influenced 
the apparent bioavailability of the orange juice flavanones. The lower 
excretion of hesperetin metabolites could be due to the higher intake of 
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hesperetin-7-O-rutinoside. Alternatively, it could be a consequence of 
hesperetin being less readily bioavailable than naringenin because of the 
positional impact of the hydroxy and methoxy substituents at the C3 and 
C4 positions on absorption (Crozier et al., 2010). 
1.6.5 Isoflavones 
Isoflavones occur principally in soy and soy products as aglycones or 
glycosides depend on the preparation process involved. In over age or 
cooked soybeans >95% are isoflavone glucosides, whereas on soybean-
fermented products (i.e. tofu and tempeh) 20-40% isoflavones are 
aglycones (Wang and Murphy, 1994). Isoflavone glycosides are hydrolyzed 
into aglycones prior to absorption, with some of which is further 
metabolized by colonic microflora to metabolites such as equol.  
Isoflavones are well absorbed with metabolites equivalent to 20-50% 
being excreted in urine (Manach et al., 2005).The bioavailability of 
daidzein and genistein have been reported to be are lower than that of 
their glucosides. When daidzein or daidzen-7-O-glucoside was ingested by 
humans, the plasma Cmax at 8-9 h, was 3-6-fold higher in the glucoside feed. 
Several metabolites were detected after deconjugation including 
dihyrodaizein, O-desmethylangolensin, 6-hydroxy-daidzen, 8-hydroxy-
daidzein, 3-hydroxy-daidzein, and equol (Rüfer et al., 2008). In contrast, 
5-fold higher plasma Cmax concentrations, with a 4 h Tmax, were observed 
with aglycones when a crude preparation of soya saponins was ingested 
with high amounts of daidzein and genistein or their mixed glucosides 
(Izumi et al., 2000). This similar to the findings of (Zubik and Meydani, 
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2003). A study in which 50 g of kinako (baked soya bean powder) was 
ingested by human volunteers resulted traces of glycosides being detected 
in plasma 1 h after intake, with most absorption occurs after deconjugation 
(Hosoda et al., 2008). The absorption of isoflavone glycosides appears to 
occur in the upper part of gastrointestinal tract, with the production of 
microbial metabolites equol, dihydrodaidzein and dihydrogenistein 
occurring in the colon (Crozier et al., 2010). 
1.6.6 Anthocyanins 
Anthocyanins are present in large amounts in some dietary 
components, especially berries, fruits and some red wines. The dietary 
intake of anthocyanins has been estimated to be 182 mg/mL (Manach et 
al., 2005) and 180–215 mg/d in the United States (Kühnau, 1976). In several 
studies showed that anthocyanins are very rapidly absorbed and excreted, 
but with only low efficiency. Typically ~0.1% of the ingested anthocyanins 
are detected in urine (Crozier et al., 2010). The absorption and excretion 
of anthocyanins are determined by the sugar moiety and structure of the 
aglycone (Wu et al., 2005). The complex array of information on 
anthocyanins bioavailability derived from human and animal models is due 
to the berry or fruit supplements containing complex anthocyanin profiles 
(Prior and Wu, 2006). Black raspberries, for instance, contain five cyanidin-
3-O-glucosides, while blueberries consist 12 anthocyanins, mainly 3-O-
glucosides, galactosides and arabinose of cyanidin, delphinidin, petunidin 
and malvidin where 3-O-methlyation can transform these parent 
compounds into another anthocyanin, which makes assessing the content of 
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anthocyanins present in plasma and urine is difficult to interpret (Crozier 
et al., 2010).   
Studies on bioavailability of anthocyanins are made more feasible by 
using strawberries which contain pelargonidin-3-O-glucoside and 
blackberries with cyanidin-3-O-glucoside as their predominant 
anthocyanins. When 200 g strawberries were fed to humans, anthocyanins 
are readily absorbed with Tmax of 1 h with pelargonidin-3-O-glucoside as the 
main metabolite detected in plasma and 0.75% of total pelargonidin-3-O-
glucoside intake excreted in urine (Mullen et al., 2008b). In other humans 
study using 200 g of blackberries, 12 anthocyanins were detected which is 
corresponds to 0.16% on anthocyanins intake (Felgines et al., 2005). It was 
suggested that the 4-monohydroxy compound pelargonidin-3-O-glucoside is 
more readily absorbed than cyanidin-3-O-glucoside which has a 3, 4-
dihydroxy structure.  
1.6.7 Flavones 
Compared to other flavonoid subclasses, the bioavailability of flavones 
has been investigated sparingly. The intestinal absorption of luteolin and 
luteolin-7-O-glycoside (Figure 1.18) in rats and humans was studied by 
Shimoi et al.(1998). Luteolin appears to be absorbed in the small intestine 
through passive diffusion, whereas its glycoside undergoes hydrolysis either 
by LPH or the colonic microflora before absorption. Luteolin was absorbed 
mainly in the  jejunum (Zhou et al., 2008) and metabolized by phase II 
enzymes into glucuronides and sulphates during passage through the 
intestinal mucosa or the liver. Methylation of luteolin mediated by COMT 
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was reported in rats with chrysoeriol and diosmetin (Figure 1.18) being 
found in plasma and urine (Shimoi et al., 1998; Chen et al., 2011). 
 
Figure 1. 18 Molecular structures of  luteolin glucoside, chrysoeriol (3-O-                      
methylation) and diosmetin (4-O-methylation). 
 
 
 
Luteolin plasma Cmax levels were lower in rats given pure luteolin as 
opposed to luteolin in a peanut hull extract (14.3 mg/kg of luteolin) (Zhou 
et al., 2008) and luteolin-7-O-glycoside in a Chrysanthemum morifolium 
extract (14.3 mg/kg) (Chen et al., 2007b). Luteolin and luteolin glucoside 
in extracts, were absorbed better than pure luteolin alone, suggesting the 
function of other components in the extract that could enhance the 
absorption efficiency.  
Humans fed with 2 g of blanched parsley containing 65 µmol of 
apigenin, attained flavone Cmax values after 7.2 h and 0-24 h urinary 
excretion was 0.22 % of intake (Meyer et al., 2006). In rats fed with 200 
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mg/kg of Chrysanthemum morifolium, the Tmax of luteolin and apigenin was 
obtained at 1.1 and 3.9 h. Their total urinary excretion of apigenin and 
luteolin was 6.6% and 16.6%, respectively, up to 72 h after the intake (Chen 
et al., 2007b). These results are unusual as, in contrast to anthocyanins, it 
appears that the 3,4-dihydroxy luteolin is absorbed more readily than the 
4-monohydroxy apigenin. It has been reported that apigenin is oxidized to 
luteolin (Gradolatto et al., 2004), Chen et al.(2007b) failed to detect such 
a transformation in rat after oral administration of apigenin. 
1.6.8 Hydroxycinnamic acids 
Caffeic acid and ferulic acid are rapidly absorbed from the small 
intestine. These compounds are normally esterified in nature. Such 
conjugation has proved to hinder absorption. Conjugation of caffeic acid, 
as in 5-O-caffeoylquinic acid, markedly reduces absorption (Olthof et al., 
2001). Although absorption of intact 5-O-caffeoylquinic acid was reported 
in some studies (Lafay et al., 2006a), hydrolysis of the parent compound by 
esterases prior to absorption remains the main process. Detailed studies on 
the bioavailability of caffeoylquinic acid has performed with healthy 
humans and volunteers with an ileostomy who ingested of 200 mL of instant 
coffee (Stalmach et al., 2010b). Caffeoylquinic acids and their metabolites 
were recovered in ileal effluent in amounts corresponding to 71 % of 
intake, with 78% as the parent chlorogenic acids and the remainder as free 
and sulphated caffeic acid. Excretion in 0-24 h urine was 8% of total intake, 
and the main metabolites were ferulic acid-4-O-sulphate, caffeic acid-3-O-
sulphate, isoferulic acid-3-O-glucuronide and dihydrocaffeic acid-3-O-
sulphate. In humans with an intact colon, urinary excretion was 29% of 
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caffeoylquinic acid intake. This is due to high accumulation of 
dihydroferulic acid and feruloglycine, sulphated and glucuronidated 
dihydrocaffeic and dihydroferulic acids in the urine produced by the colonic 
microflora metabolism that was absent in ileostomy patients. 
Ferulic acid is the abundant hydroxycinnamate in tomatoes, beers and 
cereals. Rats fed with ferulic acid excreted metabolites including 
sulphated, glucuronidated and sulfo-glucuronidated ferulic acids (Azuma et 
al., 2000). Urinary recoveries of these metabolites varies from 10 to 72 % of 
the amount ingested which may resulted from the use of enzymes with 
different efficiencies to release the aglycones prior to quantitative analysis 
(Stalmach et al., 2012).  
1.7 Catabolism of (poly)phenols and role of colonic 
microflora 
(Poly)phenols largely present in food in the form of esters, glycosides, or 
polymers that typically undergo limited absorption in the proximal 
gastrointestinal tract. As noted above, prior to absorption into the small 
intestine, flavonoid glycosides are deglycosylated by LPH/CBG, and metabolised 
during the passage probably in the enterocytes of the gastrointestinal tract and 
the liver, with methylation, sulfation and glucuronidation steps. This process will 
increase their hydrophilicity and reduced any toxicity effects and facilitates 
their biliary and urinary elimination.  
However, not all dietary (poly)phenol absorption starts in the upper GI 
tract. It has been reported that 90-95% of the dietary (poly)phenols are not 
absorbed in the small intestine (Clifford 2004). Among these (poly)phenols are 
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oligomeric and polymeric proanthocyanidins, (poly)phenols glycosylated with 
rutinose, chlorogenic acids and lignans which normally reach the colon and are 
catabolised by colonic microflora (Aura, 2008; Selma et al., 2009) which indicate 
the potential important of colon in the bioavailability equation. In colon, 
(poly)phenols and related compounds are catabolise by gut microflora enzymes 
(esterase, glucosidase, demethylation, and decarboxylation enzymes activities) 
forming low molecular weight phenolic compounds that can be absorbed in the 
large intestine (Rechner et al., 2004; Aura, 2008). These transformations include 
deglycosylation, the hydrolysis of esters and amides and deglucuronidation 
(Stalmach et al., 2010b), which may result in catabolites that might be more 
bioactive than the parent compounds. Released aglycones will undergo C-ring 
fission which produces more or less active compounds depending of the products 
formed. The type of catabolic products produce by ring fission where the 
heterocylic oxygen ring is split by the microflora depends on the type of 
flavonoids: flavonols mainly produce hydroxyphenylacetic acid, flavones and 
flavanones mainly transform to hydroxyphenylpropionic acids (Serra et al., 
2012), where as flavan-3-ols are catabolized to phenylvalerolactones and 
hydroxyphenylpropionic acids, following this they will further converted to 
benzoic acid derivatives (Spencer, 2003). These catabolites are absorbed  
through the colonic barrier and further transformed by conjugation with glycine, 
glucuronic acid or sulphate groups (Rechner et al., 2002). These hepatic 
catabolites may undergo enterohepatic circulation, release in the blood and 
excreted from the body via urine, whereas non-absorbed phenolic catabolites 
are eliminated through the faeces. 
Human gastrointestinal tract consists of the mouth, oral cavity, 
oesophagus, stomach, small intestine, and eventually the colon which is the 
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most heavily colonized region of the digestive tract comprising ~1012 bacteria/g 
colonic contents with many hundreds of different bacterial species (Gross et al., 
2010). The identification and quantification of the colonic catabolites 
constitutes important research as a wide range of low molecular weight phenolic 
compounds are produced along with short chain fatty acids derived from 
carbohydrates that exert a prominent effect on human health. 
  The activity of colonic microflora on dietary (poly)phenols is often 
responsible for the modulation of its biological activity and beneficial health 
effects as in the case of the isoflavone daidzein which exist in planta principally 
as glycosides which require the action -glucosidase for the uptake to the 
peripheral circulation. The aglycone is either absorbed or further metabolized by 
colonic microflora with daidzein being reduced to O-demethylangolensin and 
equol (Figure 1.19) (Kim et al., 2009). The production of equol varies greatly 
among individuals, with only 30-40% of Western populations being equol 
producers (Manach et al., 2005). The inability to produce equol was reported 
due to the lack of specific components of the intestinal microflora (Yuan et al., 
2007). Equol producers may gain more health benefits from soy consumption 
than those non producer, since the (3S)-equol has been shown to be more 
estrogenic than its precursor (Setchell et al., 2002).  
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Figure 1. 19 Proposed pathway of equol formation from reduction of isoflavone daidzein 
by colonic microflora. 
 
Certain large molecules require the action of microbes in order for it to be 
absorbed, as in the case of ellagitannins. Studies in human and animal 
microbiota, showed that ellagitannins are hydrolyzed to ellagic acid that is 
converted to a series of urolithins ( onza lez-Barrio et al., 2011). Urolithins occur 
as glucuronides and sulphates in human plasma, and the amounts produced vary 
markedly between  individuals ( onza lez-Barrio et al., 2010). The potential 
benefit effect of urolithins have been reported, with the finding that urolithin A 
can inhibit colon cancer (Sharma et al., 2009).
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2 PHYTOCHEMICAL ANALYSIS OF A MALAYSIAN 
MEDICINAL HERBAL PLANT: FICUS DELTOIDEA  
2.1 Introduction 
Ficus deltoidea (Figure 2.1A) is a member of the Moraceae and is one of 
about 40 genera of the mulberry family. F. deltoidea, also known as F. 
diversifolia, is referred to as mistletoe fig, which comes from its epiphytic habit 
of growing on larger trees. It is a shrub of upright cascading habit, which can 
reach 15 feet in height. Compared to other members of the fig family such as F. 
microcarpa, F. carica and F. elastica, it is small plant, and is widely cultivated 
as a houseplant because of its attractive spoon-shaped foliage and greenish-
white fruits which turn purple when ripe. The plant has very small flowers 
massed on the inside walls called ostioles, it is invisible externally and in 
Chinese medicine is called “the no flower fruit” (Mat-Saleh and Latif, 2002; 
Lansky et al., 2008). 
F. deltoidea is native to South East Asia, Borneo, and the Philippines. It is 
well known among the eastern practitioners of traditional medicine and is 
referred to by different names such as ‘mas cotek’ (gold droplet) or ‘serapat 
angin’ in Malaysia, ‘tabat barito’ in Indonesia and ‘kangkalibang’ in Africa. It has 
a unique feature with the underside of the leaves having dot-like mark (Figure 
2.1B) referred to as “a drop of gold” from where the plant derives its common 
name. 
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Figure 2. 1 A) A young Ficus deltoidea plant: B) A dot-like mark on the underside of the 
leaves is a key characteristic of this species. 
 
 
A young fruit, green colour 
A mature fruit, turns to red 
A 
B 
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The fig family has been utilised for many different purposes, eaten as 
dried fruit, the leaves used to prepare a tea, while aerial roots and bark, even 
its wood ash, are used for making lye, an ingredient for preparing soba, a 
traditional Okinawa food (Ao et al., 2008). There are several studies with fig 
plants which have reported that their antioxidant activities are attributed by the 
presence of phenolic compounds such as flavonoids (Teixeira et al., 2006; 
Çalişkan and Aytekin Polat, 2011). These flavonoids include of flavones, 
isoflavones, flavan-3-ols and anthocyanins (Dueñas et al., 2008). However, the 
types of flavonoids present are seemingly related to differences between variant 
subspecies and/or geographical distribution (Abdel-Hameed, 2009; Shi et al., 
2011). 
F. deltoidea has been used as a traditional medicine for prevention and 
cure of various diseases such as diabetes, rheumatism, and breast cancer. The 
leaves are the main ingredient of herbal preparations, although other parts are 
also used including fruits, roots and even the whole plant. F. deltoidea is in high 
demand locally in south East Asian countries both as raw materials, such as dried 
leaves, or as processed herbal products (Figure 2.2).  
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A. F. deltoidea extract in a form of capsule B. As ready to drink herbal tea
C. Prepared as herbal tea in a sachet D.  As an ointment for topical use
 
Figure 2. 2   F. deltoidea based herbal products. 
 
However few, if any, of the products, such as those illustrated in Figure 
2.2, have been tested scientifically and in reality are unproven in terms of their 
safety and efficacy. It is possible that such products may have toxicity effects 
due to the adulterations, and customers may well be misled by health claims and 
other information printed on the packaging.  
Although fig plants such as F. carica has been investigated in some detail 
as a consequence of the economic value of their fruit (Oliveira et al., 2010; 
Gaaliche et al., 2011), there is little information on F. deltoidea. In the 
circumstances, using modern analytical techniques to analyse the phytochemical 
constituents of F. deltoidea is a key first step in determining the therapeutic 
value of this plant. This will also assist in providing information for the 
standardization of its diverse herbal products. 
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Aims of study 
The aim of this study was to investigate the (poly)phenolic content of 
F.deltoidea to see if there were compounds present that could justify the 
reported efficacy and claimed medicinal properties of this Malaysia herbal 
spesies. 
2.2 Materials and methods 
2.2.1 Chemicals and reagents 
HPLC grade methanol was purchased from Rathburn (Walkerburn, UK). 
The flavonoid standards, (+)-catechin, apigenin-8-C-glucoside (vitexin), 
apigenin-6-C-glucoside (isovitexin) and luteolin-6-C-glucoside (isoorientin) were 
obtained from Extrasynthese (Genay, France). Gallic acid and delphinidin-3-
galactoside were supplied by AASC Ltd (Southampton, UK). Procyanidin B2, (–)-
epicatechin, formic acid, phosphoric acid, metaphosporic acid and Folin-
Ciocalteu reagent, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid 
(Trolox) and 2, 2-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium 
salt (ABTS) were purchased from Sigma-Aldrich (Dorset, UK). Other chemicals 
were supplied by Fisher Scientific (Leicestershire, UK). 
2.2.2 Plant material 
  Dried leaves of F. deltoidea, purchased from a local market in Pahang, 
Malaysia, were dried further for 2 days at 45°C before being ground to a powder 
which was extracted with boiling water for 1 h after which the infusion was 
filtered and dried by Mini spray dryer B-290 (Buchi, Switzerland) to form a 
powder which was shipped to Glasgow by courier in an airtight plastic container. 
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2.2.3  Sample preparation 
  One hundred mg of a powdered F. deltoidea extract was dissolved in 10 
mL of methanol-water (1:1, v/v), centrifuged at 10000 g for 5 min at 4 ºC prior 
to analysis of the supernatant. 
2.2.4  Determination of total phenol content 
The total phenolic of F. deltoidea extract was measured in gallic acid 
equivalents using the Folin-Ciocalteu assay of Singleton and Rossi (Singleton and 
Rossi, 1965). In brief, 200 µL of a 1:5 dilution sample was added to 10 mL of a 
1:10 diluted Folin–Ciocalteau reagent and 1.8 mL of distilled water. After 5 min, 
7 mL of a Na2CO3 solution (115 g/L) was added and the reaction mixture was left 
at room temperature for 2 h. The absorbance of the solution was read at 765 nm 
against water blank on Cecil 3000 series spectrophotometer (Cecil Instrument 
Ltd, Cambridge, UK). The absorbance was compared to a standard curve 
prepared with 50 to 500 mg/L gallic acid and results expressed as gallic acid 
equivalents (GAE). 
2.2.5  Ferric reducing antioxidant potential (FRAP) assay 
The antioxidant activity of F. deltoidea extracts were estimated using FRAP 
assay (Benzie and Strain, 1996). This method measures the ability of a solution 
to reduce a ferric-2,4,6-tri-2-pyridyl-s-triazine (TPTZ) complex (Fe3+- TPTZ) to 
the ferrous form Fe2+, producing an intense blue colour with absorption at 593 
nm. The reaction is non-specific and any half time reaction, which has a less 
positive redox potential, under reaction conditions, than the Fe3+/Fe2+-TPTZ 
half-life reaction will drive the Fe3+-TPTZ reduction. In the FRAP assay excess 
Fe3+ is used and the rate limiting factor of the Fe2+-TPTZ, and hence colour 
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formation, is the reducing ability of the sample. 1.5 mL of FRAP reagent (10 mM 
TPTZ and 20 mM ferric chloride Fe3+ in acetate buffer pH 3.6) was added to 50 
µL sample and 150 µL distilled water at 30 sec intervals. The mixture was 
incubated for 4 min prior absorbance reading at 593 nm. Optical density 
obtained was compared to a standard curve prepared with 0.1 to 1.0 mM ferrous 
sulphate (FeSO4) and antioxidant activity expressed as the mean concentration 
of Fe 2+ produced/mmol. A drawback of this assay is that some of polyphenol 
compounds such as tannic acid and quercetin react slowly to Fe3+ TPTZ, whereas 
compounds like thiols and proteins cannot be measured by this assay (Prior et 
al., 2005). 
2.2.6  HPLC-PDA-MS2 with on-line antioxidant detection 
Use was made of a Surveyor HPLC system (Thermo Scientific, Waltham, 
MA, USA), comprising a pumping system, autosampler, and degasser coupled to a 
photodiode array absorbance (PDA) detector scanning from 200 to 700 nm 
controlled by Xcalibur software version 1.3. Separations were carried out using 
MAX-RP 4 µm, 250 mm x 4.6 mm C12 reverse phase column (Phenomenex, 
Torrance, CA) maintained at 40ºC and eluted at a flow rate of 1.0 mL/min with 
60 min gradient from 15 to 50% methanol in water containing 0.1% formic acid. 
After passing through the flow cell of the PDA detector column eluate was 
directed to a fluorescence detector (Jasco FP-920 with excitation at 280 nm, and 
emission at 315 nm), then split and 20% directed to an LCQ Duo mass 
spectrometer (Thermo Scientific) with an electrospray interface operating with 
negative ionisation in full scan data dependent MS2 mode from 150 to 1000 amu. 
For the detection of components with antioxidant activity, the remaining 800 
µL/min of the HPLC eluate was mixed with an ABTS solution flowing at 0.5 
mL/min and the resultant mixture passed through a holding coil before being 
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directed to a P2000 absorbance detector (Thermo Scientific) operating at 720 
nm (Stewart et al., 2005) (Figure 2.3). Data were analysed using Xcalibur 
software and peaks were quantified in Trolox equivalents. 
 
Figure 2. 3  ABTS-online HPLC system for the measurements of antioxidant activities of 
F. deltoidea extracts. 
 
2.2.7 Analysis of procyanidins  
Thiolytic degradation of F. deltoidea extract was carried out on a dried 
sample  as described by  Guyot et al.(2000) which were reacted with 400 µL of 
benzyl mercaptan (5% in methanol, v/v) in 200 µL of acidified methanol (3.3% 
HCl, v/v) at 40ºC for 30 min, with samples being vortexed every 10 min. The 
HPLC-PDA-FL-MS2 analysis with conditions as described above except for the use 
of a 60 min gradient of 3–55% acetonitrile in 1% aqueous formic acid.  
HPLC pump
PDA 
recorder
Reagent pump
Absorbance detector 
at 720 nm
Column
ABTS.+ solution
Reaction loop
Abs at 280 nm
Abs at 720 nm
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2.3 Results 
2.3.1 Identification of phenolic compounds 
Three aqueous extracts of F. deltoidea were analysed by gradient reverse 
phase HPLC with PDA, fluorescence, antioxidant and MS detection. HPLC 
fluorescence and absorbance profiles at 280 and 365 nm are presented in Figure 
2.4.  The mass spectral properties of the 26 numbered peaks along with their 
identification/partial identification are summarised in Table 2.1.   
Identifications were based on the following criteria:  
Peak 1 (tR - 6.6 min, max - 270 nm) was gallocatechin based on co-
chromatography with a (+)-gallocatechin and a negatively charged molecular ion 
[M-H]– at m/z 305 which yielded MS2 fragments at m/z 261, m/z 221 and m/z 
179. Reversed phase HPLC does not separate the (+)- and (–)-gallocatechin so the 
enantiomer is not specified.  This is also the case with the other flavan-3-ols 
that were detected. 
Peak 2 (tR - 11.4 min, max - 275 nm) was identified as epigallocatechin as it 
co-eluted with a standard and both had a [M-H]–  at m/z 305 and MS2 ions at  m/z 
261, m/z 221 and m/z 179.  
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Figure 2. 4 HPLC  profiles of F. deltoidea.  The chromatograms were recorded at UV 365 
nm and 280 nm. The numbering of their peaks indicates their subsequent identification by 
MS.
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Table 2. 1 HPLC and mass spectral characteristic and identity of phenolics present in F. deltoidea analysed by HPLC-ESI/MS. 
Peak tR (min)  max Compound [M-H]
- (m/z) MS2 fragments ions (m/z)  
1 6.6 270 (+)-Gallocatechin 305 261, 221, 179 
2 11.4 275 (–)-Epigallocatechin 305 261, 221, 179 
3 12.5 280 (+)-Catechin 289 245, 205, 179 
4 12.7 280 (Epi)catechin-(Epi)afzelechin 561 435, 289, 273 
5 14.2 280 (Epi)catechin-(Epi)afzelechin 561 435, 289, 273 
6 15.1 275 (Epi)catechin-(Epi)afzelechin-(Epi)afzelechin 833 561, 543, 289 
7 15.9 280 (Epi)catechin-(Epi)afzelechin 561 435, 289, 271 
8 18.5 275 (Epi)catechin-(Epi)afzelechin-(Epi)afzelechin 833 561, 289, 271 
9 19.4 280 (–)-Epicatechin 289 245, 205, 179 
10 21.8 350 Luteolin-6-8-C-diglucoside (Lucenin-2) 609 519, 489, 399 
11 25.7 340 Apigenin-6, 8-C-diglucoside (Vicenin-2) 593 503, 473, 353 
12 27.0 345 Luteolin-6-C-hexosyl-8-C-pentoside 579 489, 459, 399 
13 27.8 345 Luteolin-6-C-glucosyl-8-C-arabinoside 579 489, 459, 399 
14 29.6 335 Apigenin-6-C-arabinosyl-8-C-glucoside 
(Isoschaftoside) 
563 503, 473, 443 
15 30.4 345 Luteolin-6-C-arabinosyl-8-C-glucoside 579 489, 459, 399 
16 30.7 335 Apigenin-6-C-glucoside-8-C-arabinoside 
(Schaftoside) 
563  503, 473, 443 
17 31.4 335 Luteolin-8-C-glucoside (Orientin) 447 369, 357, 327 
18 31.9 320 Apigenin-6-C-pentosyl-8-C-glucoside 563 473, 443, 353 
19 33.0 310 4-p-Coumaroylquinic acid 337 191, 173, 163 
20 35.5 335 Apigenin-8-C-glucoside (Vitexin) 431 413, 341, 311 
21 36.5 335 Apigenin-6-C-glucosyl-8-C-pentoside 563 473, 443, 353 
22 37.5 335 Apigenin-6,8-C-dipentoside 533 515, 473, 443 
23 38.5 335 Apigenin-6,8-C-dipentoside 533 515, 473, 443 
24 39.6 335 Apigenin-6-C-glucoside (Isovitexin) 431 413, 341, 311 
25 42.1 335 Apigenin-6,8-C-dipentoside 533 515, 473, 443 
26 44.7 335 Apigenin-6,8-C-dipentoside 533 515, 473, 443 
  
                    Peak numbers and retention times refer to Figure 2.3  tR-retention time, [M-H]
- - negatively charged molecular ion.  
Chapter 2 2013 
 
65 
 
Peak 3 (tR - 12.5 min, max - 280) was catechin based co-
chromatography with a standard.  Both compounds fluoresced and had a [M-
H]– at m/z 289 which fragmented to produce daughter ions at m/z 245, m/z 
205 and m/z 179. 
Peaks 4, 5 and 7 (tR - 12.7, 14.2 and 15.9 min, max - 280 nm) were all 
identified as mixed type-B dimers of (epi)catechin and (epi)afzelechin. This 
identification was on the basis of each yielding a [M-H]– at m/z 561 which 
upon MS2 produced ions at m/z 435, m/z 425 (Retro Diels-Alder reaction 
[RDA]), m/z  of 407, m/z 289 (an (epi)catechin unit) and m/z 271 (an 
(epi)afzelechin unit) as reported by de Souza et al.(2008). The m/z of 407 
results from water elimination of m/z 425. The heterocyclic ring fission (HRF) 
of the dimer produces m/z 435 (loss of 126 Da), indicated that ring A of the 
extension unit had a 1, 3, 5-trihydroxybenzene structure. The quinone 
methide (QM) cleavage of the interflavan bond gives rise to m/z 271 and m/z 
289 which indicated the extension and terminal unit of this sequence as 
reported earlier by Verardo et al.(2010). 
Peaks 6 and 8 (tR - 15.1 and 18.5 min, max - 275 nm) exhibited a [M-H]
– 
ion at m/z 833, and the resulting MS2 spectrum comprised of ions at m/z 561 
([M-H-272]–), m/z 543 ([M-H-290]–), m/z 289 and m/z 271. The production of 
m/z 289 and 271 reveals that epi(afzelechin) is located in the upper unit, 
whereas (epi)catechin constitutes the lower one. The MS2 of this ion also 
produced minor fragment ions at m/z 697 and m/z 679 which are keeping 
with RDA fission. MS3 led to fragment ions at m/z of 425 and m/z of 407, RDA 
of a dimer. Both peaks therefore yield spectra indicative of the presence of a 
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type-B procyanidin trimer consisting of one (epi)catechin unit and two 
(epi)afzelechin units, in keeping with the findings de Souza et al.(2008). 
Peak 9 (tR - 19.4 min, max - 280 nm), this also produced a strong 
fluorescent peak and was identified as epicatechin based on a [M-H]– at m/z 
289 which gave rise to MS2 ions at m/z 245, m/z 205 and m/z 179. The 
identification was confirmed by co-chromatography with an authentic 
standard. 
Peak 10 (tR - 21.8 min, max - 350 nm) had a [M-H]
– at m/z 609, and its 
MS2 spectrum consisted of ions at m/z 489 ([M-H-120]–), m/z 519 ([M-H-90]–) 
and m/z 399 ([M-H-120-90]–), corresponding to the fragmentation of a flavone 
C-diglycoside, which, based on the data of  Ferreres et al.(2003) is 
tentatively identified as luteolin-6,8-C-diglucoside (aka lucenin-2). 
Peak 11 (tR - 25.7 min, max - 340 nm) was characterised by a [M-H]
– at 
m/z 593 which produced daughter ions at m/z 503 ([M-H-90]–), m/z 473 ([M-
H-120]–), and indicative of the cleavage of a C-glycoside. These fragments, 
based on the findings of  Han et al.(2008) are in keeping with the presence of 
apigenin-6, 8-C-diglucoside (aka vicenin-2). 
Peak 12 (tR - 27.0min, max - 345 nm ) exhibited a [M-H]
– ion at m/z 579 
and MS2 fragments at m/z 489 ([M-H-90]–), m/z 459 ([M-H-120]–), in keeping 
with the presence of a C-linked hexose sugar and m/z 399 ([M-H-120-60]–) 
corresponding to the further fragmentation of a pentose unit and m/z 285.  
These data indicate the presence of luteolin (m/z 285) + hexose (m/z 162) + 
pentose (m/z 132). Thus peak 12, in keeping with the data of Figueirinha et 
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al.(2008) is tentatively identified as either a luteolin-6-C-hexosyl-8-C-
pentoside or luteolin-8-C-hexosyl-6-C-pentoside. 
Peak 13 (tR - 27.8min, max - 345 nm) and peak 15 (tR -30.4 min, max - 
345 nm) both had [M-H]– ion at m/z 579 and an MS2 spectrum with ions at m/z 
489 ([M-H-90]–), m/z 459 ([M-H-120]–), indicating the presence of a C-linked 
hexose moiety, and m/z 399 ([M-H-180]–). This is a C-glycosylflavone 
fragmentation pattern similar to that reported by Ferreres et al.(2008) and 
on the basis of their elution sequence peak 13 is tentatively identified as 
luteolin-6-C-glucosyl-8-C-arabinoside and peak 15 as luteolin-6-C-arabinosyl-
8-C-glucoside. 
Peak 14 (tR - 29.6 min, max - 335 nm) and peak 16 (tR - 30.7 min, max - 
335 nm), both had a [M-H]–  at m/z 563 which produced daughter ions at m/z 
503 ([M-H-60]–), m/z 473 ([M-H-90]–) and m/z 443 ([M-H-120]–).The ([M-H-60]–) 
indicates a pentose substitution, in addition to that of a hexose sugar. By 
reference to the mass spectrometric and chromatographic data of Han et 
al.(2008) peak 14 was tentatively identified as apigenin-6-C-arabinosyl-8-C-
glucoside (aka isoschaftoside) and peak 16 as apigenin-6-C-glucosyl-8-C-
arabinoside (aka schaftoside). 
Peak 17 (tR - 31.4 min, max - 335 nm) had a [M-H]
– at m/z 447 and an 
MS2 spectra with ions at m/z 357 ([M-H-90]–) and m/z 327 ([M-H-120]–). In 
keeping with the findings of Kazuno et al.(2005) and co-chromatography with 
a reference compound this peak was identified as luteolin-8-C-glucoside (aka 
orientin). 
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Peak 18 (tR - 31.9 min, max - 320 nm) and peak 21(tR -36.5 min, λmax - 
335 nm) gave the same [M-H]– ion at m/z 563 and its MS2 spectrum consisted 
of ions at m/z 473 ([M-H-90]–), the base peak, and m/z 443 ([M-H-120]–). On 
examination of the fragment ions, it was observed that their relative 
abundances were similarly to those reported by Ferreres et al.(2003) 
suggesting that peak 18 was apigenin-6-C-arabinosyl-8-C-glucoside. The 
fragmentation pattern of peak 21 resembles data reported by Han et 
al.(2008) suggesting that the peak may be apigenin-6-C-glucosyl-8-C-
pentoside. 
Peak 19 (tR - 33.0 min, max - 310 nm) was a chlorogenic acid with a [M-
H]– at m/z 337 and MS2 fragments at m/z 191, m/z 173 and m/z 163. Based 
on the fragmentation patterns reported by Clifford et al.(2003) this peak is 4-
p-coumaroylquinic acid. 
Peak 20 (tR - 35.5. min, max - 335 nm) and peak 24 (tR -9.6 min, max - 
335 nm) both had a [M-H]– ions at m/z 431 and MS2 ions at m/z 341 ([M-H-90]–
) and m/z 311 ([M-H-120]–). Co-chromatography and the mass spectrometric 
properties of reference compounds identified peak 20 as apigenin-8-C-
glucoside (aka vitexin) and peak 24 as apigenin-6-C-glucoside (aka isovitexin). 
Peak 22 (tR - 37.5 min, max - 335 nm), peak 23 (tR - 38.5 min, max - 335 
nm), peak 25 (tR - 42.1 min, max - 335 nm) and peak 26 (tR - 44.7 min, max - 
335 nm) all had a [M-H]– at m/z 533 which yielded MS2 fragments at m/z 443 
([M-H-90]–) and m/z 311 ([M-H-60]–) which is likely to be due to the presence 
of a pentose substitution. There was no [M-H-120]– fragment indicating the 
absence of a C-hexose conjugate. The fragmentation suggests apigenin (271) 
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+ pentose (132) + pentose (132). Peaks 22, 23, 25 and 26 are therefore 
tentatively identified as apigenin-6, 8-C-dipentosides with likely pentose 
sugars being arabinose and xyloside. 
2.3.2 Analysis of proanthocyanidins 
No polymeric flavan-3-ols were detected by analysis after thiolytic 
degradation, as no adducts were formed during the reaction and the 
catechin/epicatechin peaks did not increase significantly.  
2.3.3 Total phenols and antioxidant activity 
The total phenolic content of the aqueous F. deltoidea extract was 6.3 
± 0.2 mmol/L of gallic acid equivalents while FRAP antioxidant activity was 
7.2 ± 0.2 mmol/L of Fe2+. These values are high, equivalent to those obtained 
with purple grape juice and cloudy apple juice by Mullen et al.(2007). 
HPLC data obtained with the on-line ABTS antioxidant detection 
system are illustrated in Figure 2.5 along with absorbance traces at 280 and 
365 nm.  The chromatographic profiles are illustrated from 6-34 min as none 
of the later eluting peaks exhibited antioxidant activity. The peaks 
contributing the main antioxidant activity were the flavan-3-ol monomers (+)-
gallocatechin (peak 1), catechin (peak 3) and epicatechin (peak 9) and the 
flavone apigenin-6, 8-C-diglucoside (peak 11) and the data on the 
contribution of individual compounds the overall ABTS antioxidant activity 
are summarized in Table 2.2. The flavan-3-ols were the main antioxidants 
contributing 85% compared to the 15.0% for the flavones that was due 
principally to apigenin-6, 8-C-diglucoside. 
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Figure 2. 5 HPLC-ESI/MS profile of F. deltoidea with on-line ABTS+ antioxidant. 
Aqueous extract of F. deltoidea was analysed by gradient phase HPLC at 280 nm and 
365 nm prior with ABTS+ radical at 720 nm.         
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Table 2. 2  Content and antioxidant potential of individual compounds of water extract 
of F. deltoidea. 
 
Peak Compound Concentration 
(µM) 
Trolox 
equivalent 
( µM) 
% 
antioxidant 
 Flavan-3-ols    
1 Gallocatechin 44  ± 1 78    ± 3 9.4 
2 Epigallocatechin 87  ± 2 68    ± 2 8.2 
3 (+)-Catechin 98  ± 1 197  ± 4 24 
4 (Epi)catechin-(Epi)afzelechin 18  ± 0 69    ± 1 8.3 
5 (Epi)catechin-(Epi)afzelechin 21  ± 0 87   ± 1 11 
6 (Epi)catechin-(Epi)afzelechin-(Epi)afzelechin 5.7 ± 0 11   ± 0 1.4 
7 (Epi)catechin-(Epi)afzelechin 39  ± 0 7.2  ± 0 0.9 
8 (Epi)catechin-(Epi)afzelechin-(Epi)afzelechin 5.1 ± 0 32   ± 1 3.9 
9 (–)-Epicatechin 89  ± 3 148 ± 3 18 
 Total 407 697  
 Flavones    
10 Luteolin-6-8-C-diglucoside (Lucenin-2) 13    ± 0 15  ± 1 1.8 
11 Apigenin-6, 8-C-diglucoside (Vicenin-2) 15    ± 1 76  ± 1 9.1 
12 Luteolin-6-C-hexosyl-8-C-pentoside 11    ± 0 0 0 
13 Luteolin-6-C-glucosyl-8-C-arabinoside 3.9   ± 0 0 0 
14 Apigenin-6-C-arabinosyl-8-C-glucoside (Isoschaftoside) 7.4   ± 0 0 0 
15 Luteolin-6-C-arabinosyl-8-C-glucoside 2.0   ± 0 9.5  ± 0 1.1 
16 Apigenin-6-C-glucoside-8-C-arabinoside (Schaftoside) 33    ± 0 13   ± 1 1.5 
17 Luteolin-8-C-glucoside (Orientin) 10    ± 0 9.0  ± 0 1.1 
18 Apigenin-6-C-pent-8-C-glu 117  ± 0 3.6  ± 0 0.4 
20 Apigenin-8-C-glucoside (Vitexin) 7.8   ± 0 0 0 
21 Apigenin-6-C-glucosyl-8-C-pentoside 7.0   ± 0 0 0 
22 Apigenin-6,8-C-dipentoside 2.2   ± 0 0 0 
23 Apigenin-6,8-C-dipentoside 1.1  ± 0 0 0 
24 Apigenin-6-C-glucoside (Isovitexin) 15   ± 0 0 0 
26 Apigenin-6,8-C-dipentoside 9.3  ± 0 0 0 
 Apigenin-6,8-C-dipentoside 14   ± 0 0 0 
 Total 269 126  
 Chlorogenic acids    
19 Coumaroylquinic acid 139 ± 3 3.3   ± 0 0.4 
 Total 813 826  
*Results represent concentration of phenolics and antioxidant potential in aqueous extract 
of F. deltoidea (10 mg/mL). 
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2.4 Discussion 
In the present study HPLC-ESI-MS was used to identify the 
phytochemical presence in the aqueous extract of F. deltoidea. The 
identification of related compounds was determined based on the 
fragmentation pattern and confirmed with the reference standard when 
available. Using this technique with negative ionisation, organic sample 
passes into the ionisation chamber of a mass spectrometer and bombarded by 
the electron forming a negative ion. The simplest case of the reaction as 
follows: 
           [M-H]-.                      X- + Y. 
 
  The negatively charged molecular ion or parent ion is given the 
symbol [M-H]-. Molecular ions are energetically unstable with some will 
breakdown into smaller fragments. In this case, a molecule ion will break into 
two parts, one is negative ion (X-) whilst other is an uncharged free radical 
(Y). Only charged particles will be accelerated, deflected and detected by 
the mass spectrometer.The X- or daughter ion reflects the fragmentation 
pattern of the parent ion and will be detected by the mass spectrometer. The 
fragmentation pathways of the parent ions depend on the substitution 
pattern, the class of flavanoids and also the collision energy applied during 
the collision-induced dissociation process which will show as host line in the 
mass spectrum. The mass spectrum m/z (mass to charge ratio) is 
reproducible, later used as an identifying ‘fingerprint’. The identification will 
then be confirmed using a reference standard with the same fragmentation 
pattern.  
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In this study a total of 25 flavonoids (nine flavan-3-ols and 16 flavones) 
and one chlorogenic acid, 4-p-coumaroylquinic acid, were identified or 
tentatively identified in F.deltoidea with proanthocyanidins and flavones as 
major compounds detected (Figure 2.5). No other isomers were detected that 
could correspond to a p-coumaroylquinic acid when the total ion current 
chromatogram was scanned for the molecular ion at m/z 337. Such a 
compound, if present would be in very small amounts which is unusual since 
plant producing them generally contains several subgroups of similar 
compound or isomers (Clifford et al., 2003). It is notable that the dominance 
of 4-p-coumaroylquinic acid relative to other compounds in Ficus spp. 
according to our knowledge this has never been reported before. Thus, it 
makes the herbal extract F. deltoidea a convenient source for 4-p-
coumaroylquinic acid. 
  Four flavan-3-ol monomers were detected, namely catechin, 
epicatechin, gallocatechin and epigallocatechin which also occur in green tea 
prepared from young leaves of Camellia sinensis (Del Rio et al., 2004; Chan et 
al., 2007). Five oligomers of proanthocyanidins were also detected consisting, 
unusually, of (epi)catechin and (epi)afzelechin sub-units. The main 
fragmentation pathways for these proanthocyanidins are RDA fission and 
subsequent elimination of water, HRF and interflavanic bond cleavage 
through the QM mechanism (Lansky et al., 2008). Further analysis of the F. 
deltoidea extract after thiolytic degradation did not detect the presence of 
additional proanthocyanidin with a higher degree of polymerisation than 
three. 
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  Sixteen flavone C-glycosides were detected. Luteolin and apigenin 
derivatives were the main flavones present in F. deltoidea, and among them 
were isomers of schaftoside and vitexin (Figure 2.6) which have not been 
previously reported to occur in other Ficus species (Lansky et al., 2008; Leong 
et al., 2008). The differences in the flavonoid content of F. deltoidea and 
other fig species may be related to species differences, geographical 
distribution and environmental factors (Pistelli et al., 2000). The high level of 
phenolics contents in F. deltoidea is similar to that reported in other Ficus 
spp. (Ao et al., 2008) although the main phenolics may vary from one species 
to another (Lansky et al., 2008). Since F. deltoidea is typically consumed as 
herbal tea, it is worth noting that the high level of total phenolics are 
comparable with those occurring in black and green tea (Fan et al., 2007) as 
well as fruit juices (Mullen et al., 2007). This is similar to the findings by 
Chan et al.(2010) which indicates that herbal tea prepared from F. deltoidea 
contains a level of antioxidants comparable to black tea. 
The F. deltoidea tea exhibited both a high total phenol content and 
antioxidant activity. The HPLC with on-line detection of antioxidant activity 
demonstrated that the flavan-3-ol monomers and the (epi)catechin-
(epi)afzelechin dimers and trimers accounted for 85% of the antioxidant 
activity of the aqueous infusion of F. deltoidea leaves. Proanthocyanidins, 
which are widely distributed in pine bark, berries, grapes and cocoa products 
(Crozier et al., 2006) have become a focus of interest due to their radical-
scavenging properties and anti-inflammatory activity and anti-carcinogenic 
effects (Duthie and Crozier, 2000; Gonçalves et al., 2005; Mantena and 
Katiyar, 2006; Nandakumar et al., 2008). Procyanidins in Madiran red wine 
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produced from Tannat grapes have been linked with increased male longevity 
in the Gers region of south west France (Corder et al., 2006). 
 
Figure 2. 6 Flavones identified from F. deltoidea aqueous extract. 
 
  Flavones are active components in many herbs that have been found to 
have impact on human health. Apigenin possess pharmacological effects with 
its antioxidant, antiviral, anti-inflammatory and anti-cancer properties 
(Duthie and Crozier, 2000; Shui and Leong, 2004) while luteolin has anti-
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inflammatory effects (Chen et al., 2007a). Both apigenin and luteolin are 
reported to have protective effects against vascular diseases (Ma et al., 2008) 
and they are also potential inhibitors of cellular autoimmunity (Verbeek et 
al., 2004). As mentioned earlier, F. deltoidea has anti-diabetic properties 
(Abdel-Hameed, 2009), and arguably this could at least in part be due to the 
presence of C-glycosylflavonoids, such as vitexin, isovitexin and orientin. 
Owing to C-3hydroxylation of the B ring of flavones, these C-glycosylflavones 
possess strong α-glucosidase inhibitory activity, higher than that of acarbose, 
a drug used for treating type 2 diabetes mellitus (Li et al., 2009). Considering 
the benefits of these herbal formulations, generating practical data on their 
safety is a prerequisite to their increase use in herbal medicine. 
It was revealed the high antioxidant properties of an aqueous extract 
of F. deltoidea are due to the presence of large amounts of 
proanthocyanidins together with flavones. Arguably the reported therapeutic 
actions of F. deltoidea could be due to the synergistic actions of these 
components. Synergism derives from Greek word syn-ergo, meaning working 
together, refers to phenomenon where two or more herbal ingredients 
enhance each other’s effects more than any individual contributions 
(Williamson, 2008). This synergism may also arise as one herbal preparation 
enhancing the therapeutic effect of other active ingredients by modulating its 
ADME (absorption, distribution, metabolism and excretion) via coalistic 
combinations (Ma et al., 2009), where the ingredient in combination is more 
active than the compound alone. One reported example of a synergistic 
effect was in randomized trial of 10 healthy volunteers given caffeine, green 
tea and placebo, which later showed that green tea has thermogenic 
properties and promotes fat oxidation greater than its caffeine content per se 
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(Ma et al., 2009). These synergistic effects has also been reported in some 
herbal preparation, such as St. John`s wort (Hypericum perforatum) which is 
more active as antidepressant in a combination of ingredients (Spinella, 
2002). 
In recent years, synergy research in Phytomedicine has been 
established where its main activity is to find the scientific rationale of many 
herbal remedies derived from traditional medicines which exhibit superior 
therapeutic activities then their individual constituents. These synergistic 
effects are claimed to be due to the mixture of bioactive constituents and 
their bi-products contained in plant extracts which improve the effectiveness 
of many extracts (Wagner and Ulrich-Merzenich, 2009). 
To fully understand the mode of actions of F. deltoidea, more research 
is needed, particularly in terms of safety and efficacy before human 
intervention studies can be carried out. With its sweet taste, unlike green tea 
or black tea, together with its pleasant aroma, F. deltoidea herbal tea has 
promising potential to be utilized and commercialized as a healthy beverage. 
2.5 Conclusion 
 In conclusion, these finding suggests that the RP-HPLC-ESI-MS2 
analytical method has successfully identified a total of twenty six phenolics, 
with newly reported proanthocyanidins and the exclusive occurrence of a 
single chlorogenic acid in F. deltoidea extract. The chromatographic 
fingerprinting obtained is also a useful reference for F. deltoidea herbal 
products. All the above findings lend credence to the potential beneficial use 
of F. deltoidea extract as a healthy beverage. Nevertheless, the detailed 
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mechanism of action and the interactions among the different compounds 
responsible for this potential activity needs further investigation. 
In addition, the Information gained from this study offers a stepping 
stone towards the documentation of herbal medicinal tea and inputs to policy 
makers on the way towards regulating and standardization of F. deltoidea 
herbal products. 
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3 ABSORPTION, DISPOSITION, METABOLISM 
AND EXCRETION OF [3-14C]CAFFEIC ACID IN 
RATS 
 
3.1 Introduction 
Hydroxycinnamates, such as caffeic acid and ferulic acid, are of dietary 
significance being widely distributed in fruits, vegetables, grains, and coffee. 
They occur predominantly as esterified forms linked with sugars or organic 
acids such as quinic acid and tartaric acid (Figure 3.1) (Clifford, 1999; Crozier 
et al., 2006). Esterification with quinic acid produces a family of compounds 
collectively known as chlorogenic acids. The most widely distributed 
chlorogenic acid is 5-O-caffeoylquinic acid, which can occur along with its 3-
O and 4-O isomers (Figure 3.1), and is especially abundant in coffee, apple 
and mate (Clifford et al., 2003; Marks et al., 2007; Clifford and Crozier, 
2011). These compounds can be major constituents in the human diet and are 
of interesting as they have antibacterial and anti-inflammatory properties, 
(Almeida et al., 2006; Larrosa et al., 2009) and have been linked to potential 
protective effects against cardiovascular disease, diabetes type 2, 
Alzheimer’s disease and ischemia reperfusion injury (Lindsay et al., 2002; 
Federico et al., 2004; Gordon and Wishart, 2010).   
The potential biopharmacological properties of hydroxycinnamates are 
dependent on their absorption in the gastrointestinal tract and the associated 
metabolism. The bioavailability of caffeoylquinic acids and their primary 
metabolite, caffeic acid, have been investigated using a diversity of ex vivo 
test systems, human and animal models (Olthof et al., 2001; Gonthier et al., 
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2003b; Crozier et al., 2010; Stalmach et al., 2012). It has been reported that 
both caffeic acid and its ester, chlorogenic acid have  shown  a protective 
effects against ischemia-reperfusion injury, with the main contribution 
coming from caffeic acid which exhibit stronger antioxidant activity than its 
ester (Sato et al., 2011). Recent detailed studies with chlorogenic acid after 
the ingestion of coffee by healthy subjects, and volunteers with an ileostomy 
has been reported by (Stalmach et al., 2009; Stalmach et al., 2010b). 
Nevertheless, there is still a gap on the extent to which 
hydroxycinnamates are sequestered in body tissues and organs, a topic on 
which detailed information can only be obtained with animal-based 
investigations. Hydroxycinnamate disposition and metabolism are most 
readily monitored using an animal model and feeding radiolabeled substrates 
as demonstrated in flavonol bioavailability study in which [2-14C]quercetin-4′-
O-glucoside was fed to rats (Mullen et al., 2008c). 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 3. 1 Structures of common dietary hydroxycinnamates. 
 
 
Chapter 3 2013 
 
81 
 
Aims of study 
The aims of the current study focused on the absorption, disposition, 
metabolism and excretion of [3-14C]trans-caffeic acid (Figure 3.1) over a 72 h 
period following ingestion of the labeled hydroxycinnamate by male Sprague-
Dawley rats. 
3.2 Material and methods 
3.2.1 Synthesis of [3-14C]trans-caffeic acid 
 [3-14C]trans-Caffeic acid (Figure 3.1) (specific activity 2.2 mCi/mmol) 
was synthesized by Dr. S.T. Caldwell and DR. R.C. Hartley (Department of 
Chemistry, University of Glasgow) as described by Omar et al.(2012).  
3.2.2 Chemicals and reagents 
trans-Caffeic acid was obtained from AASC Ltd. (Southampton, UK) and 
cis-caffeic acid was prepared by exposing a methanolic solution of trans-
caffeic acid to UV light (Hartley and Buchan, 1979). HPLC grade methanol and 
acetonitrile were purchased from Rathburn Chemicals (Walkerburn, UK). 
Formic acid and scintillation cocktail (Optiflow Safe One) were supplied by 
Fisher Scientific (Leicestershire, UK). Tissue solubilizer was obtained from 
National Diagnostic (Hull, UK). 
3.2.3 Rats and feeding procedures 
The rat feeding and samples collection (urine, faeces, blood, plasma, 
cage washing, tissues, organs, and GI tract) were carried out at the University 
of Montpellier by Dr. Cyril Auger and Dr. Jean-Max Rouanet (Omar et al., 
2012). In brief, the description of animal handling are as follows.Sprague-
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Dawley rats (Iffa Credo, L'Arbresle, France) weighing ~250 g, handled 
according to the guidelines of the Committee on Animal Care at the 
University of Montpellier and NIH guidelines, were housed individually in 
stainless steel metabolic cages with free access to deionised water.They were 
kept under a 0700 to 1900 h light regime, at a temperature of 23 ± 1°C, with 
constant humidity.  
The rats were deprived of food for 16 h before being fed by gavage with 
0.5 mL of water/ethanol (92:8, v/v) containing of 1.52 mg (140 x 106 dpm) [3-
14C]trans-caffeic acid, a dose equivalent to 6.08 mg/kg body weight. At the 
following time points: 1, 3, 6, 12, 24, 48, and 72 h, three rats were 
anaesthetized with pentobarbital (60 g/L pentobarbital, 60 mg/kg body 
weight). Blood was drawn by cardiac puncture with a heparin-moistened 
syringe and plasma and erythrocytes were separated by centrifugation at 
2300 g for 10 min at room temperature, before being frozen in liquid nitrogen 
and stored at –80°C. The whole body tissues were perfused in situ with 
chilled 0.15 M NaCl to remove residual blood, after which brain, heart, lungs, 
kidneys, liver, testes, muscle and spleen  were removed, rinsed in saline, 
blotted dry, frozen and stored at –80 °C. The gastrointestinal (GI) tract was 
removed intact along with its contents, and then separated into stomach, 
duodenum, ileum/jejunum, caecum and colon. All tissues were weighed 
before being frozen. Faeces and urine were collected from each rat during 
the course of the study and they too were frozen and stored at –80°C. 
Samples were shipped to the University of Glasgow on dry ice. Upon arrival 
tissues were freeze-dried, weighed, ground to a powder and stored at –80°C, 
along with plasma and urine prior to analysis. The weight of all freeze-dried 
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organs and total volumes of liquid samples are summarized in the Appendix 
3.1 and 3.2. 
3.2.4  Measurement of total radioactivity in tissues and body 
fluids 
   Ten milligram aliquots of powdered freeze-dried samples and 100 μL 
volumes of plasma and urine were treated overnight with 1 mL of tissue 
solubilizer at 50°C in shaking water bath. This produced clear solutions to 
which was added 10 mL of scintillation cocktail before the determination of 
radioactivity using a LS 6500 multi-purpose liquid scintillation counter 
(Beckman, USA). 
3.2.5 Sample preparation 
   One hundred milligram aliquots of powdered tissues and 100 μL of 
plasma were extracted with 1.5 mL methanol:water (1:1, v/v) containing 
0.1% formic acid. If only very low amounts of total radioactivity had been 
detected in a sample, it was not extracted and further processed. After 
mixing 30 min the extract was centrifuged at 1000 g for 10 min, the 
methanolic supernatant decanted and the pellet re-extracted. The two 
supernatants were combined, and concentrated to one third of volume in 
vacuo after which 10 L aliquots were taken to measure radioactivity and 
ascertain the amount of sample required for analysis by HPLC with 
radioactivity counting (RC) and tandem mass spectrometry (MS2) detection. 
Urine was analyzed directly without further processing. 
Chapter 3 2013 
 
84 
 
3.2.6  HPLC analysis with PDA, radioactivity and MS2 detection 
 HPLC was used with RC and MS2 detection for identification and 
quantification of radiolabeled compounds as described previously (Mullen et 
al., 2002). Samples were analyzed on a Surveyor HPLC system comprising an 
autosampler cooled to 4 °C, an HPLC pump, and a PDA detector, scanning 
from 250 nm to 700 nm (Thermo Finnigan, CA). HPLC was carried out using a 
250 mm x 4.6 mm i.d. 4 µm Synergi C18 RP-Max column (Phenomenex, 
Macclesfield, UK) maintained at 40 °C and eluted at flow rate 1 mL/min with 
a 60 min gradient of 5-40% acetonitrile in 0.1 % formic acid. After passing 
through the flow cell of the absorbance monitor, the column eluate was split 
and 0.3 mL directed to a Finnigan LCQ Duo tandem mass spectrometer with 
an electrospray interface in negative-ionisation mode operating in full scan 
mode from m/z 150 to 600. The remaining 0.7 mL of eluate was mixed at a 
“T” with scintillation cocktail pumped at 3.0 mL/min and directed to a 
radioactivity monitor (Reeve Analytical Model 9701, LabLogic, Sheffield, UK) 
fitted with a 1.0 mL homogeneous flow cell.   
The mass spectrometer was operated in negative ionisation mode.  
Tuning was optimized by infusing a standard of ferulic acid dissolved in the 
initial HPLC mobile phase into the source at flow rate of 0.3 mL/min.  
Analyses were carried out using full scan, data-dependant MS2 scanning from 
m/z 100 to 600. Capillary temperature was 300 °C; sheath and auxiliary gases 
were 80 and 60 units/min, respectively, and collision energy was set at 35%. 
Data was processed by Xcalibur software programme version 2.1. Each 
samples was analysed in triplicate and data were presented as mean values  
standard error (n=3). 
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3.3 Results 
3.3.1 Distribution of radioactivity in rat GI tract 
  Three rats were sacrificed 1, 3, 6, 12, 24, 48, and 72 h after each 
ingested 140 x 106 dpm of [3-14C]caffeic acid and the distribution of 
radioactivity in tissues, plasma, urine and faeces, as well as the cage 
washings, which consisted of a mixture of urine and faeces was determined. 
The data obtained are presented in Tables 3.1 and 3.2. In Table 3.1 data are 
presented as the amounts of radioactivity recovered in the various tissues and 
fluids while in Table 3.2 it is presented as radioactivity recovered as a 
percentage of the ingested 140 x 106 dpm of [3-14C]caffeic acid. The 
radioactivity in the GI tract, tissues, organs, and plasma are the amounts 
present at each time point, while that in urine, faeces, and cage washings 
are the cumulative amounts that have left the body after ingestion. 
One hour after ingestion, 62% of the ingested radioactivity remained in 
the stomach with 7.9% having moved to the duodenum and 9.1% reaching the 
jejunum/ileum. Overall 80% of the radioactivity was still present in the GI 
tract but after 3 h, this dropped to 45% of intake. After 3 h, the level in the 
stomach declined to 7.1% as radioactivity appeared in increased amounts in 
the jejunum/ileum, caecum and colon. After 6 h, radioactivity in the GI tract 
had fallen to 28% of the quantity ingested and was present mainly in the 
caecum and colon. At later time points the amount of radioactivity declined 
further and what remained was present in the distal rather than the proximal 
GI tract (Tables 3.1 and 3.2).  
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3.3.2 Distribution of radioactivity in rat plasma, urine, faeces 
and cage washings 
 After 1 h 2.4% of the ingested radioactivity was detected in plasma. 
However, there was rapid decline and at subsequent time points, 
radioactivity in the circulatory system (plasma and red blood cells) had fallen 
to <0.1% of intake (Tables 3.1 and 3.2). Over the 3-72 h period radioactivity 
in the GI tract fell from 45% to 0.3% of intake while there was a 68% excretion 
in urine. This indicates that the [14C]caffeic acid-derived compounds, despite 
passing through the circulatory system in quantity do not accumulate to any 
extent as they are removed extremely rapidly by urinary excretion from the 
kidneys. The majority of the radioactivity in urine was excreted within 24 h 
of the ingestion of [3-14C]caffeic acid. 
The total radioactivity passing out of the body in faeces over the 72 h 
period after ingestion was 4.6% of intake, and even if the cage washings 
which comprised mainly of faecal material were added to this figure it is still 
much lower than the 68% excreted in urine. 
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Table 3. 1 Distribution of radioactivity (dpm x 10 
3
) in the tissues, GI tract, plasma, red blood cells, cage washing, urine and faeces 1-72 h after ingestion of 140 
x 10
6
 dpm of [
14
C]trans-caffeic acid by rats 
a 
Tissue 1 h 3 h 6 h 12 h 24 h 48 h 72 h 
Stomach   87,349 ± 14,248 9,940 ± 8,426 260 ± 89 519 ± 275 105 ± 25 313 ± 263 108 ± 31 
Duodenum 11,134 ± 2,672  11,325 ± 9,052 262 ± 70 408 ± 243 84 ± 6             78 ± 5 15 ± 3 
Jejunum/Ileum 12,701 ± 1,460  22,343 ± 4,141 1,508 ± 308     1,891 ± 766 1,472 ± 851 960 ± 119 60 ± 6 
Caecum 18 ± 4     8,446 ± 5,215     27,484 ± 19,727 5,441 ± 1,493 1,896 ± 320 440 ± 107  205 ±  96 
Colon   34 ± 19  10,303 ± 7,683    9,273 ± 2,124 5,503 ± 2,839 2,593 ± 545 411 ± 194    57 ± 31 
Subtotal GI tract    111,236 ± 16,507 
 
62,356  ± 12,761       38,787 ±  18,749   13,769 ± 2,760 
 
     6,150 ± 1,234 
 
       2,202 ± 521 
 
         444 ± 114 
Kidney       4,496 ± 1,257 1,678 ± 384    4,493 ± 2,956 195 ± 25 96 ± 24 49 ± 15            13 ± 1 
Brain     9 ± 3            3 ± 0    4 ± 0 3 ± 2              1 ± 0 1 ± 0 1 ± 0 
Testes     86 ± 36  20 ± 2               18 ± 3 8 ± 4              7 ± 4 1 ± 0 1 ± 0 
Lungs        119 ± 18     54 ± 10   28 ± 5 6 ± 2           12 ± 6 3 ± 1 1 ± 0 
Heart               81 ± 11    20 ± 5   18 ± 2 3 ± 9 5 ± 3 2 ± 1            60 ±1 
Muscle         129 ± 42    69 ± 42      48 ± 19 9 ± 3              10 ± 3               4 ± 1              3 ±1 
Liver        474 ± 40           142 ± 35            190 ± 44           50 ± 6 46 ± 17             13 ± 2              6 ± 0 
Spleen   10 ± 2   2 ± 0   3 ± 1          0.4 ± 0          0.6 ± 0              0.8 ± 0           0.2 ± 0 
Red blood cell     4 ± 2 34 ± 9 12 ± 4 17 ± 12 6 ± 6 0  0 
Subtotal tissues  (B)        5,407 ± 1,340 2,021 ± 390   4,815 ± 2,953           293 ± 17        184 ± 41   75 ± 14 26 ± 2 
Total (A+B)  116,643 ± 17,596  64,377 ± 13,128    43,601 ± 21,692  14,055 ± 2,762 6,333 ± 1,275       2,276 ± 531  470 ± 113 
 
Sample 0-1 h 0-3 h 0-6 h 0-12 h 0-24 h 0-48 h 0-72 h 
Plasma 3,388  ± 3,299 41 ± 11 37 ± 5 5 ± 1               9 ± 8 2 ± 1 ndb 
Urine 5,435 ± 1,868    11,157 ± 2,759      23,089 ± 1,651   24,178 ± 3,719c      87,363 ± 11,381 93,708 ± 33,689 95,597 ± 34,018 
Faeces nd nd nd 1,519 ± 1,463          1,928 ± 739 5,701 ± 1,265      6,419 ± 936 
Cage washings 3,950 ± 3,667     2,841 ± 759        4,818 ± 1,693 12,531 ± 2,194      5,940 ± 1,883 7,153 ± 1,941     8,928 ± 2,143 
Subtotal (C)   12,773 ± 5,001 
 
      14,039 ± 3,298       27,944 ± 1,269 
 
38,233 ± 2,539 
 
   95,240 ± 34,986   106,564 ± 35,498 
 
 110,944 ± 35,240 
Total (A+ B+C )      129,417 ± 17,268   
 
    78,416 ± 10,685 
 
          71,546 ± 22,939 
 
   52,308 ± 4,866 
 
101,573 ± 35,408   108,840 ± 34,968 
 
 111,414 ± 35,231 
 
a
Radioactivity in the cage washings, urine and faeces are the cumulative amounts that have left the body since ingestion at 0 h. 
b
nd = not detected. 
c
This value is low because of 
spillage of an undetermined volume of urine during collection. 0-24, 0-48 and 0-72 h estimates based on a combination of data obtained with 0-12, 12-24, 24-48 and 48-72 h 
samples. 
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Table 3. 2  Percentage distribution of radioactivity expressed as a percentage intake in tissues, GI tract, plasma, red blood cells, cage washing, 
urine and faeces 1-72 h after ingestion of 140 x 10
6
 dpm of [
14
C]trans-caffeic acids by rats a. 
 
Tissue 1 h 3 h 6 h 12 h 24 h 48 h 72 h 
Stomach 62 % 7.1% 0.2% 0.4% 0.1% 0.2% 0.1% 
Duodenum 7.9% 8.1% 0.2% 0.3% 0.1% 0.1% <0.1% 
Jejunum/Ileum 9.1% 16% 1.1% 1.4% 1.1% 0.7% <0.1% 
Caecum <0.1% 6.0% 19.6% 3.9% 1.4% 0.3% 0.1% 
Colon <0.1% 7.4% 6.6% 3.9% 1.9% 0.3% <0.1% 
Subtotal  GI tract (A) 80% 45 % 28 % 9.8% 4.4% 1.6 % 
 
0.3% 
Kidney 3.2% 1.2% 3.2% 0.1% 0.1% <0.1% <0.1% 
Brain <0.1%     <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 
Testes 0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 
Lungs      0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 
Heart         <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 
Muscle 0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 
Liver      0.3% 0.1% 0.1% <0.1% <0.1% <0.1% <0.1% 
Spleen <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% 
Red blood cell <0.1% <0.1% <0.1% <0.1% <0.1% <0.1% Nd 
Subtotal tissues (B) 3.9 % 1.4% 3.4% 0.2% 0.1% 0.1% 0% 
Total (A + B) 83% 46% 31% 10% 4.5% 1.6% 0.3% 
 
Sample 0-1 h 0-3 h 0-6 h 0-12 h 0-24 h 0- 48 h 0-72 h 
Plasma 2.4% <0.1% <0.1% <0.1% 0.1% <0.1% ndb 
Urine 3.9% 8.0% 16% 17%c 62% 67% 68% 
Faeces nd nd nd 1.1% 1.4% 4.1% 4.6% 
Cage washings 2.8% 2.0% 3.4% 9% 4.2% 5.1% 6.4% 
Total (C) 9.1% 10% 20% 27% 68 % 76% 79% 
Total (A + B + C)     92%  56%    51% 37% 73%  78 % 80% 
a
Radioactivity in the cage washings, urine and faeces are the cumulative amounts that have left the body since ingestion at 0 h. 
b
nd = not detected. 
c
This value is low 
because of spillage of an undetermined volume of urine during collection. 0-24, 0-48 and 0-72 h estimates based on a combination of data obtained with 0-12, 12-24, 
24-48 and 48-72 h samples.  
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3.3.3 Distribution of radioactivity in rat tissues 
   The amount of radioactivity detected in the various body tissues 
outside the GI tract are also presented in Tables 3.1 and 3.2. The quantities 
detected in brain, testes, lungs, heart, muscle, and spleen were minimal, 
<0.1% of intake.  However 1.2–3.2% of intake was present in the kidneys with 
~10-fold lower levels in the liver after 1 h and 3 h. Despite the 140 x 106 dpm 
intake of [3-14C]caffeic acid the maximum amount of radioactivity transferred 
to the brain of the rats was a mere 9 x 103 dpm 1 h after ingestion (Table 
3.1). 
3.3.4 Identification of radiolabeled compounds 
   Aliquots of methanolic extracts of urine, faeces and sections of the GI 
tract containing >20 x 103 dpm of radioactivity were analyzed with HPLC-PDA-
RC-MS2 and MS3 the consecutive reaction monitoring (CRM). The data 
obtained from MS2 and MS3 daughter ions were then compared with the 
available standards for trans- and cis-caffeic acid and in the case of other 
metabolites were referred to published MSn fragmentation patterns (Poquet 
et al., 2008; Stalmach et al., 2009; Farrell et al., 2011). A total of 13 
radiolabeled compounds were detected and nine were identified on the basis 
of the properties summarized in Table 3.3. These are described below. 
Peaks 3 (tR- 16.8 min) and 6 (tR- 18.3 min)  had a negatively charged 
molecular ion ([M-H]–) at m/z 355 which yielded an M–176 daughter ion at 
m/z 179 which equates with the loss of a glucuronide moiety, and a further 
MS2 fragment at m/z 135 corresponding to caffeic acid. These metabolites 
were detected in urine, and in keeping with data of Farrell et al.(2011), were 
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tentatively identified as a caffeic acid-4′-O-glucuronide (peak 3) and caffeic 
acid-3-O-glucuronide (peak 6).  
Peaks 4 (tR- 18.1 min) and 5 (tR- 19.2min) both having a [M-H]
– at m/z 
179, which upon MS2 produced an ion at m/z 135, were caffeic acid 
constituents. Based on cochromatography with reference compounds, the 
earlier eluting peak 4 was identified as trans-caffeic acid, the radiolabeled 
substrate ingested by the rats, while the later eluting minor component, peak 
5 was cis-caffeic acid. Both compounds were detected in the GI tract at the 1 
h and 3 h time points. 
Peak 7 (tR- 20.2 min), which was detected in urine had a [M-H]
– at m/z 
369, that produced an MS2 ion m/z 193, a 176-amu loss indicative of cleavage 
of a glucuronide moiety.The fragmentation pattern and chromatographic 
properties suggest this peak is ferulic acid-4-O-glucuronide and this was 
confirmed by cochromatography with a chlorogenic acid metabolite 
previously identified as ferulic acid-4′-O-glucuronide by Stalmach et al.(2009). 
Peaks 8 (tR- 22.8 min) and 9 (tR- 25.4 min) both had a [M-H]
– at m/z 
259, which upon MS2 produced an ion at m/z 179, with an 80 amu loss of a 
sulphate unit. Peak 8 was identified as caffeic acid-4-O-sulphate and peak 9 
as caffeic acid-3-O-sulphate on the basis of cochromatography with 
previously identified chlorogenic (Stalmach et al., 2009). 
Peak 10 (tR- 26.1 min) and peak 11 (tR- 29.7 min) both had a [M-H]
– at 
m/z 273, which produced a daughter ions at m/z 193, an 80 amu loss of 
sulphate. The identity of these metabolites were confirmed as ferulic acid-4-
O-sulphate (peak 10) and isoferulic acid-3-O-sulphate (peak 11) on the basis 
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of cochromatography with a previously identified metabolite of chlorogenic 
acids (Stalmach et al., 2009). 
It was not possible to identify peak 1, 2, 12 and 13 ( see Figure 3.2, 3.3 
and 3.4), named respectively as unknowns A, B, C and D, since they did not 
ionise and produce recognizable mass spectra. Unknown A and D were 
detected in caecum and colon, unknown B in the faeces, and unknown C in 
urine (Table 3.3). 
3.3.5 Radiolabeled compounds in the GI tract 
   HPLC-RC profiles of radioactivity in the various segments of the GI 
tract 1, 3, and 6 h after [14C]trans-caffeic intake are illustrated in Figure 3.2. 
The amounts of the various radiolabeled compounds detected are expressed 
both as dpm x 103 and as a percentage of the total radioactivity of each 
segment of the GI tract in Table 3.4.  
One hour after ingestion of [14C]trans-caffeic acid most radioactivity 
remained  in the GI tract. The main components in the stomach, duodenum, 
and ileum were the unmetabolized trans isomer (76-87%) along with smaller 
amounts of cis-caffeic acid (13-24%). Three hours after intake the 
radioactivity had progressed down to the distal GI tract with trans-caffeic 
acid remaining the main radiolabeled component in the ileum (72%) and 
caecum (30%). The ileum also contained cis-caffeic acid (16%). The caecum, 
contained unknown A (41%), unknown D (11%), and caffeic acid-3-O-sulphate 
(18%). No radiolabeled compound was present in the colon in detectable 
amounts at this stage. 
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Six hours after [14C]trans-caffeic acid intake most of the radioactivity 
remaining in the GI tract was in the caecum and colon in the form of the 
unknown metabolite D, peak 13 (Figure 3.2, Table 3.4). At the later 12, 24, 
48, and 72 h time points only traces of radioactivity remained in the GI tract 
with no metabolites present in sufficient quantities to facilitate identification 
(Figure 3.3).  
3.3.6 Radiolabeled compounds in urine and faeces 
   Radioactivity in urine and faeces (Tables 3.1 and 3.2) are the 
cumulative amounts that had been excreted from the body of the rats after 
ingestion of [14C]trans-caffeic acid. HPLC-RC profiles of radiolabeled 
metabolites detected in urine are illustrated in Figure 3.4, with mean 
quantitative data presented in Table 3.5.  
In the first hour after intake, seven radiolabeled metabolites were 
excreted in urine. These were caffeic acid-4-O-glucuronide (38%), caffeic 
acid-3-O-glucuronide (2.1%), ferulic acid-4-O-glucuronide (3.2%), caffeic 
acid-4-O-sulphate (16%), caffeic acid-3-O-sulphate (11%), ferulic acid-4-O-
sulphate (28%) and isoferulic acid-3-O-sulphate (1.4%). 
Analysis of the urine samples, detected the presence of unmetabolized 
trans-caffeic acid in the 0-3 h, 0-6 h, 0-12 h and 12-24 h samples. Caffeic 
acid-3-O-glucuronide and ferulic acid-4-O-glucuronide were detected only in 
0-1 h urine. Caffeic acid-4-O-sulphate, caffeic acid-3-O-sulphate, ferulic 
acid-4-O-sulphate, and the smaller quantities of isoferulic acid-3-O-sulphate 
were all excreted in the 0-1 h urine and the amounts remained relatively 
constant in the 0-3 h, 0-6 h and 0-12 h samples but declined in the 0-24 
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urine. Caffeic acid-4-O-glucuronide followed a similar profile, but it 
excretion was more prolonged with relatively high amounts in the 12-24 h 
urine. None of these metabolites were excreted after 24 h and the 24-48 h 
and 48-72 h samples contained only low levels of the unknown metabolite C 
in quantifiable amounts (Figure 3.4, Table 3.5). 
The 0-12 h and 0-24 h faeces contained the unknown metabolite B 
(Figure 3.3, Table 3.5), and although increased amounts of radioactivity were 
present in the 24-48 and 48-72 h faecal material, no metabolites were 
present in sufficient amounts to facilitate identification and quantification.  
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Table 3. 3 HPLC-MS2 identification of trans-caffeic acid metabolites in extracts of tissues and body fluids after ingestion of 140 x 106 dpm 
[14C]trans-caffeic acid by rats a. 
 
Peak 
No 
HPLC 
tR 
(min) Compound 
[M-
H]– 
(m/z) MS2 (m/z) MS3 (m/z) Location 
1 15.6 unknown A -   Caecum 
2 16.4 unknown B -   Faeces 
3 16.8  caffeic acid-4-O-glucuronide 355 179 135 urine 
 4 18.1 trans-caffeic acida 179 135  GI tract, urine 
 5 19.2 cis-caffeic acida 179 135  GI tract 
 6 18.3 caffeic acid-3-O-glucuronidea 355 179 135 urine 
 7 20.2 ferulic acid-4-O-glucuronidea 369 193, 113, 175  urine 
 8 22.8 caffeic acid-4-O-sulphatea 259 179 135 urine 
 9 25.4 caffeic acid-3-O-sulphatea 259 179 135 jejunum/ileum, 
caecum, urine  
 
10 26.1 ferulic acid-4-O-sulphatea 273 193 178, 149, 134 urine 
 11 29.7 isoferulic acid-3-O-sulphatea 273 193 178 caecum, urine 
 12 30.4 unknown C -   urine 
 13 43.0 unknown D -   caecum, colon 
 
a
Indicates cochromatography with a reference compound. 
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Table 3. 4  Levels of 14C-labeled compounds in the GI tract 1, 3, 6, and 12 h after ingestion of 140 x 106 dpm of [14C]trans-caffeic acid by rats a. 
 
Compound (Peak )  1 h Stomach 1 h Duodenum 1h Ileum 3 h Ileum 3 h Caecum 6 h Caecum 6 h Colon 12 h Caecum 12 h Colon 
unknown–A (1) ndb Nd nd nd 3,460 (41%) nd nd Nd nd 
trans-caffeic acid (4) 73,681 (87%) 9,060 (81%) 9,712 (76%) 16,128 (72%) 2,538 (30%) nd nd Nd nd 
cis-caffeic acid (5) 11,739 (13%) 2,075 (19%) 2,988 (24%) 3,567 (16%) n.d. nd nd Nd nd 
caffeic acid-4-O-sulphate (8) nd Nd nd nd n.d. nd nd Nd nd 
caffeic acid-3-O-sulphate (9) nd Nd nd 2,647 (12%) 1,536 (18%) nd nd Nd nd 
unknown –D(13) nd Nd nd n.d. 912 (11%) 27,484 (100%) 9,272 (100%) 5,441 (100%) 5,502 (100%) 
 
a
Data expressed as dpm x 10
3
 and in parentheses as a percentage of the radioactivity in each sample at individual time point. 
b
nd= not detected.
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Table 3. 5 Levels of 14C-labeled metabolites in urine 0-72 h and faeces 12 and 24 h after ingestion of 140 x 10 6 dpm of [14C]trans-caffeic acid by 
ratsa. 
 Urine Faeces 
Compound (Peak ) 0-1 h 0-3 h 0-6 h 0-12 h 0-24 h 24-48 h 48-72 h 0-12 h 0-24 h 
 
caffeic acid-4’-O-glucuronide (3) 
 
2,084 (38%) 
 
1,536 (14%) 
 
3,308 (14%) 
 
5,671 (24%) 
 
35,489 (42%) 
 
ndb 
 
nd  
 
Nd 
 
nd 
unknown–B  (2) 
 
nd 
 
nd 
 
nd 
 
nd 
 
nd 
 
nd 
 
nd 
 
1,519 (100%) 
 
1,928 (100%) 
 
trans caffeic acid (4) 
 
nd 
 
2,437 (22%) 
 
7,466 (32%) 
 
6,185 (26%) 
 
8,358(9.9%) 
 
nd 
 
nd 
 
 
nd nd 
 
nd 
 
caffeic acid-3-O-glucuronide (6) 
 
 
 
112 (2.1%) 
 
nd 
 
nd 
 
nd 
 
 nd 
 
nd 
 
nd 
 
Nd 
 
nd 
ferulic acid-4-O-glucuronide (7) 
 
171 (3.2%) 
 
nd 
 
nd 
 
nd 
 
nd 
 
nd 
 
nd 
 
Nd 
 
nd 
caffeic acid-4-O-sulphate (8) 
 
875 (16%) 
 
2,242 (20%) 
 
2,995 (13%) 
 
3,073 (13%) 
 
6,813 (8.1%) 
 
nd 
 
nd 
 
nd 
 
nd 
caffeic acid -3-O- sulphate(9) 
 
569 (11%) 
 
1,364 (12%) 
 
2,563 (11%) 
 
3,506 (15%) 
 
7,383 (8.8%) 
 
nd 
 
nd 
 
nd 
 
nd 
ferulic acid -4-O- sulphate (10) 
 
1,545 (28%) 
 
3,169 (28%) 
 
5,642 (24%) 
 
4,691 (19%) 
 
9,693 (12%) 
 
nd 
 
nd 
 
nd 
 
nd 
isoferulic acid-3-O-sulphate (11) 
 
684 (1.4%) 
 
409 (4.8%) 
 
1,114 (5%) 
 
1,052 (4.4%) 
 
nd 
 
nd 
 
nd 
 
nd 
 
nd 
 
unknown–C (12) 
 
nd 
 
nd 
 
nd 
 
nd 
 
16,627(20%) 
 
6,345 (100%) 
 
1,889 (100%) 
 
nd 
 
nd 
 
a
Data expressed as dpm x 10
3
 and in parentheses as a percentage of the radioactivity in each sample at individual time point. nd-not detected.
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Figure 3. 2 HPLC-RC analysis of radiolabeled compounds in the individual sections of 
the GI tract rats, 1, 3, and 6 h after the ingestion of [14C]caffeic acid. For the 
identification of numbered peaks see Table 3.3. 
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Figure 3. 3  Radiolabeled compounds in the GI tract and faeces at 12, 24, and 48 h 
after the ingestion of [14C]caffeic acid. For the identification of numbered peak see 
Table 3.3 
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Figure 3. 4 HPLC-RC analysis of radiolabeled compounds in the urine 0-72 h after 
ingestion [14C]caffeic acid. For the identification of numbered peak see Table 3.3. 
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3.3.7 Radiolabeled compounds in kidney, liver and other 
tissues 
The amount of the radioactivity accumulated in tissues outside GI tract 
was minimal throughout the study with most being detected in the kidneys 1, 
3 and 6 h after the intake (1.2–3.2%). Despite the high amount of the 
radioactivity excreted in the urine, only trace amounts of radioactivity were 
detected in plasma. Due to low level of radioactivity in all these samples, no 
metabolites were identified by HPLC-RC-PDA-MS2. 
3.4 Discussion 
The study was designed to obtain the information on the absorption, 
metabolism, and overall bioavailability of [14C]trans-caffeic acid following its 
ingestion by rats. Based on the data obtained from HPLC-PDA-RC-MS2 
analyses, information on the metabolism and catabolism of the radiolabeled 
substrate as it passed through the GI tract and was excreted in urine and, to 
a lesser degree, faeces are presented in Tables 3.4 and 3.5 and summarised 
in Figure 3.5.  
After 1 h, most of the radioactivity remained in the stomach in the form 
of trans-caffeic acid and its cis isomer.  Smaller amounts of these compounds 
were also present in the duodenum and the ileum/jejunum. At this point, the 
plasma contained 2.4% of the ingested radioactivity indicating some 
absorption in the small intestine (Renouf et al., 2010), however  no 
metabolite was present in identifiable quantities. Urine collected in the first 
hour contained caffeic acid metabolites, indicative of absorption in the 
proximal GI tract. The metabolites were caffeic acid-4-O-glucuronide, 
caffeic acid-3-O-glucuronide, ferulic acid-4-O-glucuronide, caffeic acid-3-O-
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sulphate, caffeic acid-4-O-sulphate, ferulic acid-4-O-sulphate, and smaller 
amounts of isoferulic acid-3-O-sulphate which reflect phase II metabolism of 
caffeic acid upon its removal from the lumen of the GI tract, possibly in the 
intestinal epithelium or the liver. Previous published results have 
demonstrated that caffeic acid incubation with human hepatoma HepG2 cells 
produced methylated, glucuronidated and sulphated conjugates, which 
suggested the phase II metabolism occurs in  the liver  (Mateos et al., 2006). 
The same pattern of caffeic acid metabolism was also observed in rat 
hepatocytes and isolated microsomal fractions (Moridani et al., 2002).  
Absorbed caffeic acid are subjected to conjugation by various enzymes 
before entering the blood stream: methylation by COMT catalyses the 
transfer of a methyl group S-adenosyl-L-methionine to (poly)phenols, which 
activity is highest in the liver and kidneys, sulfation by SULT and -
glucuronidation by UDP-glucoronosyltransferases, a membrane bound 
enzymes that catalyze the transfer of glucuronic acid (Manach et al., 2004; 
Williamson and Clifford, 2010). In humans, 15 isoforms of UDP-
glucuronosyltranferases have been identified, one known as  UGT1A located 
in the intestine, may play an important role in the first-pass metabolism of 
(poly)phenols (Fisher et al., 2001). 
In the jejunum/ileum trans- and cis-caffeic acid were the main 
compounds detected after 1 and 3 h of ingestion of 14C-caffeic acid. At this 
juncture, the main radioactive compound in the caecum was trans-caffeic 
acid along with smaller amounts of caffeic acid-3-O-sulphate and the 
unidentified compounds, metabolites A and D. Radioactivity in the caecum 
and colon at 6 and 12 h was exclusively in the form of the unknown 
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metabolite D while the unknown B was the sole radiolabeled metabolite to be 
detected in faeces.   
Urine collected 0-6 h after [14C]trans-caffeic acid intake contained 
radiolabeled caffeic acid-4-O-glucuronide, caffeic acid-3-O-sulphate and 
caffeic acid-4-O-sulphate, ferulic acid-4-O-sulphate, isoferulic acid-4’-O-
sulphate and caffeic acid. The increased amounts of radiolabeled caffeic 
acid-4-O-glucuronide in the 0-12 and 0-24 h, and isoferulic acid-4-O-sulphate 
in the 0-12 h, urine samples suggest that the formation of these derivatives 
may occur in the lower GI tract. Sulphates were the main hydroxycinnamate 
metabolites but it is not possible to determine the extent sulfation occurs in 
the wall of the small intestine and the colon or is hepatic in origin. Similarly 
in humans, sulfation is more dominant than glucuronidation for caffeic acid as 
shown with human intestinal S9 homogenates (Wong et al., 2010). SULT 
catalyze the transfer of sulphate moiety from 3′-phosphoadenosine-5′-
phosphosulphate to a hydroxyl group  of (poly)phenols  and occur mainly in 
the liver (Falany, 1997; Piskula and Terao, 1998). However, later a human 
study has indicated that SULT 1A1 which is the most active isoform for 
sulfation of caffeic, isoferulic and dihydrocaffeic acid (Wong et al., 2010) is 
highly expressed in the liver and intestine (Teubner et al., 2007). 
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Faeces (0-24 h)
Figure 3. 5 Schematic of the metabolism of [
14
C]caffeic acid in rats following ingestion, movement down the GI tract, and subsequent 
appearance of radiolabeled metabolites in faeces and excretion in urine. Values for caffeic acid and metabolites inside the boxes represent 
their percentage of total radioactivity in the individual sections of the GI tract and/or faeces and urine. Values outside the boxes indicate 
radioactivity as a percentage of the amount ingested. 
 
Chapter 3 2013 
 
104 
 
Over the 72 h post-ingestion period, a total of 68% of the radioactivity was 
excreted in urine indicating that, despite the low levels in plasma, substantial 
amounts of radioactivity were passing through the circulatory system en route to 
the kidneys and excretion in urine. Urine and to the lesser extent faeces were 
reported to be the main route of radioactivity disposal from the body, where 
48% and 68% radioactivity were recovered  in the urine with 25% and 19% in the 
faeces of rats 24 h following the injection of [3-14C]cinnamic and [2-14C]ferulic 
acid (Teuchy and Van Sumere, 1971). High recovery of radioactivity (82-90%) was 
also observed in the urine of rats and mice after administration [3-14C]-cinnamic 
acid (Nutley et al., 1994). 
The urinary excretion and the low levels of radioactivity in faecal samples 
also demonstrate efficient absorption and high bioavailability of caffeic acid. 
Studies in humans which utilized coffee as main source for the hydroxycinnamic 
acids have provided the supporting evidence of the high bioavailability of these 
compounds where plasma concentration peaks were observed 0.5 h after the 
administration of green coffee and decaffeinated coffee, with more than 30-50% 
of the ingested moieties were recovered in plasma (Olthof et al., 2003; Monteiro 
et al., 2007; Farah et al., 2008) This is in keeping with the high urinary excretion 
of hydroxycinnamate metabolites after the consumption of caffeoylquinic acid-
rich coffee by human volunteers (Stalmach et al., 2009). 
 The high absorption of caffeic acid observed in the study is in line with 
the fact that free form of hydroxycinnamic is more efficiently absorbed than its 
esterified form. Ingested caffeic acid in rats showed the maximum concentration 
of metabolites 100-fold greater than that of chlorogenic acid metabolites 
(Azuma et al., 2000; Olthof et al., 2001). Ferulic acid is reported to be 
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efficiently absorbed (up to 25%) from tomatoes in human, with 50% of its 
excreted by rats and the absorption markedly reduced to 3% when ingested with 
wheat bran (Bourne and Rice-Evans, 1998; Adam et al., 2002; Kern et al., 2003a; 
Mateo et al., 2009).  
The proposed pathway for the metabolism of caffeic acid as it passes 
through the body of the rats is illustrated in Figure 3.6. trans-Caffeic acid 
underwent some degree of conversion to its cis isomer, as well as methylation, 
sulfation, and glucuronidation, events that were readily monitored through the 
use of a 14C-labeled substrate. The routes are similar, but not identical, to those 
operating in humans after the ingestion of 5-O-caffeoylquinic acid (Stalmach et 
al., 2009; Stalmach et al., 2010b). In humans, methylation via COMT appears 
more extensive as evidenced by the occurrence of a more diverse spectrum of 
ferulic acid, isoferulic acid, dihydroferulic acid metabolites appearing in plasma 
and urine as major components (Rechner et al., 2001; Monteiro et al., 2007). 
Also in humans in the small intestine and colon, in contrast to rats, 
dehydrogenation of the hydroxycinnamate side chain occurs as indicated by 
formation of dihydrocaffeic acid and dihydroferulic acid metabolites 
(Peppercorn and Goldman, 1972). Arguably the absence of these metabolites in 
rats reflects differences in the composition of their colonic microflora. Humans, 
unlike rats, also produce feruloglycine as a caffeic and ferulic acid metabolite, 
and this is probably a reflection of differences in hepatic enzymes (Kern et al., 
2003b). 
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Figure 3. 6 Proposed routes of metabolism of trans-caffeic acid following ingestion by 
rats. CAI-caffeic acid isomerise, COMT-catechol-O-methyltransferase, SULT- 
sulfotransferases, UGT-uridine-5-diphosphate-glucuronosyltransferase. 
 
The formation of cis-caffeic acid in the stomach within 1 h is of interest, as 
it was not a contaminant of the [14C]trans-isomer that was ingested by the rats. 
Possibly there is a mammalian or gut bacterial enzyme able to produce this 
transformation, but reduction to dihydrocaffeic acid and non-specific oxidation 
to yield both cis- and trans-caffeic acid is another possibility. However, the 
absence of dihydrocaffeic acid does not support this option.  
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The relative proportions change little after the bolus has left the stomach 
(Table 3.4), suggesting that the gut microflora are not involved. Although Poquet 
et al.(2008) have observed a putative cis-ferulic acid glucuronide, no 
radiolabeled metabolites of cis-caffeic acid were detected in the present study. 
3.5 Conclusion 
In conclusion this study has proved the advantages of using radiolabeled 
compound to monitor the absorption, disposition, metabolism, and excretion 
compound of interest in this case, caffeic acid. This is support by the evidence 
that ~80% of [3-14C]caffeic acid intake has been recovered in rats. Caffeic acid is 
highly bioavailable and based on the pathway proposed, its metabolism in rats 
although is not identical, is following the same routes as in human. 
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4 CAFFEIC ACID METABOLISM BY COLONIC 
MICROFLORA 
 
4.1 Introduction 
Caffeic acid is the prominent hydroxycinnamic acid representing between 
75-100% of the total hydroxycinnamic acid content of fruits either in the free 
form or esterified as in chlorogenic acids such as 5-O-caffeoylquinic acid (5-CQA)  
(Manach et al., 2004; Crozier et al., 2006). There is evidence indicating that 5-
CQA is absorbed less readily in the small intestine than caffeic acid. Some 
esterase-catalysed hydrolysis of 5-CQA, releasing caffeic acid, occurs in the 
small intestinal mucosa but most progresses along the GI  tract  and enters the 
large intestine where it is subject to the action of the colonic microbiota (Booth 
et al., 1957; Scalbert et al., 2002). Caffeic acid released by hydrolysis of 5-CQA 
in the colon can be absorbed into the circulatory system but can also be subject 
the further metabolism prior to absorption (Chesson et al., 1999). There was 
evidence of absorption of intact 5-CQA in the stomach of rats (Lafay et al., 
2006b) but in humans most evidence points to only limited absorption of 5-CQA 
per se (Stalmach et al., 2012). 
In rats, ingested 5-CQA appears to be hydrolyzed in the upper part of the 
GI tract with caffeic acid and aromatic metabolites being rapidly detected in 
plasma (Azuma et al., 2000; Nardini et al., 2002). 5-CQA which is not hydrolysed 
passes to the colon where it will be hydrolyzed by the microflora releasing 
caffeic acid and quinic acid (Figure 4.1).  
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The colonic microflora will transform caffeic acid to dihydrocaffeic acid 
[aka 3-(3,4-dihydroxyphenyl)propionic acid], 3-(3-hydroxyphenyl)propionic 
acid, 3-hydroxybenzoic acid, m-coumaric acid, hippuric and 3-hydroxyhippuric 
acid. Dihydrocaffeic acid generated by gut microflora also associated with the 
coffee intake (Clifford, 2000). Many of these compounds have been considered 
to exert physiological effects with evidence for the prevention of different 
cancer and cardiovascular diseases being obtained in several studies (Tanaka et 
al., 1993; Jin et al., 2005).  
 
 
 
 
Figure 4. 1 Degradation of caffeic acid by colonic microflora. 
 
 Aims of the study 
The aim of this study was to investigate the metabolism of caffeic acid 
during in vitro incubation with human colonic microflora. Analysis of catabolites 
was performed by GC-MS.  
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4.2 Materials and methods 
 
4.2.1 Chemicals and reagents 
 
  Caffeic acid was purchased from AASC Ltd (Southampton, UK). Analytical 
grade chemicals were used in preparing the buffer, macromineral, micromineral 
and reducing solutions. Manganese chloride, cysteine hydrochloride, sodium 
sulphate nonahydrate, resazurin were purchased from Sigma-Aldrich (Dorset, 
UK). Ammonium bicarbonate and calcium chloride were obtained from Fisher 
Scientfic (UK), while cobalt chloride and magnesium sulphate were supplied by 
VWR International (UK). HPLC grade methanol and formic acid were purchased 
from Fisher Scientfic Ltd (Leichestershire, UK). 
4.2.2 Fermentation medium 
  The fermentation medium was prepared by mixing 2.5 g of tryptone in 
450 mL of distilled water and 112.5 L of micromineral solution (consisting of 
13.2 g of CaCl2.2H2O, 10 g of MnCl2.4H2O, 1 g of CoCl2.6H2O, 8 g FeCl3.6H2O and 
distilled water up to 100 mL). This mixture was agitated to dissolve the 
chemicals and then 225 mL of buffer solution (consisting of 2 g of NH4HCO3, 17.5 
g NaHCO3 and distilled water added up to 500 mL), 225 mL of macromineral 
solution (consisting of 2.85 g of Na2HPO4, 3.1 g KH2PO4, 0.3 g MgSO4.7H2O and 
500 mL distilled water was added) and 1125 μL of 0.1% (w/v) resazurin solution 
(a redox indicator) were added. This fermentation medium was adjusted to pH 7 
using 6 M HLC and subsequently sterilised by boiling for a few minutes and 
allowed to cool under oxygen-free nitrogen (OFN) around 30 minutes to remove 
oxygen (medium colour changed from blue to pink). For each 10 mL of the 
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medium, 0.5 mL reducing solution (consisting of 312.5 mg of cysteine 
hydrochloride, 2 mL of 1 M NaOH, 312.5 mg Na2S.9H2O and make up to 50 mL 
with distilled water) was added. 
4.2.3  Subjects 
Five subjects, (3 female and 2 male) all Asian, were recruited for the study, 
designated as volunteer 1 (V-1), volunteer 2 (V-2), volunteer 3 (V-3), volunteer 4 
(V-4) and volunteer 5 (V-5). They were all non-smokers, aged between 25-40 
years, had no history of gastrointestinal problems and had not taken antibiotics 
for at least three months prior to the study. The volunteers were asked to follow 
a low (poly)phenol diet for 48 h prior to faecal collection (See Appendix 4.1). All 
collected faecal samples were processed within 30 min of passage. 
 
4.2.4 In vitro fermentation  
 
The in vitro fermentation was performed according to the method previously 
described by (Jaganath et al., 2009) For each donor, 6.4 g of freshly voided 
faecal sample was homogenized with 20 mL of sodium phosphate buffer to 
obtain 32 % faecal slurry. Five mL of the slurry was added to 44 mL pre-reduced 
fermentation medium and 1 mL of substrate (with or without glucose) in 100 mL 
fermentation bottles (total volume of 50 mL). The substrates used were as 
follows: 
Control- distilled water: 
1. 55 µmoles of caffeic acid with 0.5 g of glucose. 
2. 55 µmoles of caffeic acid without glucose 
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After the addition of the substrate, the fermentation bottles were purged 
with oxygen OFN and sealed airtight. Samples were placed horizontally in a 
shaking water bath at 60 strokes/min and incubated at 37°C for 48 h, aiming to 
stimulate the conditions in the colonic lumen. Aliquots of the fermented faecal 
samples (3-5 mL) were collected after 0, 1, 2, 4, 6, and 8 h and stored 
immediately at -80°C. 
4.2.5 Extraction of phenolic acids for GC-MS analysis 
Phenolic acid extraction, derivatization, and analysis of faecal slurries for 
GC-MS analysis were adapted after a method of Roowi et al.(2010). A 60 μg 
aliquot of 2,4,5-trimethoxycinnamic acid was added to 1 mL of faecal slurry. 
Samples were acidified by adding 300 L of 1M HCL and partitioned twice against 
1.5 mL volumes of ethyl acetate. The upper organic phases were combined, 
transferred to an amber glass vial and dried at 40°C under a stream of nitrogen. 
Samples were further dried by the subsequent addition and evaporation of 200 
L of dichloromethane. Three hundred microliter of N,methyl-N-
(trimethylsily)trifluoroacetamide and pyridine mixture (1:4, v:v) was added to 
each vial, and the head space flushed with a gentle flow of nitrogen before 
sealing. Samples were derivatized at 80°C for 20 min for complete silylation. A 
set of standard calibrations solutions of phenolic acids ranging from 54-216 
µg/mL was prepared and treated in a similar manner to the extracted samples. 
4.2.6 GC-MS analysis of faecal slurries 
Derivatized samples were analyzed with GC-MS (Agilent 6890 Series) 
equipped with a split/splitless injector and a Agilent 7683 autosampler. 
Separations were carried out on a ZB-5MS (30 m x 0.25 id x 0.25 m) capillary 
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column (Phenomenex, UK) with helium carrier gas (1.2 mL/min). Derivatized 
samples (1 L) were injected with 1 L syringe into the GC injection port in split 
mode with a 1:25 ratio. The GC-MS conditions were as follows: The inlet 
temperature was maintained at 220°C. The oven was programmed from 40°C 
(held 0.1 min) to 160°C at 20°C/min, to 200°C at 1.5°C/min, to 250°C at 10°C 
to a final temperature of 300°C at 40°C/min held for 5 min. The transfer line 
was maintained at 310°C. Data analysis and acquisition were performed using 
MSD Chemstation software. Phenolic compounds were identified based on their 
retention time, mass spectra of authentic standards and NIST library screening. 
4.2.7 Statistical analysis 
  All samples were analyzed in triplicate for GC-MS.  Data are presented as 
mean values  standard error (n=3). When appropriate, data were subjected to 
statistical analysis using (ANOVA) to determine the significance difference of 
glucose supplement between samples. Statistical analyses were performed using 
PSPP (free software). 
4.3 Results 
4.3.1 Degradation of caffeic acid incubated with faecal slurries 
  Analysis of the faecal slurries incubated with caffeic acid revealed the 
degradation of caffeic acid by the colonic microflora. The rate of caffeic acid 
degradation at 6 time points over 8 h periods during incubation with 55 µmoles 
of caffeic acid in 5 volunteers are presented in Figure 4.2.   
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Figure 4. 2 Degradation of caffeic acid (55 µmoles).  
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Caffeic acid was rapidly degraded by human microbiota, from all the 
volunteers. The initial substrate dose was 55 µmoles, from which 77-89% (43-49 
µmoles, without glucose) and 82-92% (46-52 µmoles, with glucose) of caffeic 
acid, was recovered at the initial 0 h time point. In the absence of glucose 
caffeic acid was completely metabolized at 6 h in samples from three 
volunteers, V-1, V-2 and V-5, and the clearance was enhanced with the addition 
of glucose as all the caffeic acid had disappeared. However, in V-3 and V-5 the 
disappearance of caffeic was not affected by the addition glucose where caffeic 
acid clearance was 8 h under both conditions.  
Overall the results demonstrate the effect of glucose supplement was 
different among the five volunteers (p< 0.5). Based on the graph presented in 
Figure 4.3, only V-1 and V-3 showed clear effect of glucose supplement with the 
rate of degradation of caffeic acid with slower degradation of caffeic acid being 
enhanced. This is keeping with glucose acting as a carbon source for the bacteria 
(Wang and Gibson, 1993; Edwards et al., 1996) which enhanced colonic 
catabolism of caffeic acid, although the profiles varied substantially between 
individual volunteers.  
4.3.2 Identification of phenolic acid catabolites 
A summary of the four identified catabolites identified by GC-MS is presented 
in Table 4.1 and illustrated in Figure 4.3. 3-Phenylpropionic acid was detected in 
trace amounts in the faecal incubates but was also present in the control 
(distilled water) indicating that it was not a product of caffeic acid catabolism. 
It was therefore, not quantified.  
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Incubation with active human microbiota resulted in rapid degradation of 
caffeic acid. Disappearance of caffeic acid was associated with the appearance 
of three catabolites which were identified as phenylacetic acid, 3-(3-
hydroxyphenyl)propionic acid and dihydrocaffeic acid (aka 3,4,-
dehyroxyphenyl)propionic acid). Accumulation of these metabolites are 
presented in Table 4.2, and illustrated in Figure 4.4 respectively. 
Table 4. 1 GC-MS identification of phenolic acids detected in human faecal slurries after 
incubation with caffeic acid. 
 
Compound 
 
tR (min) 
 
Identified 
ion (m/z) 
 
Qualifier ion (m/z) 
 
 
Identification 
 
Phenylacetic acid 6.59 73 164,193,91 Standard 
 
3-Phenylpriopionic acid  7.75 104 73,207,91,222 Standard 
 
3-(3'-Hydroxyphenyl)propionic 
acid 
13.3 205 192,310,177,73 Standard 
 
Dihydrocaffeic acid 20.8 179 398,267,73,280 Standard 
 
Caffeic acid 29.4 396 73,219,307,384 Standard 
 
Phenylacetic acid was detected in incubates from all volunteers with and 
without the addition of glucose. Low levels of this catabolite were detected as 
earlier at 0 h with the addition of glucose in all the volunteers. Its amount 
increased slightly over the time. In all volunteers the highest accumulation of 
this catabolite was between 6-8 h, with the amount varying depending upon the 
presence or absence of glucose. The highest amount of phenylacetic acid was 
detected in V-2 (21.2 µmoles) in the absence of glucose. 
3-(3-Hydroxyphenyl)propionic acid  (3HPPA) was detected in incubates from 
all volunteers with and without the addition of glucose. This catabolite was 
estimated as the second product of caffeic catabolized during the incubation. It 
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was initially detected at 2 h. Its accumulation was enhanced by the presence of 
glucose, in samples from all volunteers. The highest amount of this catabolite 
was detected at 8 h, with the main producers being V-1 and V-2 (32 µmoles).  
Dihydrocaffeic acid was the main catabolite detected during incubation of 
human faecal slurries with caffeic acid. In all volunteers the disappearance of 
caffeic acid was marked with a gradually increase of dihydrocaffeic acid, which 
was first detected at 1 h. The production of dihydrocaffeic acid was enhanced 
with the addition of glucose in all volunteers. The formation of dihydrocaffeic 
acid reached a peak between 4-6 h in faecal samples from all volunteers with 
the highest amount recorded being 45 µmoles in V-2 in the presence of glucose. 
Overall the results demonstrate that caffeic acid degradation varied in 
the faecal samples from different individuals. The impact of the presence of 
glucose in the incubation medium also varied (p< 0.5). Based on the results 
presented in Table 4.2, the effect of glucose supplement varied between 
individuals and also in terms of formation of the catabolites. In the absence of 
glucose, the formation of phenylacetic acid was higher in V-1, V-2 and V-3, 
whereas in V-4 and V-5 the amount of phenylacetic acid was higher in the 
presence of glucose. In all volunteers except V-5, glucose addition increased the 
formation of 3-(3-hydroxyphenyl)propionic acid. Interestingly, the formation of 
dihydrocaffeic acid was enhanced in all volunteers in the presence of glucose. 
Therefore, although the effect of glucose supplement varied between these 
Asian volunteers, it appears that the formation of dihydrocaffeic is enhanced by 
the addition of glucose to the faecal incubates. 
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Figure 4. 3 Chromatogram of faecal material from V-1 (at 4 h) during incubation with 
caffeic acid analysed by GC-MS. 
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Volunteer Metabolite Glucose 0 h 1 h 2 h 4 h 6 h 8h 
V-1 Caffeic acid - 49 ± 5.9 50 ± 0.8 44 ± 1.7 22 ± 0.7 0 0 
  + 45 ± 1.2 47 ± 1.3 30 ± 2.5 0 0 0 
 Phenylacetic acid - 0 0 1.0 ± 0.2 2.1 ± 0.1 4.9 ± 0.2 7.1 ± 0.1 
  + 0.7 ± 0.1 1.4 ± 0.1 2.1 ± 0.3 2.4 ± 0.2 2.9 ± 0.1 2.9 ± 0.1 
 3-(3-hydroxyphenyl)propionic 
acid 
- 0 0 0 2.8 ± 0.1 13  ± 0.7 32  ± 1.0 
  + 0 0 0.5 ± 0.0 4.0 ± 0.2 6.1 ± 0.1 8.8 ± 0.3 
 Dihydrocaffeic acid - 0 0 4.4 ± 0.1 20  ± 0.7 30  ± 1.1 4.7 ± 0.1 
  + 0 0 10 ± 5.1 35  ± 1.5 37  ± 1.6 42  ± 1.7 
 Total - 49 ± 2.6 50 ± 0.4 50 ± 0.7 47 ± 0.2 48 ± 0.4 44 ± 0.4 
  + 46 ± 0.5 48 ± 0.5 43 ± 2.0 42 ± 0.6 46 ± 0.7 53 ± 0.7 
V-2 Caffeic acid - 46 ± 3.0 44± 2.5 35 ± 1.8 0 0 0 
  + 48 ± 3.3 48 ± 0.5 32 ± 2.5 0 0 0 
 Phenylacetic acid - 0.4 ± 0.0 0.8 ± 0.0 1.5 ± 0.1 14 ± 5.6 18 ± 0.9 21 ± 0.5 
  + 0.5 ± 0.0 1.0± 0.0 1.5 ± 0.1 3.9 ± 0.3 5.4 ± 0.2 6.8 ± 0.4 
 3-(3-hydroxyphenyl)propionic 
acid 
- 0 0 0 3.0 ± 0.1 20 ± 3.6 32 ± 6.7 
  + 0.2± 0.2 0.3 ± 0.3 0.6 ± 0.5 1.6 ± 1.2 2.0 ± 1.7 2.6 ± 2.1 
 Dihydrocaffeic acid - 0 0.3 ± 0.0 3.9 ± 0.2 25± 8.2 8.6 ± 0.1 0 
  + 0 2.7 ± 0.0 13 ± 0.3 45± 7.5 37 ± 2.9 32 ± 0.7 
 Total - 46 ± 1.3 45 ± 1.1 41 ± 0.7 41 ± 3.6 46 ± 0.5 53 ± 1.2 
  + 50± 1.4 52 ± 2.1 47 ± 0.2 51 ± 3.1 44± 1.2 41 ± 0.8 
V-3 Caffeic acid - 52 ± 5.5 50 ± 8.9 47 ± 5.7 25 ± 4.8 0.8 ± 0.1 0 
  + 48 ± 0.9 42 ± 7.8 32 ± 0.7 7.9 ± 1.1 1.4 ± 0.1 0 
 Phenylacetic acid - 0 1.0 ± 0.2 1.6 ± 0.1 4.1 ± 0.6 6.7 ± 1.7 13 ± 0.9 
  + 0.4 ± 0.0 0.8 ± 0.0 1.5 ± 0.1 1.1 ± 0.9 4.1 ± 0.2 5.4 ± 0.5 
 3-(3-hydroxyphenyl)propionic 
acid 
- 0 0 0 0.6 ± 0.0 13 ± 5.0 15 ± 5.0 
  + 0 0 2.4  ± 0.8 5.2 ± 0.9 9.8 ± 1.6 7.0 ± 0.5 
 Dihydrocaffeic acid - 0 0 0 21 ± 5.8 26  ± 3.4 24 ± 1.8 
  + 0 0.3 ± 0.0 6.9 ± 0.3 29 ± 1.1 31 ± 0.6 30 ± 1.4 
 Total - 52 ± 2.4 51 ± 3.8 50 ± 2.5 51 ± 2.5 46 ± 1.8 52 ± 1.9 
  + 47 ± 0.4 43 ± 3.4 43 ± 0.3 43 ± 0.1 46 ± 0.6 42 ± 0.5 
V-4 Caffeic acid - 47 ± 1.8  44 ± 1.5 23 ± 0.7 9.9 ± 0 0 0 
  + 49 ± 2.1  38 ± 0.3 34 ± 1.5 0 0 0 
 Phenylacetic acid - 0 5.9 ± 0 2.5 ± 0.3 1.5 ± 0.0 5.1 ± 0.3 11 ± 0.9 
  + 0.4 ± 0.0 0.8 ± 0 2.8 ± 1.8 6.7 ± 5.5 14 ± 1.0 14 ± 0.3 
 3-(3-hydroxyphenyl)propionic 
acid 
- 0 0 0.1 ± 0.0 0.1 ± 0.0 2.6 ± 0.2 14 ± 0.8 
  + 0 0 1.2 ± 1.5 2.1 ± 1.5 1.3 ± 1.0 1.8 ± 2.0 
 Dihydrocaffeic acid - 0 0 17 ± 1.2 30 ± 0.7 33 ± 2.0 24 ± 2.6 
  + 0 0.4 ± 0.0 13 ± 1.0 44 ± 2.7 35 ± 1.6 27 ± 4.3 
 Total - 47 ± 0.8 50 ± 0.6 43 ± 0.4 41 ± 0.3 40 ± 0.8 49 ± 0.9 
  + 50 ± 0.9 39 ± 0.1 51 ± 0.2 52 ± 1.7 49 ± 0.6 43 ± 1.7 
V-5 Caffeic acid -  43 ± 2.1  43 ± 1.8 24 ± 5.9 9.4 ± 0.5 5.7 ± 1.1 0 
  +  51 ± 0.7  43 ± 3.2 40 ± 0.4 9.0 ± 0.5 1.2 ± 0.4 0 
 Phenylacetic acid - 0 0.2 ± 0.1 0.4 ± 0.2 1.2 ± 0.1 1.0 ± 0.1 1.3 ± 0.4 
  + 1.1 ± 0.3 1.8 ± 0.1 0.9 ± 0.1 4.6 ± 1.1 4.2 ± 2.9 3.1 ± 2.1 
 3-(3-hydroxyphenyl)propionic 
acid 
- 0 0 0 1.4 ± 0.5 2.8 ± 0.8 9.0 ± 0.8 
  + 0 0 0 0 2.8 ± 0.3 6.6 ± 1.1 
 Dihydrocaffeic acid - 0 0   23 ± 11 32 ± 6.0 33  ± 12 37 ± 11 
  + 0 0 6.5 ± 0.7 27 ± 1.3 37 ± 4.7 31 ± 4.2 
 Total - 43 ± 0.9 43 ± 0.8 48 ± 4.6 44± 2.6 42 ± 5.0 47 ± 4.6 
  + 52 ± 0.3 45 ± 1.4 48 ± 0.3 41± 0.5 46 ± 1.8 42 ± 1.5 
Table 4. 2  Degradation of caffeic acid (55 µmoles) and formation of catabolites in human faecal slurries. Data are 
expressed as µmoles ± standard error ; (+) incubated with 0.5 g glucose, (-) incubated without glucose. 
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Figure 4. 4 Formation of 3HPPA (3-(3-hydroxyphenyl)propionic acid), phenylacetic acid, and dihydrocaffeic acid during incubation of caffeic acid ( 55 
µmoles) with human faecal slurries.
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4.4 Discussion 
Caffeic acid is a common dietary component found in a large range of plant-
derived food products. The C6-C3 hydroxycinnamate is reported to have potential 
health effects with in vitro chemoprotective, antioxidant, and anti-inflammatory 
properties (Natella et al., 1999; Karlsson et al., 2005). For these events to occur 
in vivo, caffeic acid must be readily bioavailable. Studies on the bioavailability 
of hydroxycinnamates suggest that they are absorbed in both the small and large 
intestine with the colonic microflora playing a key role. In the present study, the 
microbial metabolism of caffeic acid (3,4-dihydroxycinnamic acid) was 
investigated using an in vitro fermentation model of human faecal samples 
obtained from Asian volunteers. 
In vitro fermentation to study the colonic metabolism has been used by 
many researchers with the number of samples collected varying, as seen in the 
study of colonic degradation of rutin and green flavan-3-ols  (Jaganath et al., 
2009; Roowi et al., 2010) with only three donors, while in another study used 
four donors (Aura et al., 2005). Though the sample size were small, statistical 
analyses showed that the subsequent degradation of substract was dependent 
upon the interindividual composition of the colonic microflora and also the 
presence of glucose (Jaganath et al., 2009). 
 Earlier work on caffeic acid degradation by colonic microflora was 
studied by Gonthier (2006) using human faecal sample. 3-(3-
Hydroxyphenyl)propionic and benzoic acid were identified as the major 
catabolites produced by the colonic microflora. In the present study, the effect 
of of glucose supplement and bacteria composition upon caffeic acid 
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degradation was investigated using 55 µmoles of caffeic acid incubated with 
human faecal slurries obtained from 5 different individuals. A higher 
concentration of caffeic acid compared to 1 µmoles utilised by Gonthier (2006) 
was used to see if the concentration of the substrate could effect the production 
of the catabolites. 
Caffeic acid was shown to be rapidly degraded in vitro by the colonic 
microflora. This is shown by the reduced amount of caffeic acid recovered at 0 h 
in all faecal slurries samples although the amount detected was significantly 
different between individuals (p < 0.5). The effect of glucose supplemention was 
also studied and thus demonstrated that the caffeic acid degradation was 
enhanced with the addition of sugar to the faecal incubates with time point 
clearance 4 h while it was 6 h in that absence glucose.  
Incubation of caffeic acid (55 µmoles) into human faecal slurries resulted 
in the appearance of a number of catabolites namely phenylacetic acid, 3-(3-
hydroxyphenyl) propionic acid and dihydrocaffeic acid. Colonic bacteria 
potentially involved in such catabolism include Escherichia coli, Bifidobacterium 
lactis, and Lactobacillus gasseri (Couteau et al., 2001). 
In human faecal samples caffeic acid was rapidly reduced to form 
dihydrocaffeic acid and 3-(3-hydroxyphenyl)propionic acid, which in vivo, are 
absorbed via large intestine and converted to 3-hydroxyhippuric acid, 
presumably in the liver, prior to excretion in urine (Rechner et al., 2004). 
Dihydrocaffeic has been reported to be the major microbial transformation 
product of caffeic acid (Renouf et al., 2010). This supported by the current 
findings. 
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Free dihydrocaffeic acid has been detected in plasma and urine after 
coffee consumption (Goldstein et al., 1984), while the presence of  conjugated 
dihydrocaffeic acid has  been detected in human plasma after intake of 
artichoke leaf extracts (Wittemer et al., 2005). More recently Stalmach et al. 
(2009) detected dihydrocaffeic acid, and dihydrocaffeic acid-3-O-sulphate in 
plasma and dihydrocaffeic acid-3-O-sulphate and dihydrocaffeic acid-3-O-
glucuronide in urine after the consumption of a 5-CQA-rich coffee. These 
conjugates were not detected in the faecal incubations indicating that while the 
colonic bacteria produce dihydrocaffeic acid from caffeic acid, further phase II 
metabolism producing glucuronide and sulphate conjugates probably occurs in 
the wall of the colon and/or is hepatic in origin. Dihydrocaffeic acid which 
resulted from the microbial hydrogenation of the side chain of caffeic acid 
exerts antioxidant activity are similar to caffeic acid when tested using FRAP 
assay  (Lekse et al., 2001). Dihydrocaffeic acid unlike 5-CQA can enter 
erythrocytes that help to reduce the trans-membrane oxidant stress generated 
by extracellular ferricyanide (Poquet et al., 2008). The biological effects after 
the intake of green tea and chocolate may also due to  dihydrocaffeic acid as it 
is also a microbial metabolite of catechin and procyanidins (Cos et al., 2004; 
Cabrera et al., 2006). 
In a previous study (Chapter 3), ingestion of [3-14C]caffeic acid by rats 
resulted the excretion of radiolabeled caffeic acid-3-O-glucuronide, ferulic acid-
4-glucuronide, caffeic acid-4-O-sulphate, caffeic acid-3-sulphate, ferulic acid-
4-sulphate and isoferulic acid-3-O-sulphate in urine, with faeces containing of 
two unknown metabolites. In the in vitro study none of the above conjugated 
metabolites were found in human faecal samples indicating the role of the liver 
and/or wall of the colon as sites of sulfation and glucuronidation. Interestingly 
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the absence of ferulic acid and isoferulic acid catabolites in the in vitro study 
also indication that the colon and/or the liver, rather than that microbiota, are 
the potential site of methylation reactions catalysed by COMT. 
Reduction of the side chain of caffeic acid and dehydroxylation at the C4 
position of dihydrocaffeic acid results in the formation of 3-(3-hydroxyphenyl) 
propionic acid (Aura, 2008). 3-(3-Hydroxyphenyl)propionic acid is a known 
metabolite of colonic degradation of flavonols, flavan-3-ols, flavanones, and 
hydroxycinnamates (Gonthier et al., 2006; Serra et al., 2012), and has been  
proposed as the likely precursor of 3-hydroxyhippuric found in urine (Rechner et 
al., 2004).  
 Dehydroxylation, –oxidation and glycination in the liver will convert 3-
(3-hydroxyphenyl)propionic acid to the urinary metabolite hippuric acid 
(Rechner et al., 2004). Hippuric acid (N-benzoyl-glycine) a glycine conjugate of 
benzoic acid is primarily derived from plant phenolics and aromatic amino acids 
via bacterial transformation, however it is also synthesized from compounds 
such as benzoic acid, quinic acid, tryptophan, tyrosine and phenylalanine 
(Spencer, 2003). The liver is the active site for the formation of hippuric acid, 
which is why it was not produced by the faecal incubations in the present study.  
The dehydroxylation of 3-(3-hydroxyphenyl)propionic acid will produce 3-
phenylpropionic acid which is subject to -oxidization with the resultant 3-
phenylpropionic acid being converted to benzoic acid (Peppercorn and Goldman, 
1971; Scheline, 1991). In vivo, benzoic acid is conjugated with glycine either in 
the liver and excreted as hippuric acid in urine (Olthof et al., 2003). In the 
present study there was only traces amount of 3-phenylpropionic acid which was 
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also presence in the control, indicating that this is not solely a product of caffeic 
acid catabolism, whereas only traces of benzoic acid were detected in the faecal 
samples of some volunteers. The results obtained thus support the operation of 
the proposed catabolic pathway illustrated in the Figure 4.5. 
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Figure 4. 5 Proposed scheme of colonic degradation of caffeic acid in humans. 
 
However in a previous study, benzoic acid and 3(3-hydroxyphenyl)propionic 
were the main catabolites detected when 1 µmol of caffeic acid was incubated 
with human faecal samples (Gonthier et al., 2006). In this study caffeic acid was 
cleared after 2 h of incubation. The differences observed could be due to the 
high amount of 55 µmoles caffeic acid used in the present study where the 
earliest clearance of caffeic acid was observed at 4 h of incubation (V-1, V-2 and 
V-4). The different amount of faecal material used between these studies in 
which resulted in a different density of colonic microflora, could also be the 
reason for these variations. 
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 The rate of caffeic acid degradation and catabolites produced also varied 
among individuals, and thus may reflect the individual variations in intestinal 
bacterial colonization (Meijer-Severs and van Santen, 1986). It has been 
proposed there is a high degree of complexity of bacteria species among human 
individuals that is determined by the diet, which  supplies nutrients not only to 
the host but also to the intestinal bacteria (Blaut and Clavel, 2007). In the 
present study all volunteers were of Asian origin, which should have reduced the 
variations. Their diet is different from the typical western diet. Thus raises 
other questions as to whether diet and ethnicity could have some affect on the 
colonic microbial population.  
In vitro fermentation was used to assess the colonic metabolism of caffeic 
acid, which aimed to mimic the events occurring in the human colon. It has been 
used by other researchers to investigate the fate of flavonoids catabolised by the 
colonic microbial (Peppercorn and Goldman, 1971; Rechner et al., 2004; Aura, 
2008). However in many cases, the experimental approach used were varied in 
terms of its inoculums size, type of media, anaerobic conditions, choice of 
buffer and mixing rate in which could affect the bacterial ecotypes that 
resulting the catabolism of flavonoids (Edwards et al., 1996). The advantage of 
using this in vitro model to elucidate the pathway of the degradation of caffeic 
acid, is that it can be determined in a reliable and affordable manner (Edwards 
et al., 1996). It must be noted that this in vitro model may not fully depict the 
in vivo conditions, where the concentration of catabolites produced is based on 
the combination of catabolism and absorption which cannot be induced in vitro. 
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4.5 Conclusions 
In summary, the rate and extent of in vitro caffeic acid degradation varied 
somewhat in the faecal samples provided by the five volunteers. It was clearly 
observed that dihydrocaffeic is the main catabolite of caffeic acid with its 
formation being enhanced by the addition glucose. The glucose supplement also 
affected the formation of phenylacetic acid and 3-(3′-hydroxyphenyl) propionic 
acid but the extent to which this occurred varied between individuals. 
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5 SUMMARY 
 
Dietary (poly)phenols are naturally occurring compounds widely distributed 
in higher plants, such as in fruits and vegetables, and a number of derived  
products such as fruit juices, tea, coffee and chocolate. (Poly)phenols are the 
most abundant antioxidants in the human diet and are of interest due to their 
potential beneficial effects on human health. 
In the first series of analyses presented in the thesis, a study was carried 
out with herbal medicinal plant, Ficus deltoidea from Malaysia. This plant is 
locally known as ‘Mas cotek’ and its phytochemical contents antioxidant activity 
were discussed in Chapter 2. Flavones, flavan-3-ols and a single of p-
coumaroylquinic acid, a hydroxycinnamic acid, are groups of flavonoids and non-
flavonoid compound detected in the aqueous extract of F. deltoidea. The herbal 
product derived from this plant has been claimed to possess therauptic effects.  
With the exception of a protective impact on the gastrointestinal tract, 
dietary (poly)phenols must be absorbed before any reported beneficial effects 
can take place. The absorption, distribution, metabolism and excretion (ADME) 
is an important area in determining the effect of consumed (poly)phenols in 
human health. In an attempt to obtain more information about ADME, a study 
has been conducted with rats into the bioavailability of caffeic acid which is a 
hydroxycinnamate related to p-coumaroylquinic acid which was found to occur 
in Ficus deltoidea. The study was designed toinvestigate fate of the 
hydroxycinnamate by feeding a radiolabeled substrate, [3-14C]caffeic acid, after 
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which at a number of time points various tissues, organs, urine, faeces and cages 
washing were collected and analysed as described in Chapter 3. 
Previous studies have demonstrated that not all consumed (poly)phenol 
compounds are absorbed directly into the circulation from the small intestine 
and are readily bioavailable. In such circumstances, substantial quantities of the 
compounds ingested will reach the colon. In the colon they will undergo 
transformation by microbiota with some of the resultant catabolites being 
absorbed and released into the circulatory system. The important role of the 
colonic microflora was investigated in a study described in the last chapter of 
this thesis, Chapter 4.  In this study, the catabolism of caffeic acid by the 
colonic microbiota was studied using human faecal slurries obtained from five 
Asian donors.   
5.1 Phytochemical analysis of F. deltoidea extract and its 
antioxidant properties 
   
The use of medicinal plants for prevention and treatment of various 
diseases has been documented since ancient times. In modern medicine many 
drugs developed are of natural origin, which can be categorized as original 
natural products, products derived semi-synthetically from natural products, or 
synthetic products based on natural product models (Cragg et al., 1997). It has 
been reported that at least 119 compounds derived from 90 plant species are 
considered important drugs have been used in one or more countries, with 77% 
of these plant-derived products being used in traditional medicine (Farnsworth 
et al., 1985). 
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In Malaysia the use of herbal medicinal plants is linked with traditional 
medicines that are still being used by the major ethnic communities (Chen, 
1981). However, the information about traditional medicines and their uses are 
not fully documented thus leaving a huge gap in gathering the information on 
their potential beneficial effects. Chapter 2 has described the analysis of the 
phytochemical content of F. deltoidea a Malaysian medicinal plant. This plant 
was chosen because its popularity in Malaysia where it is used by the traditional 
practitioner for healing and prevention of several diseases with some of its 
products already being marketed commercially. In the present study, aqueous 
extract of F. deltoidea was analysed for their flavonoid contents and antioxidant 
activity. The identification and quantification of its phytochemicals was made 
feasible with the use of HPLC-ESI-MS2 and HPLC coupled with ABTS online 
detection which enable the quantification of individual compound that 
contribute to antioxidant activity. In Malaysia, F. deltoidea is usually prepared 
from leaves and consumed as herbal tea. Other parts of the plant such as fruit, 
stem and roots are however also used as the basis for herbal preparations. These 
extracts are among many herbal medicinal plants that have been used by the 
traditional practitioners for the treatment of diseases such as diabetes, 
rheumatism and breast cancer. Although it has been claimed by traditional 
practitioner that this F. deltoidea extracts have a potential beneficial effects on 
several aspects of human health, there is a lack of scientific evidence to support 
the claims. 
 Therefore the underlying objectives in Chapter 2 were to investigate, 
identify and quantify the phenolic compounds presence in F. deltoidea aqueous 
extract as a baseline for a standardized Ficus extract. The phytochemical profile 
is of importance for herbal drug standardization since it has a direct bearing on 
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the activity and the quality of the herbal potions (Nikam et al., 2012). Total 
phenolic contents and their antioxidant activities were also evaluated. Based on 
the results obtained it was demonstrated that F. deltoidea tea contains high 
levels of flavonoids mainly flavones and flavan-3-ols. The principal flavan-3-ols 
identified were gallocatechin, epigallocatechin, catechin and epicatechin, which 
were presence in high amount (44 to 98 µM) in the aqueous infusion (10 mg/mL). 
The high concentration of flavan-3-ols found in the extract is comparable to 
those reported in the fruit juices (Mullen et al., 2007) and tea (Chan et al., 
2007; Fan et al., 2007). In addition, the Ficus extract also contained five 
oligomers of proanthocyanidins consisting of (epi)catechin and (epi)afzelechin 
sub-units which are considered unusual and  have not been reported in other 
Ficus species. Overall, these flavan-3-ols accumulated in the tea in 
concentrations of ~400 µM. Flavones were also found in the aqueous infusion in 
the forms of luteolin and apigenin glucosides. In addition to this, 4-p-
coumarylquinic acid at a concentration of 139 µM was identified. There was an 
absence of other chlorogenic acids which is unusual (Clifford et al., 2003). In 
terms of the antioxidant activity of the Ficus tea, flavan-3-ols were the main 
contributor. 
 
 The findings of the study have established that flavan-3-ols and flavones 
as the main flavonoids found in the tea that can be used as reference for the 
standardization extract of various Ficus products. These flavonoids which 
exhibited high antioxidant activities may be the basis of the potential health 
effects of Ficus products. Further study should be carried out, particularly in 
terms of their safety and efficacy before human intervention study can take 
place. 
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5.2 The bioavailability of [3-14C]caffeic acid in rats 
Caffeic acid is hydroxycinnamic compound, normally esterified with quinic 
acid to form chlorogenic acid with high concentration found in coffee (Clifford 
2004). Apart from being antioxidant agents, caffeic acid has exhibited 
anticancer and antimutagenic activities, antidiabetic effect in streptozocin-
induced in diabetic rats and antihyperglycemia properties in mice (Hsu et al., 
2000; Jung et al., 2006; Weng et al., 2012). It has been shown that the 
absorption of hydroxycinnamic acid occurs throughout the gastrointestinal tract, 
with findings indicated that caffeic acid is more readily available than its 
conjugated that chlorogenic derivative caffeic acid ((Olthof et al., 2001; Konishi 
et al., 2006; Lafay et al., 2006b). 
 
This second study, discussed in Chapter 3, investigated the bioavailability 
of caffeic acid using the rat as an animal model. This study was carried out using 
[3-14C]caffeic acid. After supplementation, samples were collected from various 
organs and body fluids were analysed using HPLC-ESI-MS2 coupled to a 
radioactive detector. Monitoring the metabolism of caffeic acid was made 
feasible with the use of a radiolabeled substrate in which all derivatives and by-
product produced derived from caffeic acid metabolism can easily be 
discriminated.  
 
It was found that feeding rats with radiolabeled caffeic acid resulted in 
some transformation of the parent trans-caffeic acid into cis-caffeic acid in the 
stomach within 1 h, with movement to duodenum and ileum/jejunum also taking 
place. At this time point, small amounts of radioactivity were detected in the 
plasma indicating early absorption of caffeic acid into the circulatory system. 
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However the identification of metabolites in the plasma was not possible 
because low levels of radioactivity accumulated. Urine collected 0-1 h, after 
feeding contained metabolites thereby providing evidence of caffeic acid 
absorption in the proximal GI tract, despite the low level accumulation in 
plasma. These metabolites were caffeic acid-3 and -4-O-glucuronides, caffeic 
acid-3 and -4-sulphates, ferulic acid-4-O-glucuronide and-4-sulphate, and 
smaller amounts of isoferulic acid-3-O-sulphate. These metabolites reflect 
phase II metabolism of caffeic acid possibly in the intestinal epithelium or the 
liver. Urine collected from 0-6 h revealed sulphates as the main 
hydroxycinnamate metabolites. In this context caffeic acid is similarly 
metabolised in humans. It is not possible to determine the extent to which 
sulfation occurs in the wall of the small intestine and the colon, or in the liver. 
The study also demonstrated urine as the main route of caffeic acid metabolite 
excretion, with 48-68% of radioactivity recovered in urine, compared with 19-
25% found in rat faeces collected over a 24 h period. The high urinary excretion 
and the comparatively low level radioactivity found in faeces are evidence of 
the rapid absorption and high bioavailability of caffeic acid. Results observed in 
this study are in keeping with the previous study with unlabeled caffeic acid by 
Gonthier et al.(2006) who concluded that free caffeic acid was more efficiently 
absorbed that its esterified form. The present study also established that caffeic 
acid metabolism comprised methylation, sulphation, and glucuronidation steps 
via routes that are similar, although not identical with those found in humans 
(Stalmach et al., 2009; Stalmach et al., 2010a). 
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5.3 Caffeic acid metabolism by colonic microflora 
(Polyp)henols have attracted considerable interest due to their numerous 
beneficial effects toward human healths. These (poly)phenols are abundant in 
numerous plants but many of them are not readily bioaccesible in the small 
intestine and therefore pass to the colon. This is supported by the feeding 
studies iloestomists, which showed that only one third of the ingested 
chlorogenic acids can be absorbed in the upper gastrointestinal tract, with rest 
remainder moving to the colon to be hydrolyzed by bacteria releasing free 
caffeic  and quinic acids (Chesson et al., 1999; Couteau et al., 2001; Gonthier et 
al., 2003b).  
The colon is the active site of microbiota activities which result in 
dehydroxylation, demethylation, dehydrogenation, glycination, and 
hydrogenation to form several catabolites such as 3,4-dihydroxyphenylpropionic 
acid, 3-methoxy-4-hydroxyphenylpropionic acid, 3- and 4-
hydroxyphenylpropionic acid, 3-and 4-hydroxyphenylacetic acid, 3,4-
dihydroxyphenylacetic acid, 3-methoxy-4-hydroxyphenylacetic acid, 3- and 4- 
hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 3-methoxy-4-hydroxybenzoic 
acid, 3-hydroxycinnamic acid (m-coumaric acid), hippuric acid and 3-
hydroxyhippuric acid (Choudhury et al., 1999; Gonthier et al., 2003b; Olthof et 
al., 2003; Gonthier et al., 2006). 
The colon is rich in nutrients providing a non-hostile anaerobic environment 
that is suitable for microbial colonization. Thanks to recent advances in 
microbial ecology, immunology and metabolomics the role of these colonic 
microbes in the overall well being of the host have been highlighted. The colonic 
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bacteria develop mutual relationship with the host, and in return for the food 
supply and protected environment provided by the host, colonic microbiota help 
in maintaining host nutrition, immune modulation, pathogen colonization 
resistance, intestinal epithelial development and activity, and energy 
metabolism (Hooper et al., 2002; Bäckhed et al., 2004). The vital role of colonic 
bacteria to the host system has been revealed  by results obtained from the 
studies in germ-free animals which shown interference in cells functionality; 
reduction in cytokine production and mucosal cell turnover, underdeveloped 
mucosal associated lymphoid tissue and malfunctioning of the cell mediated 
immunity (Falk et al., 1998; Mazmanian and Kasper, 2006). The intestinal 
ecosystem is build by the interaction between its microbes, epithelium, mucosal 
immune system, microvasculature, and enteric nervous system. Between them 
there is cell signalling to ensure the system is kept in harmony, any disturbance 
could result a chronic and physiological inflammation (Clavel and Haller, 2007; 
Peterson et al., 2007; Liu et al., 2008).  
Microflora or microbiota refers to the collection of microbes colonizing a 
particular host niche, whereas microbiome refers to all the genes embedded in 
the genomes of species represented in microbiota (Hooper and Gordon, 2001). 
The microbial  densities are low in the proximal and middle small intestine but 
become very dense in the colon (10 11-1012/g) (Savage, 1986). In humans, these 
microbial are mainly anaerobic such as bifidobacteria, lactobacilli and 
bacteroides (Meijer-Severs and van Santen, 1986), with those that appear to 
participate in phenolic metabolism being Bacteroides, Clostridium, Eubacterium, 
Ruminococcus, and Eggertheilla (Blaut and Clavel, 2007). Therefore, the colon is 
an active site for (poly)phenol catabolism with biotransformation into simple 
phenols, phenolic acids, aromatics, and lactones (Aura, 2008; Selma et al., 
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2009). Catabolites produced in the colon can be excreted in faeces but can also 
be absorbed into the enterocytes via passive diffusion and further metabolized 
in the liver by phase II enzymes, prior to re-entering to the circulation system 
and elimination in urine.  
Dietary (poly)phenols are known to be an important factor in modulating 
immunocompetence of an individual, therefore understanding the role of the 
diet in relation to colonic microflora is essential when promoting functional 
foods or nutritional foods with supposed beneficial effects on human health. To 
understand the effect of that colonic microflora on the catabolism of 
(poly)phenols, studies were conducted using caffeic acid, a prominent compound 
of hydroxycinnamic acids. Caffeic acid is widely found in vegetables, fruits, tea, 
coffee, and wine. Despite the high intake of this compound in human diet the 
information regarding its metabolism is still scarce. In Chapter 4, the breakdown 
of the hydroxycinnamic acid by human microbiota was investigated in vitro by 
incubating 55 µmoles of caffeic acid with human faecal slurries obtained from 
five Asian donors. No radiolabeled caffeic acid remained so the study was 
carried out using unlabeled substrate with catabolites being analysed by gas 
chromatography–mass spectrometry (GC-MS). This GC-methodology, despite  
requiring TMSi derivatization, is better suited to the analysis of phenolic and 
aromatic catabolites that our HPLC-MS instrumentation as a consequences of 
poor ionisation of the free acids ( a nchez-Pata n et al., 2011). 
From results obtained, it can be concluded that caffeic acid catabolism by 
colonic microflora is very much dependent on two main factors. First is the 
composition and density of the colonic microflora. Inter-individual differences in 
terms of bacteria composition have resulted in different amounts of catabolites 
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produced and variations in the time of their formation. Caffeic acid catabolism 
by colonic microflora resulted the production of three main catabolites, 
identified as dihydrocaffeic acid, 3-(3-hydroxyphenyl)propionic acid and 
phenylacetic acid. Although the main catabolites produced were the same in all 
faecal samples, there were quantative variations in the amounts produced. For 
example, dihydrocaffeic acid which is the main caffeic acid catabolite and 
formed in all individuals. The earliest formation of dihydrocaffeic acid was 
detected at 1 h in faecal samples from V-2, V-3 and V-4, but it only appeared at 
2 h from samples of V-1 and V-5. Beside the time differences in the formation of 
dihydrocaffeic acid, the quantity produced also varied with faecal samples from 
different individuals. These inter-individual variations were observed in terms of 
the catabolites produced, presumably due to differences in microflora 
composition. Variable densities of colonic microflora have be reported with 
Lactobacillus and Bifidobacterium sub-populations between and within adult 
individuals (McCartney et al., 1996). It has also been suggested that the 
difference in the microbial ecology may be prompted by an Asian diet. This is 
suggested due to the fact that intestinal tract is sterile at birth and it is only 
during postnatal development that the human microbial ecology will undergo 
dramatic changes (Isolauri, 2012). The microbial ecology may be influenced, by 
the human diets, as it has been proposed that Western diets may contribute to 
environmental changes in colonic microbiota that affect energy storage and 
obesity (Bäckhed et al., 2004). 
  Glucose supplement was a second factor that influenced the formation of 
caffeic acid catabolites. The addition of glucose to the medium in this study was 
important to mimic in vivo conditions which reflect the dietary fiber intake. 
Glucose is required as an energy source, to stimulate the growth and the 
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production of bacteria (Edwards et al., 1996). In the presence of glucose, the 
colonic microflora catabolism of caffeic acid catabolism moved towards the 
production of dihydrocaffeic acid and 3-(3-hydroxyphenyl)propionic acid, 
whereas without glucose more dihydrocaffeic acid was produced along with 
phenylacetic acid. After 4 h incubation in the presence of glucose no caffeic acid 
remained in two faecal samples from two volunteers (V-1 and V-4). The effect of 
glucose addition was also reported by Jaganath et al.(2009) in which glucose 
enhanced deglycosylation of rutin to quercetin. 
5.4 Future research 
Phytochemical analysis of F. deltoidea lead to the identification of 
potentially bioactive flavonoid compounds in this herbal medicinal plant. As a 
consequence, further study in terms of its bioavailability should be conducted. 
This study is essential, as it can provide more information of absorption and 
metabolism of different groups of flavonoids that occur in the herbal tea. Prior 
to that, toxicological studies are required in terms of its safety and efficacy 
before human intervention study can be conducted. With more information at 
hand, it is possible that one day Ficus products can be further targeted for drug 
development or at least could be recognize as a beverage for health as seen in 
tea and coffee. 
The bioavailability of caffeic acid has been investigated using rats fed 
with 14C-radiolabeled material. Although preparations of radiolabeled compound 
are laborious, difficult to achieved, the data obtained in the present study 
demonstrates the value of feeding radiolabeled substrate. The ready 
discrimination of the 14C-labeled metabolites produced allowed the ready 
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identification of caffeic acid-derived components. In rats, caffeic acid was not 
retained in the body and it was shown that after 72 h, ~80 % of ingested 
radioactivity had been excreted in urine. Perhaps in the future ethical 
permission can be obtained to feed radiolabeled caffeic acid and other 
compounds, with seemingly low bioavailability such flavones to humans.  
Human or animal intervention studies are important in the study of 
bioavailability of (poly)phenols. However, the additional use of in vitro 
gastrointestinal models is important as they can provide mechanistic knowledge 
regarding microbial (poly)phenol bioconversions. Metabolomic datasets from in 
vitro studies when linked with in-depth microbiome analyses offers the 
possibility of the discovery of new (poly)phenol metabolites metabolites with 
potential health-promoting effects. In addition they will also identify the 
particular microbial groups and species that are responsible for the 
biotransformation of (poly)phenols, which can be used to evaluate strategies 
that target the enrichment of (poly)phenol-converting species such as 
Clostridium orbiscidens and Eubacterium ramulus (Schoefer et al., 2003; Clavel 
et al., 2006). With more emerging technologies to come such as molecular 
approaches using ribosomal RNA (rRNA), high-throughput diversity approaches 
such as phylogenetic microarrays, quantitative technologies such as fluorescence 
in situ hybridization (FISH), and real-time quantitative PCR (RT-qPCR) will help 
in assessing more information regarding the of the microbiota species 
responsible for the (poly)phenol biotransformation in the colon (van Duynhoven 
et al., 2010). 
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  APPENDICES 
 Appendix 3.1 Dry weight (in gram) of tissues/ organ samples of rats after feeding with 14C-radiolabeled compound. n.a- samples were not 
available. Rats were divided into three groups A, B and C. Each group consisted of animal that were sacrificed at 1, 3,6,12, 24, 48 and 72 
h. 
 
Rat 
 Time  Liver Kidney  Brain  Heart  Lungs stomach Muscle Ceacum  Colon Spleen Duodenum Ileum/jej 
(group) (h)                         
A 1 2.65 1.90 1.51 0.83 0.99 2.20 2.67 0.62 0.66 0.15 0.62 0.95 
 
3 2.37 1.42 1.48 0.74 1.01 1.91 3.32 0.59 1.66 0.14 0.81 0.87 
 
6 2.61 1.70 1.06 0.83 0.93 1.37 3.51 0.85 1.06 0.15 0.82 0.93 
 
12 2.25 1.69 0.98 0.82 1.03 1.56 2.82 1.51 0.97 0.12 0.65 0.61 
 
24 2.43 1.51 1.39 0.82 1.04 2.05 3.52 0.51 0.60 0.12 0.71 0.69 
 
48 2.31 1.66 1.29 0.73 2.13 1.49 2.60 0.55 0.92 0.14 0.75 0.90 
  72 2.13 1.28 1.45 0.74 1.10 1.74 2.86 0.34 0.35 0.13 0.59 0.43 
B 1 2.28 1.80 1.46 0.86 1.09 1.60 3.49 0.66 0.98 0.14 0.77 1.08 
 
3 2.67 1.64 1.15 0.75 1.04 2.89 3.01 0.80 1.41 0.15 0.84 0.93 
 
6 2.40 1.88 1.31 0.79 1.33 2.41 3.33 0.63 1.04 0.17 0.76 0.89 
 
12 2.56 1.91 1.32 0.79 1.30 2.01 3.57 0.90 1.28 0.14 0.69 0.67 
 
24 2.98 1.60 1.41 0.87 2.10 2.17 2.94 0.51 0.68 0.12 0.54 0.96 
 
48 2.31 1.62 1.48 0.70 1.02 1.56 3.32 0.83 1.55 0.14 0.70 0.71 
  72 2.14 1.75 1.20 0.75 1.24 1.67 3.78 0.62 0.64 0.15 0.65 0.57 
C 1 2.05 1.46 1.44 0.71 0.80 3.17 4.26 0.89 1.56 0.17 0.83 1.06 
 
3 2.15 1.64 1.41 0.76 0.99 1.88 1.23 1.24 1.75 0.13 0.74 0.89 
 
6 2.92 1.68 1.49 0.89 0.97 1.91 1.96 0.74 1.24 0.19 0.81 0.84 
 
12 2.44 1.77 1.47 0.73 2.59 1.87 1.31 0.37 0.77 0.12 0.66 0.71 
 
24 2.57 1.71 1.47 0.78 1.10 1.50 2.51 0.43 n.a 0.15 0.62 0.64 
 
48 2.29 1.70 1.33 2.05 0.91 2.47 2.51 1.13 n.a 0.19 0.59 0.68 
  72 2.22 1.56 1.36 0.76 0.00 2.53 3.08 0.48 0.31 0.14 0.72 0.71 
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Appendix 3.2 Total volume of liquid samples (mL) and faeces (g) collected from rats after 
feeding with 14C-radiolabeled. n.a- samples were not available. Rats were divided into three 
groups A, B and C. Each group consisted of animal that were sacrificed at 1, 3,6,12, 24, 48 
and 72 h. 
 
Rat Time  Urine  Time Cages RBC Plasma Time Faeces  
Group (h)  mL  (h) washing mL mL (h) (g) 
A 1  n.a  1 31.6 0.5 2 1  n.a  
  3           1.8  3 37.5 4.0 3 3  n.a  
  6           1.5  6 36.5 3.6 3 6  n.a  
  12           3.1  12 42.5 4.0 3.8 12  n.a  
  24           8.9  24 26.0 4.2 4.2 24 1.56 
  48(0-24)           6.3  48 31.5 5.0 3 48(0-24) 2.59 
  48 (24-48)         14.4  72 26.0 4.2 3.5 48(24-48) 1.83 
  72(0-24)         10.6      
 
  72(0-24) 3.12 
  72 (24-48)           4.5      
 
  72 (24-48) 0.24 
  72 (48-72)           1.4          72(48-72) 0.10 
B 1            -    1 32.5 5.7 5.3 1  n.a  
  3           1.4  3 40.0 4.7 4.2 3  n.a  
  6           2.6  6 41.8 3.6 3.3 6  n.a  
  12           2.7  12 33.0 4.8 3.8 12  n.a  
  24         12.3  24 27.0 3.0 3 24 0.58 
  48(0-24)           5.9  48 30.0 3.2 4.4 48(0-24) 1.86 
  48 (24-48)         10.4  72 31.5 2.2 2.2 48(24-48) 1.45 
  72(0-24)            -        
 
  72(0-24) 2.84 
  72 (24-48)            -        
 
  72 (24-48) 1.56 
  72 (48-72)           5.4          72(48-72) 1.92 
C 1            -    1 19.0 2.3 2.3 1  n.a  
  3           0.7  3 32.5 4.0 3 3  n.a  
  6           2.2  6 26.5 2.9 3.3 6  n.a  
  12           1.4  12 42.5 4.2 3.8 12  n.a  
  24           4.3  24 30.0 2.0 2 24 1.98 
  48/0-24           3.9  48 48.0 3.6 4 48(0-24) 1.12 
  24-48           5.1  72 29.5 4.0 3.2 48(24-48) 1.30 
  72/0-24           3.5      
 
  72(0-24) 2.92 
  24-48           5.0      
 
  72 (24-48) 3.73 
  48-72           4.9          72(48-72) 1.23 
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Title of study 
 
 
Invitation to take part 
Thank you for reading this. 
You are being invited to take part in a research study.  Before you decide it is important for you 
to understand why the research is being done and what it will involve.  Please take time to read 
the following information carefully and discuss it with others if you wish.  Please ask us if there 
is anything that is not clear or if you would like more information.  Take time to decide whether 
or not you wish to take part 
 
What is the purpose of the study? 
In previous study, the bioavailability of caffeic acid in rats was investigated using Caffeic acid 
which helps to determine the possible pathway for the caffeic acid using animal model. 
Therefore this study will help to monitor the degradation products of dietary flavonoids and 
caffeic acid and to delineate the possible catabolic pathways involved in the degradation of 
caffeic acid. 
 
Why have I been chosen? 
You are: 
i) a healthy individual, aged 18-60, not obese, non-smoker, in good general health, not taking 
any supplement or medication 
ii) you do not suffer from any allergy or condition affecting bowel health 
 
Do I have to take part? 
If you do decide to take part you will be given this information sheet to keep and will be asked 
to sign a consent form.  If you decide to take part you are still free to withdraw at any time and 
without giving a reason.  A decision to withdraw at any time, or a decision not to take part, will 
not affect the standard of care you receive. 
 
What will happen to me if I take part? 
You will meet a member of the Research Team from the University of Glasgow who will 
explain the study at a convenient time.  All transport costs as well as costs associated to the 
study will be reimbursed, but we cannot offer any fees.  
 
What do I have to do? 
You will be invited to follow low polyphenol diet for two days (48 h).  Diet sheets will be 
provided, and you will also be given a telephone number, to be able to call a member of the 
Research Team with any queries.  You will be asked to tell us if you think you may have slipped 
up with any of the dietary advice.  
Example of a typical intervention 
Day 1    8 am    Start of the low phenolic diet (see examples) 
 
Day 2   8 am  (24 hr)      Low phenolic diet 
 
Day 3   8 am (48h)  Return in the morning with feces sample 
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The diet involves foods with low polyphenol content, such as meats, fish, pasta, bread (but 
avoiding tea, coffee, colourful fruits and vegetables). During this period, you will be asked to 
keep a dietary intake record. 
You will be asked to record any possible slip-ups (e.g. eating high polyphenol foods by mistake 
during the low-polyphenol diet).  It is very easy to make mistakes, but vital that we know in 
order to get reliable results.   
At the end of the diet (after 48 h of low polyphenol diet) a faecal sample will be collected. The 
faecal sample should be collected in a special pot provided together with anaerobic pouch to 
keep the sample in anaerobic condition and send on the morning of day 3. 
 
What are the possible disadvantages and risks of taking part? 
There are no risks or disadvantages associated with this study other than time loss and 
inconvenience of following dietary restrictions. 
 
What are the possible benefits of taking part? 
There are no direct benefits to the volunteers associated with taking part. This study will provide 
us with a better understanding of the association between polyphenol-rich food consumption and 
colonic health. All participants who completed the study will be compensated (£30). 
 
Will my taking part in this study be kept confidential? 
All information which is collected about you during the course of the research will be kept 
strictly confidential.  Any information about you which leaves the hospital/university will have 
your name and address removed so that you cannot be recognised from it. 
 
What will happen to the results of the research study? 
Results will be presented at meetings of learned societies and published in scientific journals. 
Results will also be included in student project reports, when applicable. We will arrange a 
meeting to discuss the results with participant volunteers if they would like that. 
 
Who is organising and funding the research? 
This project is being organised by the Plant Product and Human Nutrition Group, at the 
University of Glasgow.   
 
Who has reviewed the study? 
This project has been reviewed by the University of Glasgow, Faculty of Medicine, ethics 
committee. 
 
Contact for further information 
If you require further information please contact  
Thank you for reading this information sheet 
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CONSENT FORM 
 
Title of Project:  
 
Name of Researcher: 
 
 
1. I confirm that I have read and understand the information sheet dated. ..........  
(version............ ) for the above study and have had the opportunity to ask questions. 
 
 
1. I confirm that I do not suffer from allergies to foods involved in this study. 
 
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time , without giving any reason, without my legal rights  
        being affected. 
 
 
3. I agree to my samples (urine and faecal samples) being stored and used for further 
analysis to look at biochemical compounds and bacteria, as new techniques are being 
available 
 
 
 
5.    I agree to take part in the above study.       
 
 
 
           
Name of subject Date Signature 
 
 
 
   
Researcher Date Signature 
 
1 for subject; 1 for researcher 
Centre Number: 
 
 
Study Number: 
Subject Identification Number for this trial 
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Dietary guidelines for lowpolyphenol diet, Baseline diet: 
 
Avoid all fruits, vegetables, onions, coffee, tea, chocolate, fruit juices, soft drink (i.e. irn brun, coca 
cola), alcohol, vanilla and similar flavourings, wholemeal products, spices (i.e. curry), tomato sauce, 
and beans (i.e. lentils, green beans, peas). Avoid all dietary supplements (vitamins, mineral, and herbal 
products). 
Examples of suitable breakfast include: 
Eggs 
Cheeses  
Sausage  
Beacon 
Fish  
Toast 
Bread  
Croissant (NO chocolate) 
Waffles, pancakes with butter and sugar (NO jam) 
Butter 
Milk 
Biscuits (NOT wholemeal) 
Rice based cereals (NOT Coco pops)  
Examples of suitable lunch & dinners include: 
Tuna, chicken and egg sandwiches (mayonnaise ok) 
Burger and chips (NO ketchup, relish, gherkins) 
Sausage rolls 
White pasta and cheese / cream  
Chicken / sausages and mashed potatoes (NO gravy) 
Omelette (with cheese, ham) 
Potatoes without skin 
Meats (NO ketchup, brown sauce) 
Cheese and cream cheese (NO garlic or onion-based cheeses) 
Fish and chips with salt and vinegar (NO ketchup) 
Sardines on white toast (no tomato sauce)  
Chicken fried rice with eggs and oyster sauce (NO soya products or vegetables 
Roast Chicken/ prawns with white rice 
Noodle  
Chicken nuggets and chips 
Roast Beef Sandwich with crisps 
Salmon with white rice 
Steak and mashed potatoes 
Examples of suitable snacks include: 
Biscuits (NOT wholemeal, chocolate, or fruit contains) 
Shortbreads 
Custard rice puddings 
Crisps (ready salted) 
Plain Frozen Yoghurt 
Cheese and crackers 
Plain donut without chocolate or fruit fillings 
Salted rice crackers, Rice cakes , Examples of suitable drinks include: Water and milk 
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DIETARY INTAKE RECORD 
During the day which you have to follow the diet described previously, we are going to 
ask you to record what you have been eaten at every meals. 
By asking you to record your daily diet (quantities do not have to be written down), this 
may be easier for you to choose and plan what you can eat, and this may also help you 
remembering that yo  are on a `special diet’. 
Please write down and food/drink consumed 
DAY 1- Date:_____________ 
Breakfast: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
................................. 
 
Lunch: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
................................................................................ 
 
Dinner: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
................................................................................ 
 
All-day snacks: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
............................................................................... 
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DAY 2- Date:_______________ 
Breakfast: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
................................. 
 
Lunch: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
................................................................................ 
 
Dinner: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
................................................................................ 
 
All-day snacks: 
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
.........................................................................................................
............................................................................... 
 
 
 
 
 
